
<html lang="en"     class="pb-page"  data-request-id="952b5161-54e1-4200-91bb-6374c42ff0a0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2015.58.issue-21;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.5b01275;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies" /></meta><meta name="dc.Creator" content="Matthew T.  Burger" /></meta><meta name="dc.Creator" content="Gisele  Nishiguchi" /></meta><meta name="dc.Creator" content="Wooseok  Han" /></meta><meta name="dc.Creator" content="Jiong  Lan" /></meta><meta name="dc.Creator" content="Robert  Simmons" /></meta><meta name="dc.Creator" content="Gordana  Atallah" /></meta><meta name="dc.Creator" content="Yu  Ding" /></meta><meta name="dc.Creator" content="Victoriano  Tamez" /></meta><meta name="dc.Creator" content="Yanchen  Zhang" /></meta><meta name="dc.Creator" content="Michelle  Mathur" /></meta><meta name="dc.Creator" content="Kristine  Muller" /></meta><meta name="dc.Creator" content="Cornelia  Bellamacina" /></meta><meta name="dc.Creator" content="Mika K.  Lindvall" /></meta><meta name="dc.Creator" content="Richard  Zang" /></meta><meta name="dc.Creator" content="Kay  Huh" /></meta><meta name="dc.Creator" content="Paul  Feucht" /></meta><meta name="dc.Creator" content="Tatiana  Zavorotinskaya" /></meta><meta name="dc.Creator" content="Yumin  Dai" /></meta><meta name="dc.Creator" content="Steve  Basham" /></meta><meta name="dc.Creator" content="Julie  Chan" /></meta><meta name="dc.Creator" content="Elaine  Ginn" /></meta><meta name="dc.Creator" content="Alex  Aycinena" /></meta><meta name="dc.Creator" content="Jocelyn  Holash" /></meta><meta name="dc.Creator" content="Joseph  Castillo" /></meta><meta name="dc.Creator" content="John L.  Langowski" /></meta><meta name="dc.Creator" content="Yingyun  Wang" /></meta><meta name="dc.Creator" content="Min Y.  Chen" /></meta><meta name="dc.Creator" content="Amy  Lambert" /></meta><meta name="dc.Creator" content="Christine  Fritsch" /></meta><meta name="dc.Creator" content="Audry  Kauffmann" /></meta><meta name="dc.Creator" content="Estelle  Pfister" /></meta><meta name="dc.Creator" content="K. Gary  Vanasse" /></meta><meta name="dc.Creator" content="Pablo D.  Garcia" /></meta><meta name="dc.Description" content="Pan proviral insertion site of Moloney murine leukemia (PIM) 1, 2, and 3 kinase inhibitors have recently begun to be tested in humans to assess whether pan PIM kinase inhibition may provide benefit..." /></meta><meta name="Description" content="Pan proviral insertion site of Moloney murine leukemia (PIM) 1, 2, and 3 kinase inhibitors have recently begun to be tested in humans to assess whether pan PIM kinase inhibition may provide benefit..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 27, 2015" /></meta><meta name="dc.Type" content="news" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01275" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01275" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01275" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01275" /></link>
        
    
    

<title>Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01275" /></meta><meta property="og:title" content="Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0016.jpeg" /></meta><meta property="og:description" content="Pan proviral insertion site of Moloney murine leukemia (PIM) 1, 2, and 3 kinase inhibitors have recently begun to be tested in humans to assess whether pan PIM kinase inhibition may provide benefit to cancer patients. Herein, the synthesis, in vitro activity, in vivo activity in an acute myeloid leukemia xenograft model, and preclinical profile of the potent and selective pan PIM kinase inhibitor compound 8 (PIM447) are described. Starting from the reported aminopiperidyl pan PIM kinase inhibitor compound 3, a strategy to improve the microsomal stability was pursued resulting in the identification of potent aminocyclohexyl pan PIM inhibitors with high metabolic stability. From this aminocyclohexyl series, compound 8 entered the clinic in 2012 in multiple myeloma patients and is currently in several phase 1 trials of cancer patients with hematological malignancies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01275"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01275">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01275&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01275&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01275&amp;href=/doi/10.1021/acs.jmedchem.5b01275" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 8373-8386</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00417" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Drug Annotation</span><a href="/doi/10.1021/acs.jmedchem.5b00732" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of <i>N</i>-(4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+T.++Burger">Matthew T. Burger</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gisele++Nishiguchi">Gisele Nishiguchi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wooseok++Han">Wooseok Han</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiong++Lan">Jiong Lan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Simmons">Robert Simmons</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gordana++Atallah">Gordana Atallah</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yu++Ding">Yu Ding</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Victoriano++Tamez">Victoriano Tamez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yanchen++Zhang">Yanchen Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michelle++Mathur">Michelle Mathur</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kristine++Muller">Kristine Muller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cornelia++Bellamacina">Cornelia Bellamacina</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mika+K.++Lindvall">Mika K. Lindvall</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Zang">Richard Zang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kay++Huh">Kay Huh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Feucht">Paul Feucht</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tatiana++Zavorotinskaya">Tatiana Zavorotinskaya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yumin++Dai">Yumin Dai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steve++Basham">Steve Basham</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julie++Chan">Julie Chan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elaine++Ginn">Elaine Ginn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alex++Aycinena">Alex Aycinena</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jocelyn++Holash">Jocelyn Holash</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph++Castillo">Joseph Castillo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+L.++Langowski">John L. Langowski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yingyun++Wang">Yingyun Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Min+Y.++Chen">Min Y. Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amy++Lambert">Amy Lambert</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Fritsch">Christine Fritsch</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Audry++Kauffmann">Audry Kauffmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Estelle++Pfister">Estelle Pfister</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=K.+Gary++Vanasse">K. Gary Vanasse</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pablo+D.++Garcia">Pablo D. Garcia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1.0"><span class="aff-text"><sup>†</sup>Global Discovery Chemistry, Oncology, <sup>‡</sup>Oncology Research, and <sup>§</sup>Preclinical Safety, Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Oncology Research, Novartis Institutes for Biomedical Research, CH-4056, Basel, Switzerland</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Translational Clinical Oncology, Novartis Institutes for Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#7b161a0f0f131e0c55190e091c1e093b15140d1a090f120855181416"><span class="__cf_email__" data-cfemail="97faf6e3e3fff2e0b9f5e2e5f0f2e5d7f9f8e1f6e5e3fee4b9f4f8fa">[email protected]</span></a>. Phone: 510-923-3537.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01275&amp;href=/doi/10.1021%2Facs.jmedchem.5b01275" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 8373–8386</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 27, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 August 2015</li><li><span class="item_label"><b>Published</b> online</span>27 October 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 November 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01275" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01275</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8373%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMatthew%2BT.%2BBurger%252C%2BGisele%2BNishiguchi%252C%2BWooseok%2BHan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D21%26contentID%3Dacs.jmedchem.5b01275%26title%3DIdentification%2Bof%2BN-%25284-%2528%25281R%252C3S%252C5S%2529-3-Amino-5-methylcyclohexyl%2529pyridin-3-yl%2529-6-%25282%252C6-difluorophenyl%2529-5-fluoropicolinamide%2B%2528PIM447%2529%252C%2Ba%2BPotent%2Band%2BSelective%2BProviral%2BInsertion%2BSite%2Bof%2BMoloney%2BMurine%2BLeukemia%2B%2528PIM%2529%2B1%252C%2B2%252C%2Band%2B3%2BKinase%2BInhibitor%2Bin%2BClinical%2BTrials%2Bfor%2BHematological%2BMalignancies%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8386%26publicationDate%3DNovember%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01275"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">6441</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">41</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01275" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;T. Burger&quot;},{&quot;first_name&quot;:&quot;Gisele&quot;,&quot;last_name&quot;:&quot;Nishiguchi&quot;},{&quot;first_name&quot;:&quot;Wooseok&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Jiong&quot;,&quot;last_name&quot;:&quot;Lan&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Simmons&quot;},{&quot;first_name&quot;:&quot;Gordana&quot;,&quot;last_name&quot;:&quot;Atallah&quot;},{&quot;first_name&quot;:&quot;Yu&quot;,&quot;last_name&quot;:&quot;Ding&quot;},{&quot;first_name&quot;:&quot;Victoriano&quot;,&quot;last_name&quot;:&quot;Tamez&quot;},{&quot;first_name&quot;:&quot;Yanchen&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Michelle&quot;,&quot;last_name&quot;:&quot;Mathur&quot;},{&quot;first_name&quot;:&quot;Kristine&quot;,&quot;last_name&quot;:&quot;Muller&quot;},{&quot;first_name&quot;:&quot;Cornelia&quot;,&quot;last_name&quot;:&quot;Bellamacina&quot;},{&quot;first_name&quot;:&quot;Mika&quot;,&quot;last_name&quot;:&quot;K. Lindvall&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Zang&quot;},{&quot;first_name&quot;:&quot;Kay&quot;,&quot;last_name&quot;:&quot;Huh&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Feucht&quot;},{&quot;first_name&quot;:&quot;Tatiana&quot;,&quot;last_name&quot;:&quot;Zavorotinskaya&quot;},{&quot;first_name&quot;:&quot;Yumin&quot;,&quot;last_name&quot;:&quot;Dai&quot;},{&quot;first_name&quot;:&quot;Steve&quot;,&quot;last_name&quot;:&quot;Basham&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;Chan&quot;},{&quot;first_name&quot;:&quot;Elaine&quot;,&quot;last_name&quot;:&quot;Ginn&quot;},{&quot;first_name&quot;:&quot;Alex&quot;,&quot;last_name&quot;:&quot;Aycinena&quot;},{&quot;first_name&quot;:&quot;Jocelyn&quot;,&quot;last_name&quot;:&quot;Holash&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;Castillo&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;L. Langowski&quot;},{&quot;first_name&quot;:&quot;Yingyun&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Min&quot;,&quot;last_name&quot;:&quot;Y. Chen&quot;},{&quot;first_name&quot;:&quot;Amy&quot;,&quot;last_name&quot;:&quot;Lambert&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Fritsch&quot;},{&quot;first_name&quot;:&quot;Audry&quot;,&quot;last_name&quot;:&quot;Kauffmann&quot;},{&quot;first_name&quot;:&quot;Estelle&quot;,&quot;last_name&quot;:&quot;Pfister&quot;},{&quot;first_name&quot;:&quot;K.&quot;,&quot;last_name&quot;:&quot;Gary Vanasse&quot;},{&quot;first_name&quot;:&quot;Pablo&quot;,&quot;last_name&quot;:&quot;D. Garcia&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;8373-8386&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01275&quot;},&quot;abstract&quot;:&quot;Pan proviral insertion site of Moloney murine leukemia (PIM) 1, 2, and 3 kinase inhibitors have recently begun to be tested in humans to assess whether pan PIM kinase inhibition may provide benefit to cancer patients. Herein, the synthesis, in vitro activity, in vivo activity in an acute myeloid leukemia xenograft model, and preclinical profile of the potent and selective pan PIM kinase inhibitor compound 8 (PIM447) are described. Starting from the reported aminopiperidyl pan PIM kinase inhibitor compound 3, a strategy to improve the microsomal stability was pursued resulting in the identification of potent aminocyclohexyl pan PIM inhibitors with high metabolic stability. From this aminocyclohexyl series, compound 8 entered the clinic in 2012 in multiple myeloma patients and is currently in several phase 1 trials of cancer patients with hematological malignancies.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01275&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01275" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01275&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01275" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01275&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01275" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01275&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01275&amp;href=/doi/10.1021/acs.jmedchem.5b01275" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01275" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01275" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01275%26sid%3Dliteratum%253Aachs%26pmid%3D26505898%26genre%3Darticle%26aulast%3DBurger%26date%3D2015%26atitle%3DIdentification%2Bof%2BN-%25284-%2528%25281R%252C3S%252C5S%2529-3-Amino-5-methylcyclohexyl%2529pyridin-3-yl%2529-6-%25282%252C6-difluorophenyl%2529-5-fluoropicolinamide%2B%2528PIM447%2529%252C%2Ba%2BPotent%2Band%2BSelective%2BProviral%2BInsertion%2BSite%2Bof%2BMoloney%2BMurine%2BLeukemia%2B%2528PIM%2529%2B1%252C%2B2%252C%2Band%2B3%2BKinase%2BInhibitor%2Bin%2BClinical%2BTrials%2Bfor%2BHematological%2BMalignancies%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D21%26spage%3D8373%26epage%3D8386%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291870" title="Piperidines">Piperidines</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/jmcmar.2015.58.issue-21/20151112/jmcmar.2015.58.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Pan proviral insertion site of Moloney murine leukemia (PIM) 1, 2, and 3 kinase inhibitors have recently begun to be tested in humans to assess whether pan PIM kinase inhibition may provide benefit to cancer patients. Herein, the synthesis, in vitro activity, in vivo activity in an acute myeloid leukemia xenograft model, and preclinical profile of the potent and selective pan PIM kinase inhibitor compound <b>8</b> (PIM447) are described. Starting from the reported aminopiperidyl pan PIM kinase inhibitor compound <b>3</b>, a strategy to improve the microsomal stability was pursued resulting in the identification of potent aminocyclohexyl pan PIM inhibitors with high metabolic stability. From this aminocyclohexyl series, compound <b>8</b> entered the clinic in 2012 in multiple myeloma patients and is currently in several phase 1 trials of cancer patients with hematological malignancies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23641" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23641" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Proviral insertion site of Moloney murine leukemia virus kinases, or PIMs 1, 2, and 3 kinases are serine/threonine kinases that normally function in the survival, proliferation, and differentiation of hematopoietic cells in response to growth factors and cytokines.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Cytokine signaling through the JAK/STAT pathway leads to increase transcription of the PIM genes with subsequent translation of constitutively active proteins.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> PIM1 was originally discovered as an oncogene by frequent proximal proviral insertions of murine leukemia virus in lymphomas of infected mice.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Similar unbiased insertional mutagenesis screens were used to demonstrate the oncogenic potential of PIM2<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and PIM3<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> in PIM1 and PIM1/2 knockout mice, respectively, and in doing so demonstrated the potential for functional redundancy of the PIM isoforms. In human disease, high expression and/or dysfunction of the three PIMs has been implicated in the progression of hematopoietic and solid tumor cancers.<a onclick="showRef(event, 'ref1 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref6">(1, 6)</a> High expression of PIM1 has been reported in acute lymphoblastic leukemia, acute myeloid leukemia (AML), and diffuse large B-cell lymphoma, while high expression of PIM2 has been reported in multiple myeloma.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The high expression of PIM in cancer, particularly hematopoietic cancers, is thought to play a role in promoting survival and proliferation while suppressing apoptosis. As PIMs display functional redundancy in oncogenesis and are differentially overexpressed in different cancer cell types, a pan-PIM kinase inhibitor rather than an isoform-selective inhibitor would be expected to provide superior antitumor efficacy.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In addition to cancer, PIM kinases have been reported to play a role in several autoimmune diseases.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Not surprisingly, PIM kinases have emerged as attractive therapeutic targets and have elicited several groups to investigate and report novel inhibitors of PIM<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18">(10-18)</a> including the clinical compounds SGI-1776<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and AZD1208,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> compound <b>1</b> and compound <b>2</b>, respectively, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>. PIM kinases share a high level of sequence homology within the family (>61%), and all share the unique feature of being the only kinases with a proline in the hinge,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> which results in only one hydrogen bond interaction with ATP. As the ATP <i>K</i><sub>m</sub> for PIM2 is 10–100× lower than that for PIM1 and PIM3, cell active pan PIM inhibitors have been more challenging to identify than PIM1/3 inhibitors.</div><div class="NLM_p">Recently, we described the optimization of a highly kinase selective aminopiperidine, pyridylcarboxamide scaffold,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> which binds in the PIMs ATP pocket, lacks any hydrogen bonds to the hinge, and exhibits in vitro pan PIM biochemical and cellular potencies greater than compound <b>1</b> and compound <b>2</b>. From this scaffold, compound <b>3</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, has been characterized in multiple myeloma and AML in vivo hematological mouse xenograft models<a onclick="showRef(event, 'ref7 ref21'); return false;" href="javascript:void(0);" class="ref ref7 ref21">(7, 21)</a> where a PK–PD efficacy relationship has been established. Described herein are our further efforts on the pyridylamide scaffold that have focused on the improvement of metabolic stability. These efforts have led to the identification of <i>N</i>-(4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide compound <b>8</b> (PIM447) which exhibits pan PIM potency, pharmacokinetic properties, and druglike properties suitable for clinical development. Compound <b>8</b> entered clinical trials in 2012 and is currently in several phase I trials. Compound <b>8</b> was previously known as and is synonymous with LGH447.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. PIM clinical compounds and starting point <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While compound <b>3</b> has served as a valuable in vitro and in vivo tool for studying PIM biology, the moderate to high in vitro clearance, vide infra, could pose a developability risk, especially since the PK–PD efficacy relationship observed supports maximal efficacy being driven by the maintenance of continuous free plasma levels above cellular antiproliferative EC50’s.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In vitro met ID studies in human liver microsomes indicate metabolism of compound <b>3</b> involves oxidations on carbons of the piperidine ring adjacent to both the internal and external nitrogens. This eventually leads to the removal the piperidine ring altogether, leaving the piperidine nitrogen behind, funneling into a 4-amino 3-aminoacyl pyridyl metabolite, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>. In addition to the high in vitro CL of compound <b>3</b>, the formation of an electron rich amino, aminoacyl pyridyl metabolite was not deemed as positive with respect to developability/toxicity. Thus, the challenge for medicinal chemistry was to improve the metabolic stability and reduce or eliminate the formation of a diaminopyridyl metabolite while maintaining the potency and selectivity achieved with compound <b>3</b>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Metabolism of compound <b>3</b> in human liver microsomes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The medicinal chemistry strategy to achieve this goal focused on removing the substituted piperidine portion of the molecule and replacing it with a similarly substituted cyclohexyl ring. With respect to potency, from the SAR developed leading up to compound <b>3</b>, it was known that the pyridyl nitrogen in the diaminopyridine ring and the primary amino group on the piperidine were important for potency. The X-ray crystal structure of compound <b>3</b> in PIM 1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N70">4N70</a>),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a><a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, indicates these moieties participate in three hydrogen bonds to the protein (NH<sub>2</sub> to Asp128 side chain and Glu171 backbone carbonyl, and pyridyl to Lys67). Substitution of the cyclohexyl for piperidyl could possibly allow for a similar display of the primary amino group for hydrogen bonding to Asp128 and Glu171 if the piperidine to cyclohexyl change does not change the relative conformation of the saturated six-membered ring relative to the attached <i>N</i>-acylpyridine. Additionally, it was unclear a priori what effect the piperidine to cyclohexyl change might have on potency with respect to the hydrogen bond interaction of the pyridyl nitrogen and Lys67, as the electron density and basicity of the pyridine would be altered. With respect to metabolism, while the piperidine to cyclohexyl change would remove the α or α′ N dealkylation metabolic spots adjacent to the piperidine ring nitrogen, it was unclear a priori whether this would improve overall metabolic stability or whether metabolism would just be shifted toward N-dealkylative oxidation α to the primary amino group. This α N-dealkylative oxidation (followed by loss of NH<sub>2</sub> leading to the corresponding ketone) had also been observed in the microsomal studies of compound <b>3</b> as one of several piperidine metabolites. Attempts to suppress the metabolism α to the primary amine via installation of an α methyl group led to a loss in PIM potency, unpublished results. Thus, it was unclear beforehand whether the proposed strategy of replacing piperidine with cyclohexyl would yield compounds with improved microsomal stability and with sufficient pan PIM potency. This uncertainty withstanding, cyclohexyl compounds were pursued and synthetic routes were developed.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure of compound <b>3</b> in PIM1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26034" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26034" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Initially, aminocyclohexyl targets without additional ring substitution were prepared to establish the viability of the synthetic route, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Cyclohexanedione was converted via the monotriflate to the corresponding cyclohexenoneboronate ester which underwent palladium mediated carbon bond formation with 4-chloro-3-nitropyridine to yield nitropyridylcylohexenone <b>I</b>. Subsequent 1,2 reduction of the enone yielded the allylic alcohol <b>II</b>. The protected amine group was introduced under Mitsunobu conditions with phthalimide. Reduction of the alkene and nitro groups under hydrogenation conditions followed by chiral separation yielded the enantiopure cis substituted cyclohexylpyridylaniline <b>III</b>. Amide coupling followed by phthalimide deprotection yielded target compounds <b>10</b>, <b>12</b>, and <b>16</b>.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Na<sub>2</sub>CO<sub>3</sub>, Tf<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 3 h; (b) KOAc, Pd(dppf)Cl<sub>2</sub>, pinacolatodiboron, dioxane, 80 °C, 2 h; (c) 4-chloro-3-nitropyridine, Pd(pddf)Cl<sub>2</sub>, dioxane/2 M Na<sub>2</sub>CO<sub>3</sub>, 110 °C, 2 h, 55% (3 steps); (d) NaBH<sub>4</sub>, CeCl<sub>3</sub>·7H<sub>2</sub>O, MeOH, 0 °C, 2 h, 94%; (e) PhthNH, Ph<sub>3</sub>P, (C<sub>4</sub>H<sub>9</sub>O<sub>2</sub>CN)<sub>2</sub>, THF, 0 °C, 2 h, 50%; (f) 400 PSI H<sub>2</sub>, Pd/C, MeOH, 50 °C, 48 h, 53%; (g) chiral separation; (h) heteroaryl acid, EDC, HOAT, DMF; 12 h, 91%; (i) H<sub>2</sub>NNH<sub>2</sub>, MeOH, 50 °C, 2 h, 90%.</p></p></figure><div class="NLM_p">Aminocyclohexyl targets containing the 5 position methyl group on the cyclohexyl ring were prepared as described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. (5)-Methylcyclohexanedione was converted via the monotriflate to the corresponding cyclohexenoneboronate ester which underwent palladium mediated carbon bond formation with 4-chloro-3-nitropyridine to yield after 1,2 reduction of the enone a cis cyclohexenol <b>IV</b>. <i>tert-</i>Butyldimethylsilyl protection of the alcohol, hydrogenation of the nitro and alkene groups followed by carbobenzyloxyamine protection yielded the racemic all cis, equatorial, trisubstituted cyclohexane <b>V</b>. Deprotection of the silyl ether, Dess–Martin oxidation of the alcohol to the cis disubstituted cyclohexanone, followed by lithium borohydride<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> mediated reductive amination with benzylamine reestablished the all cis equatorial cyclohexyl relative stereochemistry. Removal of the carbobenzyloxy and benzyl groups under hydrogenation conditions followed by in situ primary aliphatic amine Boc protection and chiral resolution yielded the desired all cis trisubstituted Boc protected aminocyclohexylpyridylaniline <b>VI</b>. Amide coupling followed by acetate and Boc deprotection yielded target compounds <b>6</b>, <b>8</b>, and <b>14</b>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Na<sub>2</sub>CO<sub>3</sub>, Tf<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 2 h, 78%; (b) KOAc, Pd(dppf)Cl<sub>2</sub>, pinacolatodiboron, dioxane, 80 °C, 10 h; (c) 4-chloro-3-nitropyridine, Pd(pddf)Cl<sub>2</sub>, dioxane/2 M Na<sub>2</sub>CO<sub>3</sub>, 110 °C, 1 h, 48% (2 steps); (d) NaBH<sub>4</sub>, CeCl<sub>3</sub>·7H<sub>2</sub>O, EtOH, 0 °C, 1 h, 72%; (e) TBDMSCl, imidazole, DMF, 18 h, 77%; (f) H<sub>2</sub>, Pd/C, MeOH, 15 h, 93%; (g) Cbz-OSu, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 90 h, 81%; (h) HCl, EtOH, 1 h, 94%; (i) Dess–Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>, 1 h, 91%; (j)BnNH<sub>2</sub>, LiBH<sub>4</sub>, MeOH, 3.5 h; (k) H<sub>2</sub>, Pd/C, MeOH, Boc<sub>2</sub>O, 46 h, 47% (2 steps); (l) chiral separation; (m) heteroaryl acid, EDC, HOAT, DMF; 12 h, 91%; (n) 4 M HCl/dioxane, 17 h, 80% or 25% TFA/CH<sub>2</sub>Cl<sub>2</sub>, 0.5 h, 90%.</p></p></figure><div class="NLM_p">Aminocyclohexyl targets with the additional hydroxy substitution present in compound <b>3</b> were prepared as described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Cyclohexenol <b>IV</b> was dehydrated to yield a diene which reacted with <i>N</i>-bromosuccinimide at the less hindered alkene to yield bromohydrin <b>VII</b> with the bromine cis to the methyl group. Upon base treatment intramolecular cyclization yielded the epoxide, trans to the methyl, which was opened with sodium azide yielding azido alcohol <b>VIII</b>, therein establishing the relative 1,2 trans, 1,3 cis azido, hydroxy, methyl stereochemical relationship. Subsequent azide reduction, Boc amine protection, hydroxyl acetylation, hydrogenation of the nitro and alkene groups, and chiral resolution yielded the chiral tetrasubstituted, all equatorial, aminohydroxypyridylaniline <b>IX</b>. Amide coupling followed by acetate and Boc deprotection yielded the target compound <b>4</b>. The piperidyl compound <b>3</b> was previously described,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and compounds <b>5</b>, <b>7</b>, <b>9</b>, <b>11</b>, <b>13</b>, and <b>15</b> were prepared following a similar route; see experimental part for details.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0013.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) p-TsOH, dioxane, 100 °C, 3 h, 68%; (b) NBS, H<sub>2</sub>O, THF, 0.5 h, 80%; (c) KO-<i>t</i>-Bu, THF, 0.5 h; (d) NaN<sub>3</sub>, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, 14 h, 55%; (e) PMe<sub>3</sub>, pyridine, NH<sub>4</sub>OH, 2 h; (f) Boc<sub>2</sub>O, dioxane, NaHCO<sub>3(sat.)</sub>, 2 h, 59% (2 steps); (g) Ac<sub>2</sub>O, pyridine, 14 h; (h) H<sub>2</sub>, Pd/C, MeOH, 72 h, 75% (2 steps); (i) chiral separation; (j) heteroaryl acid, EDC, HOAT, DMF, 14 h; (k) K<sub>2</sub>CO<sub>3</sub>, EtOH, 14 h; (l) 25% TFA/CH<sub>2</sub>Cl<sub>2</sub>, 0.5 h, 80% (3 steps).</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56868" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56868" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The aminocyclohexanes (<b>4</b>, <b>6</b>, <b>8</b>, <b>10</b>, <b>12</b>, <b>14</b>, <b>16</b>) along with matched pair aminopiperidines (<b>3</b>, <b>5</b>, <b>7</b>, <b>9</b>, <b>11</b>, <b>13</b>, <b>15</b>) were tested in PIM biochemical and PIM cellular assays to assess the effect of cyclohexyl replacement on target potency. PIM1–3 kinase activity was assessed in a kinase-Glo assay, with [ATP] at or below ATP <i>K</i><sub>m</sub> for each isoform. Potent PIM inhibition, picomolar and nanomolar, for all PIM isoforms was retained for the aminocyclohexyl compounds, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. While many compound matched pairs were at the limits of detection in the low ATP enzymatic assay, for the few (<b>9</b>–<b>14</b>) that were not there was a ∼3-fold potency difference between piperidine and cyclohexyl, with the piperidine analog being the more potent member of each pair. Cellular activity was assessed in the multiple myeloma derived, PIM2 driven, KMS11-luc cell line where antiproliferative activity was obtained for all compounds except <b>9</b> and <b>10</b> and target modulation as assessed by phosphorylation of S6 ribosomal protein (pS6RP) was obtained for <b>3</b>, <b>4</b>, <b>8</b>, <b>14</b>, and <b>16</b>. S6RP, which is not a direct PIM substrate but is downstream from PIM phosphorylation of TSC2, was chosen as a biomarker as it is modulation correlated best with in vivo antiproliferative activity in preclinical models.<a onclick="showRef(event, 'ref7 ref21'); return false;" href="javascript:void(0);" class="ref ref7 ref21">(7, 21)</a> Consistent with prior reports,<a onclick="showRef(event, 'ref7 ref20 ref23'); return false;" href="javascript:void(0);" class="ref ref7 ref20 ref23">(7, 20, 23)</a> there was a large shift upward relative to the low [ATP] enzymatic assays. Additionally, as in the enzymatic assay, the piperidine component of any matched pair was more potent than the corresponding cylcohexyl. The greater potency difference of matched pair <b>3</b> and <b>4</b> which contain the hydroxyl and amino groups relative to other matched pairs which lack the hydroxyl group is noteworthy, highlighting subtleties of hydrogen bonding, desolvation, and amine basicity for interactions in this region of the protein. Despite the potency decrease in replacing piperidine with cyclohexyl, aminocyclohexyl compounds still exhibit picomolar enzymatic and significant cell potency.</div><div class="NLM_p">The microsomal stability for the piperidine and cyclohexyl matched pairs <b>3</b>–<b>16</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) was assessed in human and rat liver microsomes where in addition to NADPH, UDPGA and alemethicin were added to capture PhII glucoronidation. The compounds were tested at 1 μM for 30 min, and <i>t</i><sub>1/2</sub>’s were measured from which scaled CL’int, hepatic CL (CL_H), and hepatic extraction ratio (ER_H) were determined using a well-stirred liver model. The measured <i>t</i><sub>1/2</sub>’s, hepatic CL, and hepatic extraction ratio are listed in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. In human microsomes there is a consistent increase in stability when piperidine is replaced with cyclohexyl with <i>t</i><sub>1/2</sub>’s increasing and extraction ratio decreasing. For example, the <i>t</i><sub>1/2</sub> of the cyclohexyl analog of compound <b>3</b>, compound <b>4</b>, is 3 times more stable in human microsomes than compound <b>3</b>, leading to a ∼2-fold decrease in ER value (∼0.77 versus 0.46). The stability improvement was evident in rat microsomes as well. Improved stability in preclinical species was viewed as a positive with respect to ensuring necessary exposures could be reached in safety studies. The high metabolic stability was also observed in hepatocytes, as compound <b>8</b> exhibits clearance values of 12 and 3 mL min<sup>–1</sup> kg<sup>–1</sup> in rat and human hepatocytes. From the enzymatic potency, cellular potency, and metabolic stability data depicted in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, it is evident replacing the aminopiperidine of aminopiperidine carboxamide inhibitors with an aminocyclohexyl can yield pan PIM potent, cell active compounds with high metabolic stability in human liver microsomes. Of the aminocyclohexanes described in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, compound <b>8</b> stood out with respect to cellular potency and metabolic stability and was selected for further profiling.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. PIMs 1, 2, and 3 Enzymatic and Cellular Activity of Compounds <b>3</b>–<b>16</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0014.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="."><i>K</i><sub>i</sub> (μM)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">EC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char=".">PIM1</th><th class="colsep0 rowsep0" align="center" char=".">PIM2</th><th class="colsep0 rowsep0" align="center" char=".">PIM3</th><th class="colsep0 rowsep0" align="center" char=".">KMSIlluc</th><th class="colsep0 rowsep0" align="center" char=".">KMS11luc pS6RP</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">(<i>R</i>)-CH</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.41</td><td class="colsep0 rowsep0" align="char" char=".">0.91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">(<i>R</i>)-CH</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">(<i>R</i>)-CH</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.17</td><td class="colsep0 rowsep0" align="char" char=".">0.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">(<i>R</i>)-CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">0.023</td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">(<i>R</i>)-CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.029</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">(<i>R</i>)-CH</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">0.91</td><td class="colsep0 rowsep0" align="char" char=".">0.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">(<i>R</i>)-CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char="."><0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.54</td><td class="colsep0 rowsep0" align="char" char=".">0.71</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Human and Rat Microsomal Stability of Compounds <b>3</b>–<b>16</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><i> T</i><sub>1/2</sub> (min)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">CL_H (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">ER_H</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">human</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">0.88</td><td class="colsep0 rowsep0" align="char" char=".">0.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">0.82</td><td class="colsep0 rowsep0" align="char" char=".">0.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char=".">>180</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char="."><6</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char="."><0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">0.72</td><td class="colsep0 rowsep0" align="char" char=".">0.66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">106</td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">0.94</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.86</td><td class="colsep0 rowsep0" align="char" char=".">0.48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">0.89</td><td class="colsep0 rowsep0" align="char" char=".">0.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="char" char=".">121</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td><td class="colsep0 rowsep0" align="char" char=".">0.61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">65</td><td class="colsep0 rowsep0" align="char" char=".">>180</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char="."><6</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td><td class="colsep0 rowsep0" align="char" char="."><0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">0.79</td><td class="colsep0 rowsep0" align="char" char=".">0.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char=".">42</td><td class="colsep0 rowsep0" align="char" char=".">107</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">0.55</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td></tr></tbody></table></div></div><div class="NLM_p">As the biochemical potency for compound <b>8</b> reached the limits of detection in the low [ATP] kinase Glo assay format, the potency was further assessed in a high ATP AlphaScreen assay using [ATP]’s of 2800, 500, and 2800 μM for PIMs 1, 2, and 3, respectively. Under these conditions, the <i>K</i><sub>i</sub>’s of compound <b>8</b> were determined to be 6, 18, and 9 pM for PIMs 1, 2, and 3, respectively. When compared alongside the clinical compounds <b>1</b> and <b>2</b>, <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, compound <b>8</b> is more potent in enzymatic and cellular assays.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Selected SAR of Compound <b>8</b> and Comparison to Compounds <b>1</b> and <b>2</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Pim1 <i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">Pim2 <i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">Pim3 <i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">KMS11luc EC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">610</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">0.017</td><td class="colsep0 rowsep0" align="left">0.160</td><td class="colsep0 rowsep0" align="left">0.230</td><td class="colsep0 rowsep0" align="left">0.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">0.006</td><td class="colsep0 rowsep0" align="left">0.018</td><td class="colsep0 rowsep0" align="left">0.009</td><td class="colsep0 rowsep0" align="left">0.17</td></tr></tbody></table></div></div><div class="NLM_p">The kinase selectivity of compound <b>8</b> was first determined in biochemical assays for a panel of 68 diverse protein kinases that included PIM2 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) as well as 9 lipid kinases. In this panel, only PIM2 was significantly inhibited by compound <b>8</b> with an IC<sub>50</sub> of <0.003 μM, the lowest sensitivity range for the assay. Compound <b>8</b> also inhibited GSK3β, PKN1, and PKCτ, but at a significantly lower potency with IC<sub>50</sub> between 1 and 5 μM (>10<sup>5</sup>-fold differential relative to the <i>K</i><sub>i</sub> on PIMs). The biochemical IC<sub>50</sub> for all other kinases tested in this panel was >9 μM. In follow-up cellular assays of GSK3β inhibition,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> compound <b>8</b> was tested up to 20 μM and was not active.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Kinase activity of compound <b>8</b> against 68 kinases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Additional kinase profiling of compound <b>8</b> at 1 μM against 442 kinases using the KINOMEscan binding displacement assay, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, indicated high kinase selectivity [<i>S</i>(35) = 0.021 at 1 μM, 386 nonmutant kinases including PIMs 1, 2, and 3; <i>S</i>(35) = 0.013 at 1 μM, 383 nonmutant kinases not including PIMs 1, 2, and 3], <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>. The unlabeled smaller red dots in the kinome tree, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, correspond to ERK8, GSK3β, and PRKD. The high selectivity of compound <b>8</b> is consistent with the scaffold class as reported earlier.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. KINOMEscan binding of <b>8</b> at 1 μM against 442 kinases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A crystal structure of compound <b>8</b> in PIM1 was obtained,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a><a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>. The overall binding mode is the same as for <b>1</b> with the central amide making no direct hydrogen bonds to the protein and displaying the two sides of the molecule toward the hinge/lower hinge and catalytic Lys region/ribose patch. The amino group on the cyclohexyl ring makes two hydrogen bonds to the Asp128 side chain carboxylate and the Glu171 backbone carbonyl in the ribose patch. Additionally, the methyl group fills a hydrophobic dimple in the glycine rich loop above. The acylaminopyridine ring nitrogen makes a hydrogen bond with the catalytic Lys67. The C ring fluoropyridine fills the Pro123 hinge region with no hydrogen bond interactions, and the difluorophenyl ring extends into the lower hinge region.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structure of <b>8</b> in PIM1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With an expanded understanding of the kinase selectivity of compound <b>8</b> and the structural features contributing to PIM potency in hand, the cellular activity of compound <b>8</b> across an expanded panel of 26 AML cell lines was assessed, <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>. The antiproliferative activity spanned a range from low nM to insensitivity at 10 μM, with approximately 1/3 sensitive at ≤500 nM, 1/3 sensitive between 500 nM and 3 μM, and 1/3 sensitive at >3 μM. The activity of compound <b>8</b> across the expanded AML panel was consistent with what has been reported for selective PIM inhibitors such as compound <b>2</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and compound <b>3</b><a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> wherein a range of sensitivities is evident, with highly sensitive cell lines correlating with the highest expressions of PIM1.</div><div class="NLM_table-wrap" id="tbl4">Table 4<div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center" char=".">GI<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center" char=".">GI<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Molm16</td><td class="colsep0 rowsep0" align="char" char=".">0.01</td><td class="colsep0 rowsep0" align="left">OCI-M1</td><td class="colsep0 rowsep0" align="char" char=".">2.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KG-1</td><td class="colsep0 rowsep0" align="char" char=".">0.01</td><td class="colsep0 rowsep0" align="left">SKM-1</td><td class="colsep0 rowsep0" align="char" char=".">2.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EOL-1</td><td class="colsep0 rowsep0" align="char" char=".">0.01</td><td class="colsep0 rowsep0" align="left">OCI-AML3</td><td class="colsep0 rowsep0" align="char" char=".">2.92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">M-07e</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="left">P31/FUJ</td><td class="colsep0 rowsep0" align="char" char=".">5.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">UKE-1</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td><td class="colsep0 rowsep0" align="left">Mono-MAC-1</td><td class="colsep0 rowsep0" align="char" char=".">5.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MV-4-11</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="left">THP-1</td><td class="colsep0 rowsep0" align="char" char=".">5.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CMK</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="left">OCI-AML2</td><td class="colsep0 rowsep0" align="char" char=".">5.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Set-2</td><td class="colsep0 rowsep0" align="char" char=".">0.48</td><td class="colsep0 rowsep0" align="left">NB-4</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CMK-11-5</td><td class="colsep0 rowsep0" align="char" char=".">1.03</td><td class="colsep0 rowsep0" align="left">PL-21</td><td class="colsep0 rowsep0" align="char" char=".">8.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Molm-13</td><td class="colsep0 rowsep0" align="char" char=".">1.39</td><td class="colsep0 rowsep0" align="left">SIG-M5</td><td class="colsep0 rowsep0" align="char" char=".">8.66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Hel92.1.7</td><td class="colsep0 rowsep0" align="char" char=".">1.66</td><td class="colsep0 rowsep0" align="left">NOMO-1</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TF-1</td><td class="colsep0 rowsep0" align="char" char=".">1.96</td><td class="colsep0 rowsep0" align="left">OCI-AML5</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Mutz8</td><td class="colsep0 rowsep0" align="char" char=".">1.99</td><td class="colsep0 rowsep0" align="left">F-36P</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr></tbody></table></div></div><div class="NLM_p">Within the most sensitive AML cell lines, the activity of compound <b>8</b> in KG-1 cells was further evaluated both in vitro and in vivo, as a KG-1 in vivo xenograft model was available and synergy with the AML standard of care cytarabine could be assessed given the minimal activity observed with cytarabine at the maximum tolerated dose in the model. Upon treatment of KG-1 cells in vitro at concentrations of 0.05, 0.5, and 5 μM compound <b>8</b>, a dose dependent modulation of pS6RP was evident (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>) .</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In vitro pS6RP target modulation by compound <b>8</b> in KG-1 acute myeloid leukemia cell line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The activity of compound <b>8</b> in an in vivo KG-1 AML xenograft mouse model was assessed next. Following a single oral dose of compound <b>8</b> (30 or 100 mg/kg) plasma and tumor samples were collected for pharmacokinetic and pharmacodynamic analysis, respectively. PIM kinase inhibition was determined by assessing the modulation of pS6RP in tumor lysate using the quantitative Meso Scale assay, and the results were expressed as a ratio of their phosphorylated to unphosphorylated forms (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). The plasma exposure (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>) was roughly dose proportional with a significant difference in exposures at the 24 h time point in particular. With mouse plasma protein binding of 95%, the 30 and 100 mg/kg doses maintain free plasma concentrations of ≥15 and 300 nM, respectively, throughout 24 h. At both doses there was a ∼50% reduction in pS6RP at 1, 8, and 24 h. The lack of a dose response in the target modulation may be a reflection of dynamic range of the detection method, as the ∼50% reduction of pS6RP was the maximal signal seen across multiple xenograft PK–PD studies utilizing compounds in this scaffold class even when dosed up to 300 mg/kg, data not shown. Additionally, in the higher bar KMS11.luc multiple myeloma mouse xenograft model, a dose response in pS6RP modulation at 24 h was observed when compound <b>8</b> was dosed at 25 and 100 mg/kg.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0009.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Single dose pS6RP target modulation and plasma exposure of compound <b>8</b> in KG-1 acute myeloid leukemia subcutaneous mouse tumor model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The in vivo target modulation translated to an in vivo antiproliferative effect in the KG-1 AML xenograft model when compound <b>8</b> was assessed in an 11-day study at 30 and 100 mg/kg QD doses. At the 30 mg/kg daily regimen of compound <b>8</b>, near stasis was observed with only minor increase in tumor volume relative to the vehicle control (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). In contrast, tumor regression of 31% was observed with the 100 mg/kg QD regimen. Both doses of compound <b>8</b> were well tolerated, and the activity observed was similar to that of compound <b>3</b> in the same model.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In addition to single agent activity, a combination of compound <b>8</b> with the nucleoside analog cytarabine (Ara-C), a standard-of-care in the clinical treatment of AML, was assessed. KG-1 tumors exhibited a slight but statistically significant response to Ara-C alone when delivered at 100 mg/kg daily. While this dose results in clinically relevant exposures, it is near the maximum tolerated dose in mice and required a 2-day dosing holiday. When the 30 mg/kg QD dose of compound <b>8</b> which led to tumor stasis was combined with the 100 mg/kg QD dose of Ara-C, a synergistic effect resulting in significant regression was achieved (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). When the higher 100 mg/kg QD dose was similarly combined with Ara-C, the effect did not reach statistical significance compared to the 100 mg/kg dose of compound <b>8</b> alone, as this dose achieved regression as a single agent. Similar to the single-agent Ara-C cohort, the combination of Ara-C with compound <b>8</b> at both doses induced significant body weight loss following the fifth day of administration which required dosing to be halted only in these arms for 2 days before resuming treatment. Taken together, these results demonstrate the efficacy of compound <b>8</b> both as a single agent and in combination with Ara-C, even in a model that is refractory to this standard-of-care.</div><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0010.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Antitumor activity and tolerability of single agent compound <b>8</b> and compound <b>8</b> in combination with Ara-C in KG-1 acute myeloid leukemia subcutaneous mouse tumor model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With these encouraging mouse pharmacology activities, compound <b>8</b> was profiled further with respect to developability and druglike properties. The pharmacokinetic properties of compound <b>8</b> were evaluated across multiple species (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Low to moderate in vivo CL was observed for compound <b>8</b> across species, as CL values of 20, 28, and 8 mL min<sup>–1</sup> kg<sup>–1</sup> were observed in mouse, rat, and dog, respectively. The volume of distribution was consistently large across species, with <i>V</i><sub>ss</sub> of 5.3, 6.4, and 3.6 L/kg observed in mouse, rat, and dog, respectively. Additionally, compound <b>8</b> exhibited high oral bioavailability across species, as 84%, 70%, and 71% was observed in mouse, rat, and dog, respectively.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. PK Properties of Compound <b>8</b> across Species</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">iv <i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">po <i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">71</td></tr></tbody></table></div></div><div class="NLM_p">The melting point of compound <b>8</b> as a free base is 139 °C. Its log <i>D</i> (pH 6.8) is 1.1, and its p<i>K</i><sub>a</sub> values are 9.8 and 4.2. The solubility of crystalline free base at pH 1, 3, and 6.8 is >45, 4, and 0.5 mM. The stability of compound <b>8</b> in human plasma is high, >90% after a 3 h incubation, and the human plasma protein binding of compound <b>8</b> is 95%. In the manual patch clamp hERG assay compound <b>8</b> exhibited a 12 μM IC<sub>50</sub> and in dog telemetry studies demonstrated no cardiosafety signals wherein a 2× mouse efficacious free <i>C</i><sub>max</sub> plasma concentration, 1 μM, was achieved. With a mouse efficacious unbound <i>C</i><sub>max</sub> of ∼0.5 μM, the window between the free <i>C</i><sub>max</sub> in mouse models and hERG IC<sub>50</sub> is ∼20-fold.</div><div class="NLM_p last">On the basis of favorable cellular potency, kinase selectivity, manageable preclinical pharmacology and pharmacokinetic, physical properties, and preclinical safety profiles, compound <b>8</b> was advanced into clinical trials in 2012, where a wide therapeutic window demonstrating single agent activity and a tolerable safety profile has been observed in multiple myeloma patients.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> As opposed to that seen with halted clinical compounds <b>1</b> and <b>2</b>, the observation of early clinical activity and favorable safety profile with compound <b>8</b> may be due in part to its increased potency and/or selectivity.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04287" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04287" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, the metabolic stability of a selective pan PIM kinase active aminopiperidine pyridyl carboxamide series exemplified by compound <b>3</b> was improved by replacing the chiral trisubstituted aminopiperidine with di-, tri-, and tetrasubstituted aminocyclohexanes. Synthetic routes were developed for the preparation of the substituted cylcohexanes with control of relative stereochemistry. The improved in vitro metabolic stability translated in vivo as cyclohexyl compound <b>8</b> exhibits low to moderate CL in mouse, rat, and dog. The metabolically stable aminocyclohexyl pyridyl carboxamides described exhibit picomolar pan PIM enzymatic activity, high kinase selectivity, and nanomolar cellular activity. With the combination of potent in vitro activity and low to moderate CL, compound <b>8</b> demonstrates in vivo target modulation (pS6RP), single agent antitumor activity in a KG-1 AML mouse xenograft model, and druglike properties suitable for development. Compound <b>8</b> advanced into humans in 2012 and is currently being assessed in several phase I trials.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23406" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23406" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The compounds and/or intermediates were characterized by high performance liquid chromatography (HPLC) using a Waters Millenium chromatography system with a 2695 separation module (Milford, MA). The analytical columns were Alltima C-18 reversed phase, 4.6 mm × 50 mm, flow 2.5 mL/min, from Alltech (Deerfield, IL). A gradient elution was used, typically starting with 5% acetonitrile/95% water and progressing to 100% acetonitrile over a period of 10 min. All solvents contained 0.1% trifluoroacetic acid (TFA). Compounds were detected by ultraviolet light (UV) absorption at either 220 or 254 nm. HPLC solvents were from Burdick and Jackson (Muskegan, MI) or Fisher Scientific (Pittsburgh, PA). In some instances, purity was assessed by thin layer chromatography (TLC) using glass or plastic backed silica gel plates, such as Baker-Flex silica gel 1B2-F flexible sheets. TLC results were readily detected visually under ultraviolet light or by employing well-known iodine vapor and other various staining techniques.</div><div class="NLM_p">Mass spectrometric analysis was performed on one of two LCMS instruments: a Waters system (Alliance HT HPLC and a Micromass ZQ mass spectrometer; column, Eclipse XDB-C18, 2.1 mm × 50 mm; solvent system, 5–95% (or 35–95% or 65–95% or 95–95%) acetonitrile in water with 0.05% TFA; flow rate 0.8 mL/min; molecular weight range 200–1500; cone voltage 20 V; column temperature 40 °C) or a Hewlett-Packard system (series 1100 HPLC; column, Eclipse XDB-C18, 2.1 mm × 50 mm; solvent system, 1–95% acetonitrile in water with 0.05% TFA; flow rate 0.8 mL/min; molecular weight range 150–850; cone voltage 50 V; column temperature 30 °C). All masses were reported as those of the protonated parent ions.</div><div class="NLM_p">HRMS ESI-MS data were recorded using a Synapt G2 HDMS (TOF mass spectrometer, Waters) with electrospray ionization source. The resolution of the MS system was approximately 15 000. Leucine enkephalin was used as lock mass (internal standards) infused from lockspray probe. The compound was infused into the mass spectrometer by UPLC (Acquity, Waters) from sample probe. The separation was performed on Acquity UPLC BEH C18 1 mm × 50 mm column at 0.2 mL/min flow rate with the gradient from 5% to 95% in 3 min. Solvent A was water with 0.1% formic acid, and solvent B was acetonitrile with 0.1% formic acid. The mass accuracy of the system has been found to be <5 ppm with lock mass.</div><div class="NLM_p"><sup>1</sup>H nuclear magnetic resonance (NMR) analyses described herein were performed on some of the compounds with a Varian 400 MHz NMR (Palo Alto, CA). The spectral reference was either TMS or the known chemical shift of the solvent. <sup>13</sup>C NMR spectra were recorded using a Bruker AVANCE-500 NMR spectrometer operating at a frequency of 125.77 MHz for <sup>13</sup>C equipped with a 5 mm BBO probe.</div><div class="NLM_p">Preparative separations were carried out using a Teledyne ISCO chromatography system, by flash column chromatography using silica gel (230–400 mesh) packing material, or by HPLC using a Waters 2767 sample manager, C-18 reversed phase column, 30 mm × 50 mm, flow 75 mL/min. Typical solvents employed for the Teledyne ISCO chromatography system and flash column chromatography were dichloromethane, methanol, ethyl acetate, heptane, acetone, aqueous ammonia (or ammonium hydroxide), and triethylamine. Typical solvents employed for the reverse phase HPLC were varying concentrations of acetonitrile and water with 0.1% trifluoroacetic acid.</div><div class="NLM_p">The purity of all compounds screened in the biological assays was examined by LC–MS analysis and was found to be ≥95%.</div><div class="NLM_p">(<i>S</i>)-<i>tert</i>-Butyl 1-(3-aminopyridin-4-yl)piperidin-3-ylcarbamate, <i>tert</i>-butyl (3<i>S</i>,5<i>R</i>)-1-(3-aminopyridin-4-yl)-5-methylpiperidin-3-ylcarbamate, <i>tert</i>-butyl (3<i>R</i>,4<i>R</i>,5<i>S</i>)-1-(3-aminopyridin-4-yl)-4-(<i>tert</i>-butyldimethylsilyloxy)-5-methylpiperidin-3-ylcarbamate, <i>N</i>-(4-((3<i>R</i>,4<i>R</i>,5<i>S</i>)-3-amino-4-hydroxy-5-methylpiperidin-1-yl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (<b>1</b>), and 6-(2,6-difluorophenyl)-5-fluoropicolinic acid were prepared as previously described.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> 5-Fluoro-6-(2-fluorophenyl)picolinic Acid</h3><div class="NLM_p last">To a solution of 6-bromo-5-fluoropicolinic acid (699 mg, 3.2 mmol) in DME and 2 M Na<sub>2</sub>CO<sub>3</sub> (3:1, 16 mL) were added 2-fluorophenylboronic acid (672 mg, 4.8 mmol) and Pd(dppf)Cl<sub>2</sub>-DCM (130 mg, 0.16 mmol) in a microwave vial. The vial was heated in the microwave at 120 °C for 30 min. The mixture was diluted with ethyl acetate, and 1 N NaOH was added. The organic phase was separated and extracted three more times with 1 N NaOH and once with 6 N NaOH. The combined aqueous phases were filtered and acidified to pH 1 by the addition of concentrated HCl and extracted with ethyl acetate. The organic layer was dried over magnesium sulfate, filtered, and concentrated to yield 5-fluoro-6-(2-fluorophenyl)picolinic acid (301 mg, 40%). LC/MS = 236.1 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.19 (dd, <i>J</i> = 8.61, 3.91 Hz, 1 H), 8.02 (dd, <i>J</i> = 9.39, 8.61 Hz, 1 H), 7.54–7.69 (m, 2 H), 7.35–7.44 (m, 2 H).</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> 3-Amino-6-cyclohexylpicolinic Acid</h3><div class="NLM_p last">A solution of methyl 3-amino-6-bromopicolinate (1.2 g, 5.2 mmol), cyclohexylzinc bromide 0.5 M solution in THF (13 mL, 6.5 mmol), and tetrakis(triphenylphosphine)palladium (0.25 g, 0.2 mmol) was stirred at 50 °C for 15 min. The reaction was filtered and washed with EtOAc. The organic was washed with H<sub>2</sub>O (100 mL), NaCl<sub>(sat.)</sub> (50 mL), dried over MgSO<sub>4</sub>, and the volatiles were removed in vacuo. The product was purified on silica utilizing the ISCO 0–65% gradient of hexane/EtOAc to yield methyl 3-amino-6-cyclohexylpicolinate. LCMS (<i>m</i>/<i>z</i>): 235.2 (MH<sup>+</sup>). To a solution of methyl 3-amino-6-cyclohexylpicolinate (1.2 g, 5.1 mmol) in THF (10 mL) was added 1 M LiOH (20.4 mL, 20.4 mmol). After stirring for 4 h at room temperature, 1 N HCl (20.4 mL, 20.4 mmol) was added and the THF was removed in vacuo. The resulting solid was filtered, rinsed with cold H<sub>2</sub>O (3 × 20 mL), yielding 3-amino-6-cyclohexylpicolinic acid (203 mg, 18%). LCMS (<i>m</i>/<i>z</i>): 221.0 (MH<sup>+</sup>).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> 2-(2,6-Difluorophenyl)thiazole-4-carboxylic Acid</h3><div class="NLM_p last">A solution of 2,6-difluorobenzamide (3.14 g, 0.2 mol) and Lawesson’s reagent (4.04 g, 0.1 mol) in of toluene (100 mL) was heated at 90 °C for 14 h. Upon cooling, the volatiles were removed in vacuo and purified by SiO<sub>2</sub> chromatography (25% EtOAc/hexanes) yielding 2,6-difluorobenzothioamide (3.97 g) as a light yellow solid LCMS (<i>m</i>/<i>z</i>): 174.1 (MH<sup>+</sup>). The material was used as is assuming 3.46 g. A solution of 2,6-difluorobenzothioamide (3.46 g, 0.2 mol) and ethyl bromopyruvate (2.5 mL, 0.2 mol) in ethanol (20 mL) was heated in the microwave at 130 °C for 30 min. Upon removal of volatiles in vacuo, ethyl acetate was added and the solution was washed with Na<sub>2</sub>CO<sub>3(sat.)</sub>, with NaCl<sub>(sat.)</sub>, was dried over MgSO<sub>4</sub>, filtered, and concentrated yielding ethyl 2-(2,6-difluorophenyl)thiazole-4-carboxylate (4.5 g, 84%). LCMS (<i>m</i>/<i>z</i>): 270.1 (MH<sup>+</sup>). To a solution of ethyl 2-(2,6-difluorophenyl)thiazole-4-carboxylate (4.5 g, 0.167 mol) in 2:1 THF/MeOH (100 mL) was added 1.0 M LiOH (33.5 mL, 0.335 mol). After standing for 16 h, 1.0 M HCl (33.5 mL, 0.335 mol) was added and the THF/MeOH was removed in vacuo. The resulting solid was filtered, rinsed with H<sub>2</sub>O, and dried, yielding 2-(2,6-difluorophenyl)thiazole-4-carboxylic acid (3.54 g, 88%). LCMS (<i>m</i>/<i>z</i>): 251.1 (MH<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.72 (s, 1 H), 7.65 (tt, <i>J</i> = 8.51, 6.36 Hz, 1 H), 7.28–7.39 (m, 2 H).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 3-(3-Nitropyridin-4-yl)cyclohex-2-enone (<b>I</b>)</h3><div class="NLM_p last">To a solution of cyclohexane-1,3-dione (40 g, 357 mmol) in DCM (1 L) was added Na<sub>2</sub>CO<sub>3</sub> (41.6 g, 392 mmol), and the heterogeneous solution was cooled to 0 °C. A solution of Tf<sub>2</sub>O (66.3 mL, 392 mmol) in DCM (100 mL) was added dropwise over 1 h at room temperature under a nitrogen atmosphere with an internal temperature of <2 °C. Upon addition, the reaction was stirred for 2 h (dark red solution). The solution was filtered, and to the filtrate was added saturated NaHCO<sub>3</sub> (carefully), then extracted the organics, dried with brine, then Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude material was used directly assuming 55.5 g of 3-oxocyclohex-1-enyl trifluoromethanesulfonate LC/MS = 244.9/286.0 (M + H and M + CH<sub>3</sub>CN). To a solution of 3-oxocyclohex-1-enyl trifluoromethanesulfonate (55.5 g, 227 mmol) in degassed dioxane (1 L) was added bis(pinacolato)diboron (87 g, 341 mmol), KOAc (66.9 g, 682 mmol), and Pd(dppf)Cl<sub>2</sub>–DCM (9.28 g, 11.4 mmol). The sealed reaction was heated to 80 °C for 2 h, cooled to rt, and then filtered. The dioxane solution was used for the next step without further purification. LC/MS = 140.9 (M + H of boronic acid). To a solution of 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-2-enone (50.5 g, 227 mmol) in degassed dioxane (1.4 L) and 2 M Na<sub>2</sub>CO<sub>3</sub> (335 mL) were added 4-chloro-3-nitropyridine (57.7 g, 364 mmol) and Pd(dppf)Cl<sub>2</sub>–DCM (9.28 g, 11.4 mmol) The reaction was placed under a reflux condenser and heated in an oil bath to 110 °C for 2 h. The mixture was cooled to room temperature, filtered through a pad of Celite. The pad was washed with ethyl acetate, and the filtrate was concentrated under vacuo. The residue was partitioned between brine and ethyl acetate, the layers were separated, the aqueous phase was further extracted with ethyl acetate (4×), the organics were combined, dried over sodium sulfate, filtered, and concentrated. The crude was purified via silica gel chromatography to yield 3-(3-nitropyridin-4-yl)cyclohex-2-enone <b>I</b> (27.42 g, 55%). LC/MS = 219.0 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.32 (s, 1 H), 9.21–9.42 (m, 1 H), 8.88 (d, <i>J</i> = 4.69 Hz, 1 H), 7.28 (s, 1 H), 6.01 (t, <i>J</i> = 1.37 Hz, 1 H), 2.49–2.61 (m, 5 H), 2.17–2.31 (m, 2 H).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 3-(3-Nitropyridin-4-yl)cyclohex-2-enol (<b>II</b>)</h3><div class="NLM_p last">A solution of 3-(3-nitropyridin-4-yl)cyclohex-2-enone (8.0 g, 36.7 mmol) and CeCl<sub>3</sub>·7H<sub>2</sub>O (17.4 g, 46.8 mmol) in MeOH (367 mL) was cooled at 0 °C, and NaBH<sub>4</sub> (1.39 g, 36.7 mmol) was added in portions. The reaction was stirred for 2 h at 0 °C and then quenched by adding water. The volatiles were removed in vacuo, and the residue was dissolved in EtOAc, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to yield 3-(3-nitropyridin-4-yl)cyclohex-2-enol <b>II</b> (7.59 g, 94%). LC/MS = 221.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.11 (s, 1 H), 8.75 (d, <i>J</i> = 4.99 Hz, 1 H), 7.27 (d, <i>J</i> = 4.74 Hz, 1 H), 5.72–5.85 (m, 1 H), 4.25–4.45 (m, 1 H), 2.13–2.34 (m, 2 H), 1.86–2.06 (m, 2 H), 1.68–1.86 (m, 2 H), 1.64 (d, <i>J</i> = 6.90 Hz, 1 H).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 2-(3-(3-Aminopyrin-4-yl)cyclohexyl)isoindoline-1,3-dione (<b>III</b>)</h3><div class="NLM_p last">To a homogeneous solution of 3-(3-nitropyridin-4-yl)cyclohex-2-enol (7.4 g, 33.6 mmol), triphenylphosphine (13.22 g, 50.4 mmol), and phthalimide (7.42 g, 50.4 mmol) in THF (168 mL) cooled to 0 °C was added di-<i>tert</i>-butyl azodicarboxylate (11.61 g, 50.4 mmol) in THF (32 mL). The mixture was stirred at 0 °C for 2 h. The reaction was concentrated in vacuo. The residue was purified by SiO<sub>2</sub> column chromatography (5% methanol in 1:1 ethyl acetate and hexanes) and trituration with DCM and hexanes to yield a solid, which was further triturated with DCM and hexanes to yield 2-(3-(3-nitropyridin-4-yl)cyclohex-2-enyl)isoindoline-1,3-dione (5.83 g, 50%). LC/MS (<i>m</i>/<i>z</i>): MH<sup>+</sup> = 350.2. A solution of 2-(3-(3-nitropyridin-4-yl)cyclohex-2-enyl)isoindoline-1,3-dione (5.63 g, 16.1 mmol) in MeOH (160 mL) was purged with argon for 10 min while in a steel bomb. At this time 10% Pd/C (2.57 g, 2.4 mmol) was added and the steel bomb was sealed and placed under 400 psi of H<sub>2</sub>. The reaction mixture was stirred at 50 °C for 2 days. Upon reaction completion, the solids were removed by filtration over Celite, then rinsed with EtOAc and MeOH. The filtrate was concentrated, diluted with EtOAc, and washed 2× with sat. aq 2 M Na<sub>2</sub>CO<sub>3</sub>, dried with MgSO<sub>4</sub>, filtered, concentrated, purified by SiO2 chromatography (10% MeOH in EtOAc), and triturated from EtOAc/hexanes to yield 2-(3-(3-aminopyrin-4-yl)cyclohexyl)isoindoline-1,3-dione (<b>III</b>) (2.75 g, 53%). LC/MS (<i>m</i>/<i>z</i>): MH<sup>+</sup> = 322.2. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.04 (s, 1 H), 8.01 (d, <i>J</i> = 5.09 Hz, 1 H), 7.80–7.87 (m, 2 H), 7.67–7.75 (m, 2 H), 7.05 (d, <i>J</i> = 5.09 Hz, 1 H), 4.34 (tt, <i>J</i> = 12.28, 3.77 Hz, 1 H), 3.66 (br s, 2 H), 2.60–2.72 (m, 1 H), 2.40–2.50 (m, 1 H), 2.34 (qd, <i>J</i> = 12.52, 3.91 Hz, 1 H), 2.03–2.14 (m, 1 H), 1.82–1.98 (m, 3 H), 1.45–1.65 (m, 2 H). Separation of the enantiomers under the following conditions. Column: Chiralpak OJ (25 × 2 cm). Solvent: hexane/ethanol (70:30). Flow rate: 15 mL/min. Injection volume: 5 mL (10 mg/mL solution in 1:1 MeOH/EtOH). UV: 210 nm. Peak 1: 2-((1<i>S</i>,3<i>R</i>)-3-(3-aminopyridin-4-yl)cyclohexyl)isoindoline-1,3-dione. Peak 2: 2-((1<i>R</i>,3<i>S</i>)-3-(3-aminopyridin-4-yl)cyclohexyl)isoindoline-1,3-dione.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>cis</i>-(±)-5-Methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enol (<b>IV</b>)</h3><div class="NLM_p last">To a solution of 5-methylcyclohexane-1,3-dione (56.1 g, 445 mmol) in DCM (880 mL, 0.5 M) was added Na<sub>2</sub>CO<sub>3</sub> (51.8 g, 863 mmol) and cooled to 0 °C. Tf<sub>2</sub>O (132 g, 468 mmol) in DCM (150 mL, 5.0 M) was added dropwise over 1 h at 0 °C under a nitrogen atmosphere. Upon addition, the reaction was stirred for 1 h at room temperature (dark red solution). The solution was filtered and the filtrate was quenched by careful addition of saturated NaHCO<sub>3</sub> (∼400 mL) with vigorous stirring until pH = 7. The solution was transferred to a separatory funnel, and the layers were separated. The organic layer was washed with brine, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated under vacuo, and dried under high vacuum to yield 5-methyl-3-oxocyclohex-1-enyl trifluoromethanesulfonate as light yellow oil in 78% yield (89.6 g). The triflate decomposes upon storage and should be used immediately for the next reaction. LC/MS = 259.1/300.1 (M + H and M + CH<sub>3</sub>CN). <sup>1</sup>H NMR (400 MHz, CdCl<sub>3</sub>) δ ppm: 6.05 (s, 1H), 2.70 (dd, <i>J</i> = 17.2, 4.3, 1H), 2.53 (dd, <i>J</i> = 16.6, 3.7, 1H), 2.48–2.31 (m, 2H), 2.16 (dd, <i>J</i> = 16.4, 11.7, 1H), 1.16 (d, <i>J</i> = 5.9, 3H). To a solution of 5-methyl-3-oxocyclohex-1-enyl trifluoromethanesulfonate (89.6 g, 347 mmol) in degassed dioxane (478 mL, 0.7 M) was added bis(pinacolato)diboron (176 g, 693 mmol), KOAc (102 g, 1.04 mol), and Pd(dppf)Cl<sub>2</sub>–DCM (8.5 g, 10 mmol). The reaction was heated to 80 °C for 10 h (initial heating at large scale results in exothermic formation of an orange foam on top of the solution, and the heating bath should be removed until the foam retracts; reheating to 80 °C at this point appears to be fine), then cooled to room temperature and filtered through a coarse frit glass funnel. The cake was rinsed with more dioxane (∼250 mL), and the filtrate solution was used for the next step without further purification. LC/MS = 155.1 (M + H of boronic acid). To a solution of 5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-2-enone (82 g, 347 mmol) in degassed dioxane (694 mL, 0.5 M) and 2 M Na<sub>2</sub>CO<sub>3</sub> (335 mL, 694 mmol) were added 4-chloro-3-nitropyridine (71.5 g, 451 mmol) and Pd(dppf)Cl<sub>2</sub>–DCM (14.2 g, 17.4 mmol). The reaction was placed under a reflux condenser and heated in an oil bath to 110 °C for 1 h. The mixture was cooled to room temperature, filtered through a pad of Celite. The pad was washed with ethyl acetate, and the filtrate was concentrated under vacuo. The residue was further pumped at 80 °C on a rotary evaporator for 1 h to remove boronate byproducts (M + H = 101) via sublimation. The residue was partitioned between brine and ethyl acetate, the layers were separated, the aqueous phase was further extracted with ethyl acetate (4×), the organics were combined, dried over sodium sulfate, filtered, and concentrated. The crude was purified via silica gel chromatography loading in DCM and eluting with 2–50% ethyl acetate and hexanes. The pure fractions were concentrated in vacuo to yield an orange oil. The oil was placed under high vacuum (∼500 mTorr) with seed crystals overnight to yield an orange solid. The solid was further purified via trituration in hexanes to yield 5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enone (39 g, 48% over 2 steps). LC/MS = 233.2 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm: 9.31 (s, 1H), 8.88 (d, <i>J</i> = 5.1, 1H), 7.30 (d, <i>J</i> = 5.1, 1H), 6.00 (d, <i>J</i> = 2.4, 1H), 2.62 (dd, <i>J</i> = 16.4, 3.5, 1H), 2.53–2.34 (m, 3H), 2.23 (dd, <i>J</i> = 16.1, 11.7, 1H), 1.16 (d, <i>J</i> = 6.3, 3H). To a solution of 5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enone (46 g, 198 mmol) in EtOH (990 mL) was added CeCl<sub>3</sub>·7H<sub>2</sub>O (89 g, 238 mmol). The reaction was cooled to 0 °C, then NaBH<sub>4</sub> (8.99 g, 238 mmol) was added in portions. The mixture was stirred for 1 h at 0 °C, then quenched by adding water, concentrated to remove the EtOH, added EtOAc, extracted the organics, washed with brine, then dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated and purified by SiO<sub>2</sub> chromatography (0–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to yield <i>cis</i>-(±)-5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enol <b>IV</b> (33.4 g, 72%). LC/MS = 235.2 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.07 (s, 1H), 8.79 (d, <i>J</i> = 4.70 Hz, 1H), 7.50 (d, <i>J</i> = 5.09 Hz, 1H), 5.65 (s, 1H), 4.97 (d, <i>J</i> = 5.48 Hz, 1H), 4.21 (d, <i>J</i> = 4.30 Hz, 1H), 2.04–2.15 (m, 1H), 1.75–1.98 (m, 3H), 1.07–1.19(m, 1H), 0.98 (d, <i>J</i> = 6.26 Hz, 3H).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Synthesis of <i>cis</i>-(±)-Benzyl 4-3-(<i>tert</i>-Butyldimethylsilyloxy)-5-methylcyclohexyl)pyridin-3-ylcarbamate (<b>V</b>)</h3><div class="NLM_p last">To a solution of 5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enol (<b>IV</b>) (21.9 g, 93 mmol) in DMF (93 mL, 1.0 M) were added imidazole (14 g, 206 mmol) and TBDMSCl (18.3 g, 122 mmol). After stirring for 18 h the solution was portioned between EtOAc and H<sub>2</sub>O and the layers were separated. After washing further with H<sub>2</sub>O (3×) and NaCl<sub>(sat.)</sub>, drying over MgSO<sub>4</sub>, filtering, and removal of solvents, the crude was purified via silica gel column chromatography, eluting with 0–70% ethyl acetate in hexanes to afford <i>cis</i>-(±)-4-(3-(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohex-1-enyl)-3-nitropyridine (27.3 g, 77%). LC/MS = 349.2 (M + H). To a solution of <i>cis</i>-(±)-4-(3-(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohex-1-enyl)-3-nitropyridine (23.1 g, 66.4 mmol) in methanol (221 mL), at a concentration of 0.3 M, was added 10% palladium on carbon (Degussa type, 101NE/W, 1.4 g). The resultant heterogeneous solution was put under an atmosphere of hydrogen and was stirred for 15 h. At this time the mixture was filtered through a pad of Celite, eluting with methanol. The volatiles were removed in vacuo yielding all <i>cis</i>-(±)-4-(3-(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohexyl)pyridin-3-amine (19.7 g, 93%). LCMS (<i>m</i>/<i>z</i>): 321.3 (MH<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm: 8.03 (s, 1H), 8.00 (d, <i>J</i> = 5.1, 1H), 7.0 (d, <i>J</i> = 5.1, 1H), 3.80–3.69 (m, 1H), 3.63 (bs, 1H), 3.48 (d, <i>J</i> = 5.1, 1H), 2.55 (tt, <i>J</i> = 12.2, 3.1, 1H), 1.89–2.05 (m, 2H), 1.78 (d, <i>J</i> = 12.9, 1H), 1.52–1.73 (m, 1H), 1.36–1.50 (m, 1H), 1.00–1.16 (m, 1H), 0.98 (d, <i>J</i> = 6.7, 3H), 0.89 (s, 9H), 0.08 (s, 3H), 0.06 (s, 3H). To a solution of <i>cis</i>-(±)-4-(3-(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohexyl)pyridin-3-amine (20.5 g, 64 mmol) in dichloromethane (213 mL) were added benzyl 2,5-dioxopyrrolidin-1-yl carbonate (28.7 g, 115 mmol) and DMAP (0.78 g, 6.4 mmol). After stirring for 90 h the solution was filtered through a glass frit funnel, diluted with 300 mL of DCM, washed with water (2×), brine, dried over sodium sulfate, filtered, and concentrated. The crude material was purified via silica gel column chromatography, eluting with 10–100% ethyl acetate in hexanes to yield <i>cis</i>-(±)-benzyl-4-3-(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohexyl)pyridin-3-ylcarbamate <b>V</b> (23.6 g, 81% yield). LC/MS = 455.3 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm: 8.77 (bs, 1H), 8.37 (d, <i>J</i> = 5.1, 1H), 7.29–7.49 (m, 5H), 7.17 (d, <i>J</i> = 5.1, 1H), 5.22 (s, 2H), 3.59–3.75 (m, 1H), 2.74–2.67 (m, 1H), 1.94–1.91 (m, 2H), 1.67–1.50 (m, 2H), 1.36–1.45 (m, 1H), 1.09–1.00 (m, 2H), 0.95 (d, <i>J</i> = 6.7, 3H), 0.87 (s, 9H), 0.06 (s, 3H), 0.04 (s, 3H).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>cis</i>-(±)-<i>tert</i>-Butyl (3-(3-Aminopyridin-4-yl)-5-methylcyclohexylcarbamate (<b>VI</b>)</h3><div class="NLM_p last">A solution of <i>cis</i>-(±)-benzyl 4-3-(<i>tert</i>-butyldimethylsilyloxy)-5-methylcyclohexyl)pyridin-3-ylcarbamate (<b>V</b>) (18.8 g, 41.3 mmol) in 1:2:1 6 N HCl/THF/MeOH (138 mL) was stirred at rt for 1 h. The pH was then adjusted to pH = 7 by addition of 6 N NaOH, and the volatiles were removed in vacuo. The residue was partitioned between ethyl acetate and water, the aqueous layer was extracted with EtOAc, and the organic phase was washed with NaCl<sub>(sat.)</sub>, dried over MgSO<sub>4</sub>, filtered, and upon removal of the volatiles in vacuo, silica gel column chromatography eluting with 0–20% (1:1 DCM/MeOH) in DCM afforded 13.2 g of <i>cis</i>-(±)benzyl 4-(3-hydroxy-5-methylcyclohexyl)pyridin-3-ylcarbamate in 94% yield. LC/MS = 341.2 (M + H), LC = 2.38 min. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ <i>J</i> = 5.3, 1H), 6.70 (bs, 1H), 5.20 (s, 2H), 3.72–3.65 (m, 1H), 2.79–2.74 (m, 1H), 2.04–1.97 (m, 2H),1.69–1.50 (m, 2H), 1.37–1.26 (m, 1H), 1.01–0.94 (m, 2H), 0.97 (d, <i>J</i> = 6.5, 3H). To a 0 °C solution of <i>cis</i>-(±)-benzyl 4-(3-hydroxy-5-methylcyclohexyl)pyridin-3-ylcarbamate (13.2 g, 38.8 mmol) in wet CH<sub>2</sub>Cl<sub>2</sub> (194 mL) was added Dess-Martin Periodinane (16.5 g, 38.9 mmol) and the solution was stirred for 1 h as it warmed to rt. The solution was partitioned between EtOAc and 1:1 10% Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub>/NaHCO<sub>3(sat.)</sub> and separated. Upon further washing with 1:1 10% Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub>/NaHCO<sub>3(sat.)</sub> (2x) and NaCl<sub>(sat.),</sub> drying over MgSO<sub>4</sub>, filtering, removal of solvents, cis-(±)-benzyl-4-(3-methyl-5-oxocyclohexyl)pyridin-3-ylcarbamate was obtained (11.9 g, 91%). LC/MS = 339.2 (M + H), LC: 2.47 min. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm: 8.70 (bs, 1H), 8.43 (d, <i>J</i> = 5.3, 1H), 7.30–7.45 (m, 5H), 7.20 (d, <i>J</i> = 5.3, 1H), 6.90 (s, 1H), 5.19 (s, 2H), 3.27–3.04 (m, 1H), 2.52–2.22 (m, 3H), 2.13–1.79 (m, 3H), 1.52 (q, <i>J</i> = 12.4, 1H), 1.06 (d, <i>J</i> = 6.2, 3H). A solution of cis-(±)-benzyl-4-(3-methyl-5-oxocyclohexyl)pyridin-3-ylcarbamate (11.9 g, 35.2 mmol) and benzylamine (11.3 g, 105 mmol) in MeOH (117 mL) was stirred at rt for 2 h. Upon cooling in a −78 °C bath, LiBH<sub>4</sub> (19.3 mL, 38.6 mmol, 2.0 M in THF) was added dropwise and the solution was allowed to warm to rt with stirring over 1.5 h. The solution was partitioned between EtOAc and NaHCO<sub>3(sat.)</sub>, separated, washed further with NaHCO<sub>3(sat.)</sub> and NaCl<sub>(sat.),</sub> dried over MgSO<sub>4</sub>, filtered, and after removal of volatiles in vacuo, <i>cis</i>-(±)- benzyl 4-(-3-(benzylamino)-5-methylcyclohexyl)pyridin-3-ylcarbamate was obtained as a 4:1 mixture of isomers, with the all cis as predominant (15.3 g, >99% yield). LC/MS = 430.3 (M + H), LC = 2.38 min. To a solution of <i>cis</i>-(±)- benzyl 4-(-3-(benzylamino)-5-methylcyclohexyl)pyridin-3-ylcarbamate (15.1 g, 35.2 mmol) in methanol (176 mL) was added 20% palladium hydroxide on carbon (4.9 g, 0.2 equiv). The resultant heterogeneous solution was put under an atmosphere of hydrogen and was stirred for 14 h. At this time the reaction was purged with Ar, Boc<sub>2</sub>O (15.4 g, 70.6 mmol) was added, and the solution was stirred for 8 h. Additional Boc<sub>2</sub>O (7.7 g, 35.3 mmol) was added and the solution was stirred for 16 more hours. At this time the mixture was filtered through a pad of Celite eluting with methanol. Upon removal of volatiles in vacuo, purification by silica gel chromatography eluting with 0–20% (1:1 MeOH/DCM) in DCM yielded 7 g of a white foam. Further recrystallization from 10% EtOAc/hexanes yielded <i>cis</i>-(±)-<i>tert</i>-butyl (3-(3-aminopyridin-4-yl)-5-methylcyclohexylcarbamate (5 g, 47%). LCMS (<i>m/z</i>): 306.3 (MH<sup>+</sup>), LC <i>t</i><sub>R</sub> = 2.59 min. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.04 (s, 1H), 7.98 (d, <i>J</i> = 5.1, 1H), 6.94 (d, <i>J</i> = 5.1, 1H), 4.3 (m, 1H), 3.77–3.54 (m, 2H), 2.68–2.54 (m, 1H), 2.19 (d, <i>J</i> = 12.5, 1H), 2.06 (d, <i>J</i> = 12.2, 1H), 1.83 (d, <i>J</i> = 12.9, 1H), 1.76–1.62 (m, 1H), 1.44 (s, 9H), 1.20–1.09 (m, 2H), 0.99 (d, <i>J</i> = 6.7, 3H), 0.86 (q, <i>J</i> = 12.0, 1H). Pure enantiomers were by chiral HPLC. Separation of the enantiomers was performed under the following conditions. Column: Chiralpak AD (50 mm × 500 mm). Solvent: heptane/ethanol/methanol (70:25:5). Flow rate: 60 mL/min. Injection volume: 1 g/10 mL 1:1 MeOH/mobile phase. UV: 210 nm. Analytical chiral HPLC on Chiracel OD 10 μM; solvent, heptane/EtOH (80:20); flow rate = 1.2 mL/min where peak 1 comes at 12.12 min and peak 2 comes at 19.07 min. Peak 1 = <i>tert</i>-butyl (1<i>R</i>,3<i>S</i>,5<i>R</i>)-3-(3-aminopyridin-4-yl)-5-methylcyclohexylcarbamate. Peak 2 = <i>tert</i>-butyl (1<i>S</i>,3<i>R</i>,5<i>S</i>)-3-(3-aminopyridin-4-yl)-5-methylcyclohexylcarbamate</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (±)-6-Bromo-5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enol (<b>VII</b>)</h3><div class="NLM_p last">To a solution of 5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enol (<b>IV</b>) (28.9 g, 123 mmol) in dioxane (1.2 L, 0.1 M) was added p-TSA (25.8 g, 135 mmol), and the reaction was stirred at 100 °C for 3 h. The solution was cooled to room temperature, then passed through a column of neutral alumina eluting with EtOAc to yield (±)-4-(5-methylcyclohexa-1,3-dienyl)-3-nitropyridine as a yellow oil in 68% yield (14.7 g). <sup>1</sup>H NMR indicated about 12–15% contamination of another diene isomer. LC/MS = 217.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.01 (s, 1H), 8.70 (d, <i>J</i> = 5.1, 1H), 7.29 (d, <i>J</i> = 5.3, 1H), 6.14 (dd, <i>J</i> = 5.4, 0.85, 1H), 6.05 (dd, <i>J</i> = 5.4, 2.3, 1H), 5.89 (dd, <i>J</i> = 9.6, 3.7, 1H), 2.55–2.68 (m, 1H), 2.33–2.43 (m, 1H), 2.17–2.27 (m, 1H), 1.1 (d, <i>J</i> = 7.1, 3H). To a solution of 4-(5-methylcyclohexa-1,3-dienyl)-3-nitropyridine (14.7 g, 67 mmol) in THF and water (1:1, 515 mL) was added NBS (18.2 g, 102 mmol), and the reaction was stirred at room temperature for 30 min. Upon completion, ethyl acetate and water were added to the reaction, the organic phase was washed with brine, then dried with sodium sulfate, filtered, and concentrated. The crude material was purified via silica gel column chromatography, eluting with ethyl acetate and hexanes (1:1) to give (±)-6-bromo-5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enol <b>VII</b> as a yellow oil in 80% yield (17.9 g). LC/MS = 315.0/313.0 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.17 (s, 1 H), 8.78 (d, <i>J</i> = 4.70 Hz, 1 H), 7.30 (d, <i>J</i> = 4.70 Hz, 1 H), 5.74–5.79 (m, 1 H), 4.55 (t, <i>J</i> = 3.72 Hz, 1 H), 4.27 (t, <i>J</i> = 2.54 Hz, 1 H), 2.59 (br s, 1 H), 2.28–2.36 (m, 1 H), 2.22–2.28 (m, 2 H), 1.18 (d, <i>J</i> = 6.26 Hz, 3 H).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (±)-2-Azido-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enol (<b>VIII</b>)</h3><div class="NLM_p last">To a solution of (±)-6-bromo-5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enol (<b>VII)</b> (16 g, 51.5 mmol) in THF (510 mL) was added potassium <i>tert</i>-butoxide (8.6 g, 77 mmol) in portions. The reaction turned from orange to black almost immediately. By TLC, the formation of product is clean in 30 min. The reaction was quenched by adding saturated ammonium chloride and ethyl acetate. The organic phase was washed with brine, then dried with sodium sulfate, filtered, and concentrated. The crude product was dissolved in ethanol and water (3:1, 400 mL, 0.1 M), and ammonium chloride (5.5 g, 103 mmol) and sodium azide (6.6 g, 103 mmol) were added. The dark orange reaction was stirred at room temperature overnight. The conversion to product is clean as indicated by LC/MS. The reaction was concentrated to remove the ethanol, ethyl acetate and water were added, the organic phase was dried with sodium sulfate, filtered, and concentrated. The crude material was purified via silica gel column chromatography, eluting with ethyl acetate and hexanes (1:1) to give  <b>VIII</b> in 55% yield (12 g). LC/MS = 276.0 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.18 (s, 1 H), 8.78 (d, <i>J</i> = 5.09 Hz, 1 H), 7.25 (d, <i>J</i> = 5.09 Hz, 1 H), 5.57 (t, <i>J</i> = 2.15 Hz, 1 H), 4.01–4.09 (m, 1 H), 3.45–3.58 (m, 1 H), 2.26–2.41 (m, 2 H), 2.06–2.22 (m, 2 H),1.12–1.17 (m, 3 H).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (±)-4-(3-Aminopyridin-4-yl)-2-(<i>tert</i>-butoxycarbonylamino)-6-methylcyclohexyl Acetate (<b>IX</b>)</h3><div class="NLM_p last">To a solution of (±)-2-azido-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enol (<b>VIII</b>) (12 g, 44 mmol) in pyridine and ammonium hydroxide (8:1, 225 mL) was added trimethylphosphine (9.95 g, 131 mmol), and the brown solution was stirred at room temperature for 2 h (bubbling). Upon completion, EtOH (50 mL) was added and the solution was concentrated in vacuo. More ethanol (50 mL) was added, and the reaction was concentrated again. Dioxane and sat. NaHCO<sub>3</sub> (1:1, 200 mL, 0.08 M) were added to the crude, followed by Boc<sub>2</sub>O (9.5 g, 44 mmol). The reaction mixture was stirred at room temperature for 2 h, then water and ethyl acetate were added. The organic phase was dried with MgSO<sub>4</sub>, and concentrated. The crude product was purified via silica gel column chromatography, eluting with ethyl acetate and hexanes (1:1) to afford (±)-<i>tert</i>-butyl 6-hydroxy-5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enylcarbamate (7.9 g, 59%). LC/MS = 350.1 (M + H).<sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.12 (s, 1 H), 8.75 (d, <i>J</i> = 5.09 Hz, 1 H), 7.24 (d, <i>J</i> = 4.70 Hz, 1 H), 5.46 (t, <i>J</i> = 2.35 Hz, 1 H), 4.77 (m, 1 H), 4.27 (m, 1 H), 3.48 (m, 1 H), 3.36–3.41 (m, 1 H), 1.95–2.34 (m, 4 H), 1.43–1.50 (m, 9 H), 1.14 (d, <i>J</i> = 6.26 Hz, 3 H). To a solution of (±)-<i>tert</i>-butyl 6-hydroxy-5-methyl-3-(3-nitropyridin-4-yl)cyclohex-2-enylcarbamate (7.7 g, 22 mmol) in pyridine (220 mL) was added Ac<sub>2</sub>O (6.2 mL, 66 mmol), and the reaction was stirred at room temperature overnight. Upon completion, the reaction was concentrated to dryness, then worked up with ethyl acetate and water. The organic phase was washed with brine, then dried with sodium sulfate, filtered, and concentrated to give (±)-2-(<i>tert</i>-butoxycarbonylamino)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enyl acetate in 99% yield (8.5 g). LC/MS = 392.2 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.14 (s, 1 H), 8.75 (d, <i>J</i> = 5.09 Hz, 1 H) 7.23 (d, <i>J</i> = 5.09 Hz, 1 H), 5.50–5.59 (m, 1 H), 4.81 (t, <i>J</i> = 9.78 Hz, 1 H), 4.72 (d, <i>J</i> = 9.00 Hz, 1 H), 4.40–4.53 (m, 1 H), 2.18–2.46 (m, 4 H), 2.13 (s, 3 H), 1.42 (s, 9 H), 1.01 (d, <i>J</i> = 5.87 Hz, 3 H). To a degassed solution of (±)-2-(<i>tert</i>-butoxycarbonylamino)-6-methyl-4-(3-nitropyridin-4-yl)cyclohex-3-enyl acetate (8.5 g, 22 mmol) in MeOH and EtOAc (1:1, 200 mL) was added 10% Pd/C (2.3 g, 2.2 mmol), and the reaction was stirred at room temperature under a hydrogen balloon for 3 days. Upon completion, the solution was filtered through a pad of Celite, the pad was washed with ethyl acetate, and the filtrate was concentrated. The crude material contained about 10% of the undesired isomer. The crude was dissolved in ethyl acetate (∼20%) and hexanes and heated until all dissolved. The solution was allowed to sit at room temperature for 2 days. The precipitate was then collected to give (±)-4-(3-aminopyridin-4-yl)-2-(<i>tert</i>-butoxycarbonylamino)-6-methylcyclohexyl acetate as the pure product in 75% yield (5.9 g). LC/MS = 364.3 (M + H), <i>t</i><sub>R</sub> = 0.63 min. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.05 (s, 1 H), 8.00 (d, <i>J</i> = 5.09 Hz, 1 H), 6.93 (d, <i>J</i> = 5.09 Hz, 1 H), 4.64 (d, <i>J</i> = 8.61 Hz, 1 H), 4.52 (t, <i>J</i> = 10.17 Hz, 1 H), 3.77–3.83 (m, 1 H), 3.66 (br s, 2 H), 2.68–2.74 (m, 1 H), 2.26 (ddd, <i>J</i> = 12.91, 6.85, 2.93 Hz, 1 H), 2.12 (s, 3 H), 1.83–1.99 (m, 2 H), 1.42 (s, 9 H), 1.39–1.27 (m, 2 H), 0.99 (d, <i>J</i> = 6.26 Hz, 3 H). Separation of the enantiomers was performed under the following conditions. Column: Chiralpak AD (50 mm × 500 mm). Solvent: heptane/2-propanol (80:20). Flow rate: 80 mL/min. Injection volume: 10 mL. UV: 210 nm. Peak 1, (1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-((<i>tert</i>-butoxycarbonyl)amino)-6-methylcyclohexyl acetate (<b>IX</b>), at 8.043 min. Peak 2, (1<i>S</i>,2<i>S</i>,4<i>S</i>,6<i>R</i>)-4-(3-aminopyridin-4-yl)-2-((<i>tert</i>-butoxycarbonyl)amino)-6-methylcyclohexyl acetate, at 14.581 min.</div></div><div id="sec5_12_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure for Amide Coupling and Amine Deprotection for Preparing <b>4</b>–<b>16</b>. <i>tert</i>-Butyl (1<i>S</i>,3<i>R</i>,5<i>S</i>)-3-(3-(6-(2,6-Difluorophenyl)-5-fluoropicolinamido)pyridin-4-yl)-5-methylcyclohexylcarbamate (<b>8</b>)</h3><div class="NLM_p last">A solution of <i>tert</i>-butyl (1<i>S</i>,3<i>R</i>,5<i>S</i>)-3-(3-aminopyridin-4-yl)-5-methylcyclohexylcarbamate (1.46 g, 4.78 mmol), 6-(2,6-difluorophenyl)-5-fluoropicolinic acid (1.57 g, 6.21 mmol), EDC–HCl (1.2 g, 6.21 mmol), and HOAt (0.85 g, 6.21 mmol) in DMF (24 mL, 0.2 M) was stirred at room temperature overnight. The reaction was poured into water and extracted with ethyl acetate (4×). The combined organics were washed with 0.5 N NaOH (3×), brine, dried over sodium sulfate, filtered, and concentrated to afford <i>tert</i>-butyl (1<i>S</i>,3<i>R</i>,5<i>S</i>)-3-(3-(6-(2,6-difluorophenyl)-5-fluoropicolinamido)pyridin-4-yl)-5-methylcyclohexylcarbamate in 91% yield (2.34 g). LCMS (<i>m/z</i>): 541.0 (MH<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.86 (s, 1H), 9.34 (s, 1H), 8.43 (dd, <i>J</i> = 8.6, 3.9, 1H), 8.39 (d, <i>J</i> = 5.1, 1H), 7.77 (t, <i>J</i> = 8.4, 1H), 7.58–7.43 (m, 1H), 7.17–7.05 (m, 3H), 4.43 (bs, 1H), 3.55 (bs, 1H), 2.94–2.80 (m, 1H), 2.13 (d, <i>J</i> = 12.2, 1H), 2.07–1.94 (m, 1H), 1.83 (d, <i>J</i> = 12.9, 1H), 1.60–1.47 (m, 1H), 1.43 (m, 9H), 1.40–1.30 (m, 1H), 1.05–0.89 (m, 1H), 0.86 (d, <i>J</i> = 6.3, 3H), 0.82–0.71 (m, 1H). A solution of 4 M HCl in dioxane (13.4 mL, 53.6 mmol) was added to <i>tert</i>-butyl (1<i>S</i>,3<i>R</i>,5<i>S</i>)-3-(3-(6-(2,6-difluorophenyl)-5-fluoropicolinamido)pyridin-4-yl)-5-methylcyclohexylcarbamate (2.9 g, 5.36 mmol), and the reaction mixture was stirred at room temperature for 17 h. The heterogeneous solution was concentrated in vacuo to yield a white solid which was further dissolved in MeOH and diethyl ether (1:21). The mixture was sonicated, and the precipitate was filtered. The precipitate was dried under high vacuum for several days to yield <i>N</i>-(4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide as the HCl salt in 80% yield. The free base was obtained by partitioning the salt between EtOAc and Na<sub>2</sub>CO<sub>3</sub> (sat.), washing with brine, drying over MgSO<sub>4</sub>, and removal of volatiles in vacuo. LCMS (<i>m</i>/<i>z</i>): 441.3 (MH<sup>+</sup>). HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>24</sub>H<sub>24</sub>F<sub>3</sub>N<sub>4</sub>O (MH<sup>+</sup>) 441.1902, found 441.1905. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, bis-HCl salt) δ 10.59 (s, 1H), 8.92 (s, 1H), 8.62 (d, <i>J</i> =  6.0, 1H), 8.37 (dd, <i>J</i> = 8.8, 4.0, 1H), 8.23 (t, <i>J</i> = 8.8, 1H), 8.19 (bs, 2H), 7.68–7.71 (m, 2H), 7.36–7.40 (m, 2H),3.01–3.10 (m, 2H), 2.01–2.05 (m, 1H), 1.94–1.97 (m, 1H), 1.72–1.76 (m, 1H), 1.46–1.53 (m, 2H), 1.01–1.13 (m, 2H), 0.89 (d, <i>J</i> = 6.8, 3H). <sup>13</sup>C NMR (125.77 MHz, CDCl<sub>3</sub>, free base) 160.8, 160.5, 159.8, 18, 131.8, 131.4, 125.4, 124.8, 120.7, 111.9, 111.8, 50.3, 44.3, 41.6, 39.8, 36.5, 31.6, 22.1. In variations of this general method, the Boc group could be deprotected by treatment with 25% TFA/CH<sub>2</sub>Cl<sub>2</sub> for 30 min, and upon concentration of the volatiles in vacuo, purification via RP-HPLC yielded final compounds as TFA salts after lyophilization. Compounds in free base form were obtained by partitioning HPLC purified fractions between EtOAc and Na<sub>2</sub>CO<sub>3</sub>(s), washing with brine, drying over MgSO<sub>4</sub>, and removal of volatiles in vacuo. For compounds <b>10</b>, <b>12</b>, and <b>16</b> the phthalimide group was removed by treating with hydrazine (10 equiv) in MeOH (0.1M) at 60 °C for 2 h or overnight at rt.</div></div><div id="sec5_12_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-(4-((1<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3-Amino-4-hydroxy-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (<b>4</b>)</h3><div class="NLM_p last">Following the general procedure, (1<i>R</i>,2<i>R</i>,4<i>R</i>,6<i>S</i>)-4-(3-aminopyridin-4-yl)-2-(<i>tert</i>-butoxycarbonylamino)-6-methylcyclohexyl acetate and 6-(2,6-difluorophenyl)-5-fluoropicolinic acid were coupled and deprotected to yield <b>2</b>. The acetate group was removed prior to Boc deprotection by treating with K<sub>2</sub>CO<sub>3</sub> (1.2 equiv) in EtOH (0.1 M) overnight. LC/MS = 457.3 (M + H). HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>24</sub>H<sub>24</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> (MH<sup>+</sup>) 457.1851, found 457.1855. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, HCl salt) δ 10.42 (s, 1H), 8.65 (s, 1H), 8.45 (d, <i>J</i> = 5.1, 1H), 8.33 (dd, <i>J</i> = 8.6, 3.9, 1H), 8.19 (t, <i>J</i> = 8.8, 1H), 8.0 (bs, 2H), 7.69 (m, 1H), 7.39–7.32 (m, 3H), 3.07–2.94 (m, 2H), 2.82 (m, 1H), 2.03–2.00 (m, 1H), 1.74–1.59 (m, 2H), 1.40 (m, 1H), 1.23 (m, 1H), 0.93 (d, <i>J</i> = 6.3, 3H).</div></div><div id="sec5_12_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-(4-((3<i>S</i>,5<i>R</i>)-3-Amino-5-methylpiperidin-1-yl)pyridin-3-yl)-5-fluoro-6-(2-fluorophenyl)picolinamide (<b>5</b>)</h3><div class="NLM_p last">Following the general procedure <i>tert</i>-butyl (3<i>S</i>,5<i>R</i>)-1-(3-aminopyridin-4-yl)-5-methylpiperidin-3-ylcarbamate and 5-fluoro-6-(2-fluorophenyl)picolinic acid were coupled and deprotected to yield <b>5</b>. LC/MS = 424.1 (M + H). HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>23</sub>H<sub>24</sub>F<sub>2</sub>N<sub>5</sub>O (MH<sup>+</sup>) 424.1949, found 424.1953. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, TFA salt) δ ppm 10.39 (s, 1 H), 9.13 (s, 1 H), 8.39 (d, <i>J</i> = 6.21 Hz, 1 H), 8.34 (dd, <i>J</i> = 8.58, 3.84 Hz, 1 H), 8.18 (t, <i>J</i> = 8.97 Hz, 1 H), 7.99 (br s, 2 H), 7.76–7.84 (m, 1 H), 7.60–7.72 (m, 1 H), 7.41–7.50 (m, 2 H), 7.32 (d, <i>J</i> = 6.26 Hz, 1 H), 3.66–3.79 (m, 1 H), 3.57 (d, <i>J</i> = 10.27 Hz, 1 H), 3.18 (br s, 1 H), 2.85 (t, <i>J</i> = 11.30 Hz, 1 H), 2.28–2.41 (m, 1 H), 1.82 (d, <i>J</i> = 12.32 Hz, 1 H), 1.70 (d, <i>J</i> = 6.46 Hz, 1 H), 1.05 (q, <i>J</i> = 11.88 Hz, 1 H), 0.59 (d, <i>J</i> = 6.55 Hz, 3 H).</div></div><div id="sec5_12_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-(4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-5-fluoro-6-(2-fluorophenyl)picolinamide (<b>6</b>)</h3><div class="NLM_p last">Following the general procedure <i>tert</i>-butyl (1<i>S</i>,3<i>R</i>,5<i>S</i>)-3-(3-aminopyridin-4-yl)-5-methylcyclohexylcarbamate and 5-fluoro-6-(2-fluorophenyl)picolinic acid were coupled and deprotected to yield <b>6</b>. LC/MS = 423.1 (M + H). HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>24</sub>H<sub>25</sub>F<sub>2</sub>N<sub>4</sub>O (MH<sup>+</sup>) 423.1996, found 423.1996. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, TFA salt) δ ppm 10.42 (s, 1 H), 8.72 (s, 1 H), 8.47 (d, <i>J</i> = 5.18 Hz, 1 H), 8.27 (dd, <i>J</i> = 8.61, 3.91 Hz, 1 H), 8.13 (t, <i>J</i> = 9.05 Hz, 1 H), 7.89 (td, <i>J</i> = 7.52, 1.79 Hz, 1 H), 7.81 (br s, 2 H), 7.59–7.70 (m, 1 H), 7.35–7.49 (m, 3 H), 3.09 (d, <i>J</i> = 3.62 Hz, 1 H), 2.96 (t, <i>J</i> = 12.13 Hz, 1 H), 2.00 (d, <i>J</i> = 11.88 Hz, 1 H), 1.89 (d, <i>J</i> = 12.91 Hz, 1 H), 1.75 (d, <i>J</i> = 12.52 Hz, 1 H), 1.52 (br s, 1 H), 1.41 (q, <i>J</i> = 11.95 Hz, 1 H), 0.95–1.12 (m, 2 H), 0.89 (d, <i>J</i> = 6.50 Hz, 3 H).</div></div><div id="sec5_12_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-(4-((3<i>S</i>,5<i>R</i>)-3-Amino-5-methylpiperidin-1-yl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (<b>7</b>)</h3><div class="NLM_p last">Following the general procedure <i>tert</i>-butyl (3<i>S</i>,5<i>R</i>)-1-(3-aminopyridin-4-yl)-5-methylpiperidin-3-ylcarbamate and 6-(2,6-difluorophenyl)-5-fluoropicolinic acid were coupled and deprotected to yield <b>7</b>. LC/MS = 442.3 (M + H). HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>23</sub>H<sub>23</sub>F<sub>3</sub>N<sub>5</sub>O (MH<sup>+</sup>) 442.1855, found 442.1856. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>, TFA salt) δ ppm 9.29 (s, 1 H), 8.47 (dd, <i>J</i> = 8.68, 3.94 Hz, 1 H), 8.39 (d, <i>J</i> = 6.46 Hz, 1 H), 8.07 (t, <i>J</i> = 8.68 Hz, 1 H), 7.59–7.76 (m, 1 H), 7.48 (d, <i>J</i> = 6.55 Hz, 1 H), 7.25 (t, <i>J</i> = 8.56 Hz, 2 H), 3.81–3.97 (m, 1 H), 3.72 (d, <i>J</i> = 12.67 Hz, 1 H), 3.32–3.41 (m, 1 H), 3.01 (t, <i>J</i> = 11.32 Hz, 1 H), 2.47 (t, <i>J</i> = 12.25 Hz, 1 H), 2.00 (d, <i>J</i> = 12.28 Hz, 1 H), 1.79–1.93 (m, 1 H), 1.20 (q, <i>J</i> = 12.13 Hz, 1 H), 0.73 (d, <i>J</i> = 6.60 Hz, 3 H).</div></div><div id="sec5_12_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (<i>S</i>)-3-Amino-<i>N</i>-(4-(3-aminopiperidin-1-yl)pyridin-3-yl)-6-cyclohexylpicolinamide (<b>9</b>)</h3><div class="NLM_p last">Following the general procedure (<i>S</i>)-<i>tert</i>-butyl 1-(3-aminopyridin-4-yl)piperidin-3-ylcarbamate and 3-amino-6-cyclohexylpicolinic acid were coupled and deprotected to yield <b>9</b>. LC/MS = 395.2 (M + H). HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>22</sub>H<sub>31</sub>N<sub>6</sub>O (MH<sup>+</sup>) 395.2559, found 395.2560. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>, TFA salt) δ ppm 9.33 (s, 1 H), 8.37 (d, <i>J</i> = 6.50 Hz, 1 H), 7.50 (d, <i>J</i> = 6.50 Hz, 1 H), 7.16–7.34 (m, 2 H), 3.83 (d, <i>J</i> = 12.08 Hz, 1 H), 3.65 (d, <i>J</i> = 12.76 Hz, 1 H), 3.51–3.60 (m, 1 H), 3.04–3.18 (m, 2 H), 2.61–2.73 (m, 1 H), 2.26 (dd, <i>J</i> = 13.30, 3.42 Hz, 1 H), 1.86–2.07 (m, 5 H), 1.81 (d, <i>J</i> = 12.37 Hz, 1 H), 1.64–1.77 (m, 1 H), 1.26–1.62 (m, 6 H).</div></div><div id="sec5_12_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 3-Amino-<i>N</i>-(4-((1<i>R</i>,3<i>S</i>)-3-aminocyclohexyl)pyridin-3-yl)-6-cyclohexylpicolinamide (<b>10</b>)</h3><div class="NLM_p last">Following the general procedure 2-(3-(3-aminopyrin-4-yl)cyclohexyl)isoindoline-1,3-dione and 3-amino-6-cyclohexylpicolinic acid were coupled and deprotected to yield <b>10</b>. LC/MS = 394.2 (M + H). HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>23</sub>H<sub>32</sub>N<sub>5</sub>O (MH<sup>+</sup>) 394.2607, found 394.2610. <sup>1</sup>H NMR (400 MHz, cd3od, TFA salt) δ ppm 9.47 (s, 1 H), 8.49 (d, <i>J</i> = 5.67 Hz, 1 H), 7.77 (d, <i>J</i> = 5.72 Hz, 1 H), 7.16–7.33 (m, 2 H), 3.11–3.24 (m, 1 H), 2.63–2.74 (m, 1 H), 2.26 (d, <i>J</i> = 11.98 Hz, 1 H), 2.11–2.22 (m, 2 H), 1.96–2.11 (m, 3 H), 1.91 (d, <i>J</i> = 12.81 Hz, 2 H), 1.77–1.86 (m, 1 H), 1.66–1.77 (m, 2 H), 1.40–1.66 (m, 6 H), 1.23–1.40 (m, 2 H).</div></div><div id="sec5_12_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (<i>S</i>)-<i>N</i>-(4-(3-Aminopiperidin-1-yl)pyridin-3-yl)-2-(2,6-difluorophenyl)thiazole-4-carboxamide (<b>11</b>)</h3><div class="NLM_p last">Following the general procedure (<i>S</i>)-<i>tert</i>-butyl 1-(3-aminopyridin-4-yl)piperidin-3-ylcarbamate and 2-(2,6-difluorophenyl)thiazole-4-carboxylic acid were coupled and deprotected to yield <b>11</b>. LC/MS = 416.1 (M + H). HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>20</sub>H<sub>20</sub>F<sub>2</sub>N<sub>5</sub>OS (MH<sup>+</sup>) 416.1357, found 416.1354. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, HCl salt) δ ppm 10.25 (s, 1 H), 8.88 (s, 1 H), 8.80 (s, 1 H), 8.41 (d, <i>J</i> = 6.80 Hz, 1 H), 8.33 (br s, 3 H), 7.64–7.76 (m, 1 H), 7.34–7.46 (m, 3 H), 3.86 (d, <i>J</i> = 9.34 Hz, 1 H), 3.56 (d, <i>J</i> = 13.84 Hz, 1 H), 3.37 (br s, 2 H), 3.27 (br s, 1 H), 1.93–2.05 (m, 1 H), 1.79–1.93 (m, 1 H), 1.51–1.77 (m, 2 H).</div></div><div id="sec5_12_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-(4-((1<i>R</i>,3<i>S</i>)-3-Aminocyclohexyl)pyridin-3-yl)-2-(2,6-difluorophenyl)thiazole-4-carboxamide (<b>12</b>)</h3><div class="NLM_p last">Following the general procedure 2-(3-(3-aminopyrin-4-yl)cyclohexyl)isoindoline-1,3-dione and 2-(2,6-difluorophenyl)thiazole-4-carboxylic acid were coupled and deprotected to yield <b>12</b>. LC/MS = 415.0 (M + H). HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>21</sub>H<sub>21</sub>F<sub>2</sub>N<sub>4</sub>OS (MH<sup>+</sup>) 415.1404, found 415.1403. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, TFA salt) δ ppm 10.21 (s, 1 H), 8.74 (s, 1 H), 8.64 (s, 1 H), 8.49 (d, <i>J</i> = 5.23 Hz, 1 H), 7.82 (br s, 3 H), 7.63–7.77 (m, 1 H), 7.32–7.47 (m, 3 H), 3.10 (br s, 1 H), 2.94 (t, <i>J</i> = 11.79 Hz, 1 H), 1.91–2.05 (m, 2 H), 1.71–1.90 (m, 2 H), 1.46 (q, <i>J</i> = 12.23 Hz, 1 H), 1.26–1.38 (m, 3 H).</div></div><div id="sec5_12_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-(4-((3<i>S</i>,5<i>R</i>)-3-Amino-5-methylpiperidin-1-yl)pyridin-3-yl)-2-(2,6-difluorophenyl)thiazole-4-carboxamide (<b>13</b>)</h3><div class="NLM_p last">Following the general procedure <i>tert</i>-butyl (3<i>S</i>,5<i>R</i>)-1-(3-aminopyridin-4-yl)-5-methylpiperidin-3-ylcarbamate and 2-(2,6-difluorophenyl)thiazole-4-carboxylic acid were coupled and deprotected to yield <b>13</b>. LC/MS = 430.0 (M + H). HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>21</sub>H<sub>22</sub>F<sub>2</sub>N<sub>5</sub>OS (MH<sup>+</sup>) 430.1513, found 430.1514. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, HCl salt) δ ppm 9.85 (s, 1 H), 9.24 (s, 1 H), 8.81 (s, 1 H), 8.33 (d, <i>J</i> = 5.53 Hz, 1 H), 8.12 (br s, 3 H), 7.65–7.76 (m, 1 H), 7.41 (t, <i>J</i> = 8.83 Hz, 2 H), 7.22 (d, <i>J</i> = 5.53 Hz, 1 H), 3.51 (d, <i>J</i> = 9.19 Hz, 1 H), 3.31–3.32 (m, 2 H), 2.64–2.75 (m, 1 H), 2.34 (t, <i>J</i> = 11.57 Hz, 1 H), 2.06 (d, <i>J</i> = 12.18 Hz, 1 H), 1.95 (d, <i>J</i> = 6.31 Hz, 1 H), 1.13 (q, <i>J</i> = 12.05 Hz, 1 H), 0.80 (d, <i>J</i> = 6.55 Hz, 3 H).</div></div><div id="sec5_12_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-(4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-2-(2,6-difluorophenyl)thiazole-4-carboxamide (<b>14</b>)</h3><div class="NLM_p last">Following the general procedure <i>tert</i>-butyl (1<i>S</i>,3<i>R</i>,5<i>S</i>)-3-(3-aminopyridin-4-yl)-5-methylcyclohexylcarbamate and 2-(2,6-difluorophenyl)thiazole-4-carboxylic acid were coupled and deprotected to yield <b>14</b>. LC/MS = 429.2 (M + H). HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>22</sub>H<sub>23</sub>F<sub>2</sub>N<sub>4</sub>OS (MH<sup>+</sup>) 429.1561, found 429.1561. <sup>1</sup>H NMR (400, DMSO-<i>d</i><sub>6</sub>, HCl salt): δ 10.21 (s, 1H), 8.74 (s, 1H), 8.64 (bs, 1H), 8.47 (d, <i>J</i> = 4.8, 1H), 7.99 (bs, 2H), 7.64–7.12 (m, 1H), 7.35–7.42 (m, 3H), 3.11 (bs, 1H), 2.93–3.00 (m, 1H), 2.01 (d, <i>J</i> = 12.4, 1H), 1.92 (d, <i>J</i> = 11.6, 1H), 1.74 (d, <i>J</i> = 12.4, 1H), 1.52–1.60 (m, 1H), 1.42 (q, <i>J</i> = 12.0, 1H), 1.00–1.10 (m, 2H), 0.92 (d, <i>J</i> = 6.4, 3H).</div></div><div id="sec5_12_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (<i>S</i>)-<i>N</i>-(4-(3-Aminopiperidin-1-yl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (<b>15)</b></h3><div class="NLM_p last">Following the general procedure (<i>S</i>)-<i>tert</i>-butyl 1-(3-aminopyridin-4-yl)piperidin-3-ylcarbamate and 6-(2,6-difluorophenyl)-5-fluoropicolinic acid were coupled and deprotected to yield <b>3</b>. LC/MS = 428.1 (M + H). HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>22</sub>H<sub>21</sub>F<sub>3</sub>N<sub>5</sub>O (MH<sup>+</sup>) 428.1698, found 428.1699. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 9.15 (s, 1 H), 8.46 (dd, <i>J</i> = 8.66, 3.91 Hz, 1 H), 8.38 (d, <i>J</i> = 6.70 Hz, 1 H), 8.06 (t, <i>J</i> = 8.68 Hz, 1 H), 7.59–7.71 (m, 1 H), 7.50 (d, <i>J</i> = 6.75 Hz, 1 H), 7.23 (t, <i>J</i> = 8.49 Hz, 2 H), 3.88 (dd, <i>J</i> = 12.10, 3.40 Hz, 1 H), 3.66 (d, <i>J</i> = 13.25 Hz, 1 H), 3.38–3.48 (m, 1 H), 3.11–3.29 (m, 2 H), 1.98–2.09 (m, 1 H), 1.75–1.86 (m, 1 H), 1.58–1.75 (m, 2 H).</div></div><div id="sec5_12_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-(4-((1<i>R</i>,3<i>S</i>)-3-Aminocyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (<b>16</b>)</h3><div class="NLM_p last">Following the general procedure 2-(3-(3-aminopyrin-4-yl)cyclohexyl)isoindoline-1,3-dione and 6-(2,6-difluorophenyl)-5-fluoropicolinic acid were coupled and deprotected to yield <b>4</b>. LC/MS = 427.2 (M + H). HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>23</sub>H<sub>22</sub>F<sub>3</sub>N<sub>4</sub>O (MH<sup>+</sup>) 427.1746, found 427.1749. <sup>1</sup>H NMR (CDCl3, free-base): δ 9.93(s, 1H), 9.38(s, 1H), 8.40–8.45(m,1H), 8.40(d, 1H), 7.74–7.80(m, 1H), 7.47–7.55(m, 1H), 7.19(d, 1H), 7.06–7.13(m, 2H), 2.68–2.83(m, 2H), 1.97–2.05(m, 1H), 1.65–1.95(m, 5H), 1.22–1.40(m, 3H), 1.04–1.15(m, 1H).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Microsomal Stability Testing</h3><div class="NLM_p last">The test compounds were incubated at a concentration of 1 μM in the presence of a 0.5 mg/mL microsomal protein suspension, 1 mM UDPGA, 3 mM MgCl<sub>2</sub>, 1 mM NADPH, and 25 μg of alamethicin/mg microsomal of protein. Over the time course of the incubation, duplicate samples were collected at intervals of 0, 5, 15, and 30 min for determination of metabolic rate and parent compound remaining at the end of a 30 min incubation. Phenolphthalein was used as a reference control. Data were obtained utilizing semiquantitative LC–MS/MS methods. Calculation of scaled intrinsic clearance: CL<sub>int</sub> = 0.693 × [1/<i>t</i><sub>1/2</sub> (min)] × (g of liver weight/kg of body weight) × (mL incubation/mg of microsomal protein) × (45 mg of microsomal protein/g of liver weight) with rat = 45 g of liver per kg of body weight and with human = 25.7 g of liver per kg of body weight. Hepatic clearance was extrapolated from microsomal data using well-stirred liver model CL<sub>h</sub> = [<i>Q</i><sub>h</sub> × (<i>f</i><sub>ub</sub>/<i>f</i><sub>ui</sub>) × CL<sub>int</sub>]/<i>Q</i><sub>h</sub> + (<i>f</i><sub>ub</sub>/<i>f</i><sub>ui</sub>) × CL<sub>int</sub>, where assumption is <i>f</i><sub>ub</sub>(fraction unbound in blood) = <i>f</i><sub>ui</sub>(fraction unbound in incubation) and <i>Q</i><sub>h</sub> values of 55 and 20.7 mL min<sup>–1</sup> kg<sup>–1</sup> were used for rat and human. Calculation of hepatic extraction ratio was with <i>E</i> = CL<sub>h</sub>/<i>Q</i><sub>h</sub>.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> PIM Enzymatic Assays</h3><div class="NLM_p"><i>Kinase-Glo Pim1, Pim2, Pim3 ATP Depletion Assays.</i> Pim1, Pim2, and Pim3 kinase-Glo assays using ATP (at or below ATP Km) were used as previously described<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> to determine the biochemical activity of the compounds <b>1</b>–<b>14</b> as shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</div><div class="NLM_p last"><i>High ATP Pim1, Pim2, Pim3 AlphaScreen Assays.</i> Pim1, Pim2, and Pim3 AlphaScreen assays using high ATP (11–125 × APP<i> K</i><sub>m</sub>) were used as previously described<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> to determine the biochemical activity of compounds <b>1</b>, <b>2</b>, and <b>8</b> as shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Biochemical Kinase Specificity Profile of <b>8</b></h3><div class="NLM_p last">The kinase specificity profile for compound <b>8</b> reported in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a> was determined as previously described.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Compound <b>8</b> was assessed in the Ambit KINOMEscan binding assay at 1 μM with activity presented as % of control = [(test compound signal – positive control signal)/(negative control signal – positive control signal]] × 100. Data for the 442 kinase KINOMEscan are in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01275/suppl_file/jm5b01275_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Cell Lines and Reagents</h3><div class="NLM_p last">The KMS-11.luc human multiple myeloma tumor cell line, a KMS-11 clone expressing firefly luciferase, was obtained from the University Health Network (UHN), Toronto, Ontario, Canada. KMS-11.luc was cultured in RPMI-1640 (ATCC, Manassas, VA) supplemented with 10% FBS. The AML cell line KG-1 and all others included in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a> were obtained from commercial sources (ATCC or DSMZ) and were cultured in RPMI or IMDM plus 10–20% FBS (Invitrogen) as supplier recommended.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Cellular Proliferation Assays</h3><div class="NLM_p last">Proliferation assays in KMS-11.luc were conducted as previously described<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> with the concentration at which 50% maximal inhibition is reached reported as EC<sub>50</sub>. Proliferation assays in KG-1 cells lines as well as for cell lines in the expanded AML panel, <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>, were conducted as previously described<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> with the concentration at which growth is inhibited by 50% reported as GI<sub>50</sub>.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Western Blot Analysis</h3><div class="NLM_p last">Following treatment of KG-1 cells with <b>8</b> for 2 h at the indicated concentrations, cells were lysed in RIPA buffer. Protein concentration was determined using a BCA assay (Thermo Scientific 23227), and 50 μg of lysate was separated by SDS–PAGE using 10% bis-Tris gels. Proteins were transferred onto 0.2 μm nitrocellulose membrane (Invitrogen LC2002), and pS6RP was detected using an antibody from Cell Signaling Technology (CST no. 4857) while total S6RP was detected with CST no. 2217. Following incubation with secondary antibodies, antibody binding was detected using ECL Advance (GE Healthcare RPN2135).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Phosphoprotein Assays</h3><div class="NLM_p last">Commercial electrochemiluminescence (ECL) assay kits from Meso Scale Discovery (MSD; Rockville, MD) were used to quantify the effects of compounds on the levels of phosphorylated S6RP in KG-1 cells and KMS11-luc cells. For in vitro assays, KMS11-luc cells were seeded in 96-well tissue culture plates, and then compounds were serially diluted and added to cell plates to achieve a final concentration range of 10 μM to 2 nM in 0.1% DMSO and incubated with cells for 1 h at 37 °C. Cells were pelleted by centrifugation for 7 min at 1500 rpm. Medium was gently aspirated, and MSD lysis buffer was added. Cells were lysed by placing plates on a DELFIA (PerkinElmer, Waltham MA) plate shaker at 4 °C and shaking the plates for 30 min at 600 rpm. For in vivo assays, MDS lysis buffer (MSD, Rockville, MD) was added to frozen pulverized tumor samples on ice and homogenates were prepared using the MagNA Lyser bead instrument (Roche Applied Science, Indianapolis, IN) by disrupting the samples with four cycles of 6000 rpm for 30 s at 4 °C. Supernatants were created following centrifugation at 11 000 rpm for 15 min at 4 °C, and protein concentration was determined using the BCA protein assay kit according to the manufacturer’s instructions (Pierce Chemical Company, Rockford, IL). For both assays, samples were transferred to ECL assay plates previously blocked with 3% BSA, sealed, and incubated at 4 °C overnight while undergoing gentle shaking on a DELFIA (PerkinElmer, Waltham MA) plate shaker. After overnight incubation, assay plates were processed according to manufacturer instructions.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> In Vivo Studies</h3><div class="NLM_p last">The single dose PK/PD and multiday efficacy studies in KG-1 tumored mice were carried out as previously described.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Compound <b>8</b> was formulated for oral administration in 50 mM acetate buffer, pH 4. The concentration of <b>8</b> in plasma was determined following extraction in acetonitrile using liquid chromatography and tandem mass spectroscopy (LC/MS/MS). Cytarabine (Hospira, Lake Forest IL) was diluted with bacteriostatic water and prepared fresh daily.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01275">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20556" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20556" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01275" class="ext-link">10.1021/acs.jmedchem.5b01275</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Data for the 442 kinase KINOMEscan (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01275/suppl_file/jm5b01275_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01275/suppl_file/jm5b01275_si_001.pdf">jm5b01275_si_001.pdf (155.19 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors have been deposited in the PDB with accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DWR">5DWR</a> for the PIM1:<b>8</b> complex.</p><div class="testing" data-doi="10.1021/acs.jmedchem.5b01275" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76455" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76455" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew T. Burger</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#afc2cedbdbc7cad881cddaddc8caddefc1c0d9cedddbc6dc81ccc0c2"><span class="__cf_email__" data-cfemail="5e333f2a2a363b29703c2b2c393b2c1e3031283f2c2a372d703d3133">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gisele Nishiguchi</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wooseok Han</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiong Lan</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Simmons</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gordana Atallah</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu Ding</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Victoriano Tamez</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yanchen Zhang</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michelle Mathur</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristine Muller</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cornelia Bellamacina</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mika K. Lindvall</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Zang</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kay Huh</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Feucht</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tatiana Zavorotinskaya</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yumin Dai</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steve Basham</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie Chan</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elaine Ginn</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alex Aycinena</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jocelyn Holash</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph Castillo</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John L. Langowski</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yingyun Wang</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Min Y. Chen</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amy Lambert</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Fritsch</span> - <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Audry Kauffmann</span> - <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Estelle Pfister</span> - <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">K. Gary Vanasse</span> - <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pablo D. Garcia</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry,
Oncology, ‡Oncology Research, and §Preclinical Safety, Novartis
Institutes for Biomedical Research, 4560 Horton Street, Emeryville, California 94608, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Oncology
Research, Novartis Institutes for Biomedical
Research, CH-4056, Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Translational
Clinical Oncology, Novartis Institutes for
Biomedical Research, 220 Massachusetts Avenue, Cambridge Massachusetts 02139, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2400e5436-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16213" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16213" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Weiping Jia and Dahzi Tang for analytical chemistry support and Kent Wong for in vitro DMPK support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i46" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i46"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i47" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i47"> Abbreviations Used</h2><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphospate</p></td></tr><tr><td class="NLM_term">[ATP]</td><td class="NLM_def"><p class="first last">concentration of adenosine triphospate</p></td></tr><tr><td class="NLM_term">Ara-C</td><td class="NLM_def"><p class="first last">cytarabine</p></td></tr><tr><td class="NLM_term">BAD</td><td class="NLM_def"><p class="first last">proapoptotic protein of the BCl2 family</p></td></tr><tr><td class="NLM_term">BOC</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">extraction ratio</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human-ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">JAK/STAT</td><td class="NLM_def"><p class="first last">Janus kinase and signal transducer and activator of transcription</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>m</sub></td><td class="NLM_def"><p class="first last">Michaelis constant</p></td></tr><tr><td class="NLM_term">log <i>D</i><sub>7.4</sub></td><td class="NLM_def"><p class="first last">log of the octanol–water distribution coefficient at pH 7.4 of ionized and un-ionized compound</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">PIM</td><td class="NLM_def"><p class="first last">proviral insertion of Moloney virus</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr><tr><td class="NLM_term">S6RP</td><td class="NLM_def"><p class="first last">ribosomal protein S6</p></td></tr><tr><td class="NLM_term"><i>S</i>(35)</td><td class="NLM_def"><p class="first last">number of nonmutant kinases tested with ≥65% inhibition/number nonmutant kinases tested</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40026" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40026" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 28 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Brault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracher, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaller, J.</span><span> </span><span class="NLM_article-title">PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers</span> <span class="citation_source-journal">Haematologica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span><span class="refDoi"> DOI: 10.3324/haematol.2009.017079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.3324%2Fhaematol.2009.017079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=20145274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlShu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2010&pages=1004-1015&author=L.+Braultauthor=C.+Gasserauthor=F.+Bracherauthor=K.+Huberauthor=S.+Knappauthor=J.+Schwaller&title=PIM+serine%2Fthreonine+kinases+in+the+pathogenesis+and+therapy+of+hematologic+malignancies+and+solid+cancers&doi=10.3324%2Fhaematol.2009.017079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers</span></div><div class="casAuthors">Brault, Laurent; Gasser, Christelle; Bracher, Franz; Huber, Kilian; Knapp, Stefan; Schwaller, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Haematologica</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1004-1015</span>CODEN:
                <span class="NLM_cas:coden">HAEMAX</span>;
        ISSN:<span class="NLM_cas:issn">0390-6078</span>.
    
            (<span class="NLM_cas:orgname">Ferrata Storti Foundation</span>)
        </div><div class="casAbstract">A review.  The identification as cooperating targets of Proviral Integrations of Moloney virus in murine lymphomas suggested early on that PIM serine/threonine kinases play an important role in cancer biol.  Whereas elevated levels of PIM1 and PIM2 were mostly found in hematol. malignancies and prostate cancer, increased PIM3 expression was obsd. in different solid tumors.  PIM kinases are constitutively active and their activity supports in vitro and in vivo tumor cell growth and survival through modification of an increasing no. of common as well as isoform-specific substrates including several cell cycle regulators and apoptosis mediators.  PIM1 but not PIM2 seems also to mediate homing and migration of normal and malignant hematopoietic cells by regulating chemokine receptor surface expression.  Knockdown expts. by RNA interference or dominant-neg. acting mutants suggested that PIM kinases are important for maintenance of a transformed phenotype and therefore potential therapeutic targets.  Detn. of the protein structure facilitated identification of an increasing no. of potent small mol. PIM kinase inhibitors with in vitro and in vivo anticancer activity.  Ongoing efforts aim to identify isoform-specific PIM inhibitors that would not only help to dissect the kinase function but hopefully also provide targeted therapeutics.  Here, we summarize the current knowledge about the role of PIM serine/threonine kinases for the pathogenesis and therapy of hematol. malignancies and solid cancers, and we highlight structural principles and recent progress on small mol. PIM kinase inhibitors that are on their way into first clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM0F0X8PArhLVg90H21EOLACvtfcHk0ljxEf6SRX3CNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlShu7%252FO&md5=241c17f65ee9203be2a6ee138a914781</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2009.017079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2009.017079%26sid%3Dliteratum%253Aachs%26aulast%3DBrault%26aufirst%3DL.%26aulast%3DGasser%26aufirst%3DC.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchwaller%26aufirst%3DJ.%26atitle%3DPIM%2520serine%252Fthreonine%2520kinases%2520in%2520the%2520pathogenesis%2520and%2520therapy%2520of%2520hematologic%2520malignancies%2520and%2520solid%2520cancers%26jtitle%3DHaematologica%26date%3D2010%26volume%3D95%26spage%3D1004%26epage%3D1015%26doi%3D10.3324%2Fhaematol.2009.017079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Cuypers, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selten, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quint, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zijlstra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandaag, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boelens, W.</span><span> </span><span class="NLM_article-title">Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span><span class="refDoi"> DOI: 10.1016/0092-8674(84)90309-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2F0092-8674%2884%2990309-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=6327049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADyaL2cXks1KqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1984&pages=141-150&author=H.+T.+Cuypersauthor=G.+Seltenauthor=W.+Quintauthor=M.+Zijlstraauthor=E.+R.+Mandaagauthor=W.+Boelens&title=Murine+leukemia+virus-induced+T-cell+lymphomagenesis%3A+integration+of+proviruses+in+a+distinct+chromosomal+region&doi=10.1016%2F0092-8674%2884%2990309-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Murine leukemia virus-induced T-cell lymphomagenesis:  integration of proviruses in a distinct chromosomal region</span></div><div class="casAuthors">Cuypers, H. Theo; Selten, Gerard; Quint, Wim; Zijlstra, Maarten; Maandag, Els Robanus; Boelens, Wilbert; Van Wezenbeek, Peter; Melief, Cees; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-50</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Mink cell focus-forming (MCF) proviruses were molecularly cloned from mouse lymphoma DNA.  From each clone, flanking probes were prepd. to detect common integration regions in other murine leukemia virus (MuLV)-induced lymphomas.  One clone frequently revealed variations in the mol. structure of the corresponding region (Pim-1) in other lymphomas.  Changes in the Pim region are seen in 24 of 93 lymphomas tested.  Over 50% of the early T-cell lymphomas show integration in the Pim-1 region.  The alterations are seen in different mouse strains and with various MuLVs.  The obsd. variations are caused by the integration of predominantly MCF genomes.  All integrations occur in a region spanning <20 kilobases and are assocd. with the transcriptional activation of a distinct region within the Pim-1 domain.  The activated region does not show any homol. with 13 known and 3 putative oncogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm89Z9zs2CVrVg90H21EOLACvtfcHk0ljxEf6SRX3CNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXks1KqtLY%253D&md5=8cff87b785ab0a12aacf742106aaf6a2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2884%2990309-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252884%252990309-X%26sid%3Dliteratum%253Aachs%26aulast%3DCuypers%26aufirst%3DH.%2BT.%26aulast%3DSelten%26aufirst%3DG.%26aulast%3DQuint%26aufirst%3DW.%26aulast%3DZijlstra%26aufirst%3DM.%26aulast%3DMandaag%26aufirst%3DE.%2BR.%26aulast%3DBoelens%26aufirst%3DW.%26atitle%3DMurine%2520leukemia%2520virus-induced%2520T-cell%2520lymphomagenesis%253A%2520integration%2520of%2520proviruses%2520in%2520a%2520distinct%2520chromosomal%2520region%26jtitle%3DCell%26date%3D1984%26volume%3D37%26spage%3D141%26epage%3D150%26doi%3D10.1016%2F0092-8674%2884%2990309-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Meeker, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagarajan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ar-Rushdi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croce, C. M.</span><span> </span><span class="NLM_article-title">Cloning and characterization of the human PIM-1 gene: a putative oncogene related to the protein kinases</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1002/jcb.240350204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1002%2Fjcb.240350204" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1987&pages=105-112&author=T.+C.+Meekerauthor=L.+Nagarajanauthor=A.+ar-Rushdiauthor=C.+M.+Croce&title=Cloning+and+characterization+of+the+human+PIM-1+gene%3A+a+putative+oncogene+related+to+the+protein+kinases&doi=10.1002%2Fjcb.240350204"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fjcb.240350204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.240350204%26sid%3Dliteratum%253Aachs%26aulast%3DMeeker%26aufirst%3DT.%2BC.%26aulast%3DNagarajan%26aufirst%3DL.%26aulast%3Dar-Rushdi%26aufirst%3DA.%26aulast%3DCroce%26aufirst%3DC.%2BM.%26atitle%3DCloning%2520and%2520characterization%2520of%2520the%2520human%2520PIM-1%2520gene%253A%2520a%2520putative%2520oncogene%2520related%2520to%2520the%2520protein%2520kinases%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D1987%26volume%3D35%26spage%3D105%26epage%3D112%26doi%3D10.1002%2Fjcb.240350204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">van der Lugt, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoeven, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linders, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">vad der Gulden, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berns, A.</span><span> </span><span class="NLM_article-title">Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2536</span><span class="NLM_x">–</span> <span class="NLM_lpage">2544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=2536-2544&author=N.+M.+van+der+Lugtauthor=J.+Domenauthor=E.+Verhoevenauthor=K.+Lindersauthor=H.+vad+der+Guldenauthor=J.+Allenauthor=A.+Berns&title=Proviral+tagging+in+E+mu-myc+transgenic+mice+lacking+the+Pim-1+proto-oncogene+leads+to+compensatory+activation+of+Pim-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BLugt%26aufirst%3DN.%2BM.%26aulast%3DDomen%26aufirst%3DJ.%26aulast%3DVerhoeven%26aufirst%3DE.%26aulast%3DLinders%26aufirst%3DK.%26aulast%3Dvad%2Bder%2BGulden%26aufirst%3DH.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DProviral%2520tagging%2520in%2520E%2520mu-myc%2520transgenic%2520mice%2520lacking%2520the%2520Pim-1%2520proto-oncogene%2520leads%2520to%2520compensatory%2520activation%2520of%2520Pim-2%26jtitle%3DEMBO%2520J.%26date%3D1995%26volume%3D14%26spage%3D2536%26epage%3D2544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mikkers, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipscheer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeyn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berns, A.</span><span> </span><span class="NLM_article-title">High-throughput retroviral tagging to identify components of specific signaling pathways in cancer</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span><span class="refDoi"> DOI: 10.1038/ng950</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1038%2Fng950" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=12185366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1ajs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=153-159&author=H.+Mikkersauthor=J.+Allenauthor=P.+Knipscheerauthor=L.+Romeynauthor=A.+Hartauthor=E.+Vinkauthor=A.+Berns&title=High-throughput+retroviral+tagging+to+identify+components+of+specific+signaling+pathways+in+cancer&doi=10.1038%2Fng950"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput retroviral tagging to identify components of specific signaling pathways in cancer</span></div><div class="casAuthors">Mikkers, Harald; Allen, John; Knipscheer, Puck; Romeyn, Lieke; Hart, Augustinus; Vink, Edwin; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-159</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Genetic screens carried out in lower organisms such as yeast, Drosophila melanogaster and Caenorhabditis elegans have revealed many signaling pathways.  For example, components of the RAS signaling cascade were identified using a mutant eye phenotype in D. melanogaster as a readout.  Screening is usually based on enhancing or suppressing a phenotype by way of a known mutation in a particular signaling pathway.  Such in vivo screens have been difficult to carry out in mammals, however, owing to their relatively long generation times and the limited no. of animals that can be screened.  Here the authors describe an in vivo mammalian genetic screen used to identify components of pathways contributing to oncogenic transformation.  The authors applied retroviral insertional mutagenesis in Myc transgenic (EμMyc) mice lacking expression of Pim1 and Pim2 to search for genes that can substitute for Pim1 and Pim2 in lymphomagenesis.  The authors detd. the chromosomal positions of 477 retroviral insertion sites (RISs) derived from 38 tumors from EμMyc Pim1-/- Pim2-/- mice and 27 tumors from EμMyc control mice using the Ensembl and Celera annotated mouse genome databases.  There were 52 sites occupied by proviruses in more than one tumor.  These common insertion sites (CISs) are likely to contain genes contributing to tumorigenesis.  Comparison of the RISs in tumors of Pim-null mice with the RISs in tumors of EμMyc control mice indicated that 10 of the 52 CISs belong to the Pim complementation group.  In addn., Pim3 is selectively activated in Pim-null tumor cells, which supports the validity of this approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6i2tPp4vS3rVg90H21EOLACvtfcHk0ljxEf6SRX3CNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1ajs7Y%253D&md5=fa564ec068d8e70c8aefb533008ad738</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fng950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng950%26sid%3Dliteratum%253Aachs%26aulast%3DMikkers%26aufirst%3DH.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DKnipscheer%26aufirst%3DP.%26aulast%3DRomeyn%26aufirst%3DL.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DVink%26aufirst%3DE.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DHigh-throughput%2520retroviral%2520tagging%2520to%2520identify%2520components%2520of%2520specific%2520signaling%2520pathways%2520in%2520cancer%26jtitle%3DNat.%2520Genet.%26date%3D2002%26volume%3D32%26spage%3D153%26epage%3D159%26doi%3D10.1038%2Fng950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Nawijn, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alendar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berns, A.</span><span> </span><span class="NLM_article-title">For better or for worse: the role of PIM oncogenes in tumorigenesis</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1038/nrc2986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1038%2Fnrc2986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=21150935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCjsrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=23-34&author=M.+C.+Nawijnauthor=A.+Alendarauthor=A.+Berns&title=For+better+or+for+worse%3A+the+role+of+PIM+oncogenes+in+tumorigenesis&doi=10.1038%2Fnrc2986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">For better or for worse: the role of Pim oncogenes in tumorigenesis</span></div><div class="casAuthors">Nawijn, Martijn C.; Alendar, Andrej; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-34</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Pim oncogenes are overexpressed in a wide range of tumors from a hematol. and epithelial origin.  Pim genes encode serine/threonine kinases that have been shown to counteract the increased sensitivity to apoptosis induction that is assocd. with MYC-driven tumorigenesis.  Recently, considerable progress has been made in characterizing the pathways of PIM-mediated survival signalling.  Given the unique structure of their active site and the minimal phenotype of mice mutant for all Pim family members, these oncogenes might be promising targets for highly specific and selective drugs with favorable toxicity profiles.  In this Review, we discuss the physiol. functions and oncogenic activities of Pim kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu23UDfObMZrVg90H21EOLACvtfcHk0lhMo5AHBZwmIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCjsrjE&md5=fe08e70454ca8c4d808715db87d195e1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrc2986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2986%26sid%3Dliteratum%253Aachs%26aulast%3DNawijn%26aufirst%3DM.%2BC.%26aulast%3DAlendar%26aufirst%3DA.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DFor%2520better%2520or%2520for%2520worse%253A%2520the%2520role%2520of%2520PIM%2520oncogenes%2520in%2520tumorigenesis%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D23%26epage%3D34%26doi%3D10.1038%2Fnrc2986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Garcia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ison, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavorotinskaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, X.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narberes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfister, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drueckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trappe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiguchi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamacina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aycinena, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holash, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, M.</span><span> </span><span class="NLM_article-title">Pan-PIM kinase inhibition provides a novel therapy for treating hematological cancers</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1834</span><span class="NLM_x">–</span> <span class="NLM_lpage">1845</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-2062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1158%2F1078-0432.CCR-13-2062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=24474669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1eiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1834-1845&author=P.+Garciaauthor=J.+Langowskiauthor=Y.+Wanauthor=M.+Chenauthor=J.+Castilloauthor=C.+Fantonauthor=M.+Isonauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=J.+Luauthor=X.-H.+Niuauthor=S.+Bashamauthor=J.+Chanauthor=H.+Yuauthor=M.+Doyleauthor=P.+Feuchtauthor=R.+Warneauthor=J.+Narberesauthor=T.+Tsangauthor=C.+Fritschauthor=A.+Kauffmannauthor=E.+Pfisterauthor=P.+Drueckesauthor=J.+Trappeauthor=C.+Wilsonauthor=W.+Hanauthor=J.+Lanauthor=G.+Nishiguchiauthor=C.+Bellamacinaauthor=J.+A.+Aycinenaauthor=R.+Zangauthor=J.+Holashauthor=M.+Burger&title=Pan-PIM+kinase+inhibition+provides+a+novel+therapy+for+treating+hematological+cancers&doi=10.1158%2F1078-0432.CCR-13-2062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers</span></div><div class="casAuthors">Garcia, Pablo D.; Langowski, John L.; Wang, Yingyun; Chen, Min; Castillo, Joseph; Fanton, Christie; Ison, Marjorie; Zavorotinskaya, Tatiana; Dai, Yumin; Lu, Jing; Niu, Xiao-Hong; Basham, Stephen; Chan, Julie; Yu, Jianjun; Doyle, Michael; Feucht, Paul; Warne, Robert; Narberes, Jamie; Tsang, Tiffany; Fritsch, Christine; Kauffmann, Audrey; Pfister, Estelle; Drueckes, Peter; Trappe, Joerg; Wilson, Christopher; Han, Wooseok; Lan, Jiong; Nishiguchi, Gisele; Lindvall, Mika; Bellamacina, Cornelia; Aycinena, J. Alex; Zang, Richard; Holash, Jocelyn; Burger, Matthew T.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1834-1845</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PIM kinases have been shown to act as oncogenes in mice, with each family member being able to drive progression of hematol. cancers.  Consistent with this, we found that PIMs are highly expressed in human hematol. cancers and show that each isoform has a distinct expression pattern among disease subtypes.  This suggests that inhibitors of all three PIMs would be effective in treating multiple hematol. malignancies.  Pan-PIM inhibitors have proven difficult to develop because PIM2 has a low Km for ATP and, thus, requires a very potent inhibitor to effectively block the kinase activity at the ATP levels in cells.  We developed a potent and specific pan-PIM inhibitor, LGB321, which is active on PIM2 in the cellular context.  LGB321 is active on PIM2-dependent multiple myeloma cell lines, where it inhibits proliferation, mTOR-C1 signaling and phosphorylation of BAD.  Broad cancer cell line profiling of LGB321 demonstrates limited activity in cell lines derived from solid tumors.  In contrast, significant activity in cell lines derived from diverse hematol. lineages was obsd., including acute lymphoblastic leukemia (ALL), acute myelogenous leukemia (AML), multiple myeloma and non-Hodgkin lymphoma (NHL).  Furthermore, we demonstrate LGB321 activity in the KG-1 AML xenograft model, in which modulation of pharmacodynamics markers is predictive of efficacy.  Finally, we demonstrate that LGB321 synergizes with cytarabine in this model.  We have developed a potent and selective pan-PIM inhibitor with single-agent antiproliferative activity and show that it synergizes with cytarabine in an AML xenograft model.  Our results strongly support the development of Pan-PIM inhibitors to treat hematol. malignancies.  Clin Cancer Res; 20(7); 1834-45. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriy2nkB_psKbVg90H21EOLACvtfcHk0lhMo5AHBZwmIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1eiu7k%253D&md5=c563df328e7af3ebf10c31b1a26faae4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2062%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%26aufirst%3DP.%26aulast%3DLangowski%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DCastillo%26aufirst%3DJ.%26aulast%3DFanton%26aufirst%3DC.%26aulast%3DIson%26aufirst%3DM.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DNiu%26aufirst%3DX.-H.%26aulast%3DBasham%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DDoyle%26aufirst%3DM.%26aulast%3DFeucht%26aufirst%3DP.%26aulast%3DWarne%26aufirst%3DR.%26aulast%3DNarberes%26aufirst%3DJ.%26aulast%3DTsang%26aufirst%3DT.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DKauffmann%26aufirst%3DA.%26aulast%3DPfister%26aufirst%3DE.%26aulast%3DDrueckes%26aufirst%3DP.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DNishiguchi%26aufirst%3DG.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DAycinena%26aufirst%3DJ.%2BA.%26aulast%3DZang%26aufirst%3DR.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DBurger%26aufirst%3DM.%26atitle%3DPan-PIM%2520kinase%2520inhibition%2520provides%2520a%2520novel%2520therapy%2520for%2520treating%2520hematological%2520cancers%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26spage%3D1834%26epage%3D1845%26doi%3D10.1158%2F1078-0432.CCR-13-2062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Blanco-Aparicio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnero, A.</span><span> </span><span class="NLM_article-title">PIM kinases in cancer: diagnostic, prognostic and treatment opportunities</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span><span class="refDoi"> DOI: 10.1016/j.bcp.2012.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2Fj.bcp.2012.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=23041228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Sht7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=629-643&author=C.+Blanco-Aparicioauthor=A.+Carnero&title=PIM+kinases+in+cancer%3A+diagnostic%2C+prognostic+and+treatment+opportunities&doi=10.1016%2Fj.bcp.2012.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pim kinases in cancer: Diagnostic, prognostic and treatment opportunities</span></div><div class="casAuthors">Blanco-Aparicio, Carmen; Carnero, Amancio</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">629-643</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  PIM proteins belong to a family of ser/thr kinases composed of 3 members, PIM1, PIM2 and PIM3, with greatly overlapping functions.  PIM kinases are mainly responsible for cell cycle regulation, antiapoptotic activity and the homing and migration of receptor tyrosine kinases mediated via the JAK/STAT pathway.  PIM kinases have been found to be upregulated in many hematol. malignancies and solid tumors.  Although these kinases have been described as weak oncogenes, they are heavily targeted for anticancer drug discovery.  The present review summarizes the discoveries made to date regarding PIM kinases as driving oncogenes in the process of tumorigenesis and their validation as drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtbg06YAgnArVg90H21EOLACvtfcHk0liNZkzvf7nqjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Sht7nK&md5=63957a55b281d4bbc8c4843249d30273</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DBlanco-Aparicio%26aufirst%3DC.%26aulast%3DCarnero%26aufirst%3DA.%26atitle%3DPIM%2520kinases%2520in%2520cancer%253A%2520diagnostic%252C%2520prognostic%2520and%2520treatment%2520opportunities%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D85%26spage%3D629%26epage%3D643%26doi%3D10.1016%2Fj.bcp.2012.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Jackson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pheneger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pheneger, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, L. L.</span><span> </span><span class="NLM_article-title">The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel disease</span> <span class="citation_source-journal">Cell. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1016/j.cellimm.2011.10.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2Fj.cellimm.2011.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=22078270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Cit7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=2012&pages=200-213&author=L.+J.+Jacksonauthor=J.+A.+Phenegerauthor=T.+J.+Phenegerauthor=G.+Davisauthor=A.+D.+Wrightauthor=J.+E.+Robinsonauthor=S.+Allenauthor=M.+C.+Munsonauthor=L.+L.+Carter&title=The+role+of+PIM+kinases+in+human+and+mouse+CD4%2B+T+cell+activation+and+inflammatory+bowel+disease&doi=10.1016%2Fj.cellimm.2011.10.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel disease</span></div><div class="casAuthors">Jackson, Leila J.; Pheneger, Jed A.; Pheneger, Tracy J.; Davis, Gregg; Wright, A. Dale; Robinson, John E.; Allen, Shelley; Munson, Mark C.; Carter, Laura L.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">200-213</span>CODEN:
                <span class="NLM_cas:coden">CLIMB8</span>;
        ISSN:<span class="NLM_cas:issn">0008-8749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">PIM kinases are a family of three serine/threonine kinases expressed following T cell activation.  Using potent selective small mol. antagonists of PIM-1/3 kinases, we demonstrate a potential role for these enzymes in naive and effector CD4+ T cell activation.  PIM-1/3 inhibition prevented CD4+ T cell proliferation by inducing a G0/G1 cell cycle arrest without affecting cellular survival.  In the absence of PIM-1/3 kinase activity, naive CD4+ T cells failed to fully differentiate into effector cells both in vitro and in vivo.  Therapeutic dosing of a PIM-1/3 inhibitor was efficacious in a CD4+ T cell-mediated model of inflammatory bowel disease suggesting that PIM-1 and PIM-3 kinase activity contributes to sustained disease severity.  These results demonstrate that PIM-1/3 kinases have an important role in CD4+ T cell responses and inhibition of this activity may provide a therapeutic benefit in T cell-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo49-JUG78zSLVg90H21EOLACvtfcHk0liNZkzvf7nqjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Cit7jP&md5=aa030f7e07e27d4289afdeca873b30a8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cellimm.2011.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellimm.2011.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DL.%2BJ.%26aulast%3DPheneger%26aufirst%3DJ.%2BA.%26aulast%3DPheneger%26aufirst%3DT.%2BJ.%26aulast%3DDavis%26aufirst%3DG.%26aulast%3DWright%26aufirst%3DA.%2BD.%26aulast%3DRobinson%26aufirst%3DJ.%2BE.%26aulast%3DAllen%26aufirst%3DS.%26aulast%3DMunson%26aufirst%3DM.%2BC.%26aulast%3DCarter%26aufirst%3DL.%2BL.%26atitle%3DThe%2520role%2520of%2520PIM%2520kinases%2520in%2520human%2520and%2520mouse%2520CD4%252B%2520T%2520cell%2520activation%2520and%2520inflammatory%2520bowel%2520disease%26jtitle%3DCell.%2520Immunol.%26date%3D2012%26volume%3D272%26spage%3D200%26epage%3D213%26doi%3D10.1016%2Fj.cellimm.2011.10.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Morwick, T.</span><span> </span><span class="NLM_article-title">PIM kinase inhibitors: a survey of the patent literature</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span><div class="note"><p class="first last">and references therein.</p></div><span class="refDoi"> DOI: 10.1517/13543770903496442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1517%2F13543770903496442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=20100002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=193-212&issue=2&author=T.+Morwick&title=PIM+kinase+inhibitors%3A+a+survey+of+the+patent+literature&doi=10.1517%2F13543770903496442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pim kinase inhibitors: a survey of the patent literature</span></div><div class="casAuthors">Morwick, Tina</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">193-212</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Pim kinases have recently emerged as targets of interest in oncol. and immune regulation.  Ongoing studies have identified a role for these proteins in cell survival and proliferation, both functionally and mechanistically, and overexpression has been obsd. in a no. of human cancers and inflammatory states.  Areas covered in this review: This report reviews the patent literature for Pim kinase inhibitors identified from a search of the Thomson patent databases from 1970 through July 2009.  Full analyses are provided for publications reporting Pim kinases as primary targets, and a cursory description is given for those disclosing Pim as one of a limited no. of secondary targets.  What the reader will gain: Readers will gain an overview of the various inhibitor series including coverage, potency, selectivity, protein binding features and therapeutic focus, and an appreciation for which scaffolds and structural features have been most highly exploited.  Take home message: A greater understanding of pathol. mechanisms for Pim kinases has stimulated the recent development of a variety of inhibitor classes with one compd. advancing into the clinic earlier this year.  Ongoing studies will help define applications for these inhibitors in the treatment of Pim-assocd. human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3qJ9wz2Tau7Vg90H21EOLACvtfcHk0liNZkzvf7nqjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGktbg%253D&md5=21d9c3c31b2af04e63bef9ac5adaf549</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1517%2F13543770903496442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903496442%26sid%3Dliteratum%253Aachs%26aulast%3DMorwick%26aufirst%3DT.%26atitle%3DPIM%2520kinase%2520inhibitors%253A%2520a%2520survey%2520of%2520the%2520patent%2520literature%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26issue%3D2%26spage%3D193%26epage%3D212%26doi%3D10.1517%2F13543770903496442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Mumenthaler, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodge, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearss, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanekal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taverna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agus, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A.</span><span> </span><span class="NLM_article-title">Pharmacologic inhibition of PIM kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2882</span><span class="NLM_x">–</span> <span class="NLM_lpage">2893</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1158%2F1535-7163.MCT-09-0293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=19825806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Cqur7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2882-2893&author=S.+M.+Mumenthalerauthor=P.+Y.+Ngauthor=A.+Hodgeauthor=D.+Bearssauthor=G.+Berkauthor=S.+Kanekalauthor=S.+Redkarauthor=P.+Tavernaauthor=D.+B.+Agusauthor=A.+Jain&title=Pharmacologic+inhibition+of+PIM+kinases+alters+prostate+cancer+cell+growth+and+resensitizes+chemoresistant+cells+to+taxanes&doi=10.1158%2F1535-7163.MCT-09-0293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes</span></div><div class="casAuthors">Mumenthaler, Shannon M.; Ng, Patricia Y. B.; Hodge, Amanda; Bearss, David; Berk, Gregory; Kanekal, Sarath; Redkar, Sanjeev; Taverna, Pietro; Agus, David B.; Jain, Anjali</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2882-2893</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The serine/threonine family of Pim kinases function as oncogenes and have been implicated in prostate cancer progression, particularly in hormone-refractory prostate disease, as a result of their antiapoptotic function.  In this study, we used a pharmacol. inhibitor targeting the Pim family members, SGI-1776, to det. whether modulation of Pim kinase activity could alter prostate cancer cell survival and modulate chemotherapy resistance.  Extensive biochem. characterization of SGI-1776 confirmed its specificity for the three isoforms of the Pim family.  Treatment of prostate cancer cells with SGI-1776 resulted in a dose-dependent redn. in phosphorylation of known Pim kinase substrates that are involved in cell cycle progression and apoptosis (p21Cip1/WAF1 and Bad).  Consequently, SGI-1776 compromised overall cell viability by inducing G1 cell cycle arrest and triggering apoptosis.  Overexpression of recombinant Pim-1 markedly increased sensitivity of SGI-1776-mediated prostate cancer cell apoptosis and p21Cip1/WAF1 phosphorylation inhibition, reinforcing the specificity of SGI-1776.  An addnl. cytotoxic effect was obsd. when SGI-1776 was combined with taxane-based chemotherapy agents.  SGI-1776 was able to reduce cell viability in a multidrug resistance 1 protein-based taxane-refractory prostate cancer cell line.  In addn., SGI-1776 treatment was able to resensitize chemoresistant cells to taxane-based therapies by inhibiting multidrug resistance 1 activity and inducing apoptosis.  These findings support the idea that inhibiting Pim kinases, in combination with a chemotherapeutic agent, could play an important role in prostate cancer treatment by targeting the clin. problem of chemoresistance. [Mol Cancer Ther 2009;8(10):2882-93].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnGQXKbXm4Y7Vg90H21EOLACvtfcHk0liNZkzvf7nqjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Cqur7E&md5=b6353cdc3b367e336a707147e5c99a4c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0293%26sid%3Dliteratum%253Aachs%26aulast%3DMumenthaler%26aufirst%3DS.%2BM.%26aulast%3DNg%26aufirst%3DP.%2BY.%26aulast%3DHodge%26aufirst%3DA.%26aulast%3DBearss%26aufirst%3DD.%26aulast%3DBerk%26aufirst%3DG.%26aulast%3DKanekal%26aufirst%3DS.%26aulast%3DRedkar%26aufirst%3DS.%26aulast%3DTaverna%26aufirst%3DP.%26aulast%3DAgus%26aufirst%3DD.%2BB.%26aulast%3DJain%26aufirst%3DA.%26atitle%3DPharmacologic%2520inhibition%2520of%2520PIM%2520kinases%2520alters%2520prostate%2520cancer%2520cell%2520growth%2520and%2520resensitizes%2520chemoresistant%2520cells%2520to%2520taxanes%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D2882%26epage%3D2893%26doi%3D10.1158%2F1535-7163.MCT-09-0293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Code, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowling, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hird, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, T.</span><span> </span><span class="NLM_article-title">Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4599</span><span class="NLM_x">–</span> <span class="NLM_lpage">4604</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.05.098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2Fj.bmcl.2012.05.098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=22727640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpt1Shtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4599-4604&author=L.+A.+Dakinauthor=M.+H.+Blockauthor=H.+Chenauthor=E.+Codeauthor=J.+E.+Dowlingauthor=X.+Fengauthor=A.+D.+Fergusonauthor=I.+Greenauthor=A.+W.+Hirdauthor=T.+Howard&title=Discovery+of+novel+benzylidene-1%2C3-thiazolidine-2%2C4-diones+as+potent+and+selective+inhibitors+of+the+PIM-1%2C+PIM-2%2C+and+PIM-3+protein+kinases&doi=10.1016%2Fj.bmcl.2012.05.098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases</span></div><div class="casAuthors">Dakin, Les A.; Block, Michael H.; Chen, Huawei; Code, Erin; Dowling, James E.; Feng, Xiaomei; Ferguson, Andrew D.; Green, Isabelle; Hird, Alexander W.; Howard, Tina; Keeton, Erika K.; Lamb, Michelle L.; Lyne, Paul D.; Pollard, Hannah; Read, Jon; Wu, Allan J.; Zhang, Tao; Zheng, Xiaolan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4599-4604</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel substituted benzylidene-1,3-thiazolidine-2,4-diones (TZDs) have been identified as potent and highly selective inhibitors of the PIM kinases.  The synthesis and SAR of these compds. are described, along with x-ray crystallog. of deriv. I, anti-proliferative, and selectivity data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLer-JRufp_rVg90H21EOLACvtfcHk0liRU_gLeXAjEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpt1Shtb4%253D&md5=cd1570938d48864bb739d2ccc37888f2</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.05.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.05.098%26sid%3Dliteratum%253Aachs%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DCode%26aufirst%3DE.%26aulast%3DDowling%26aufirst%3DJ.%2BE.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26aulast%3DGreen%26aufirst%3DI.%26aulast%3DHird%26aufirst%3DA.%2BW.%26aulast%3DHoward%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520novel%2520benzylidene-1%252C3-thiazolidine-2%252C4-diones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520PIM-1%252C%2520PIM-2%252C%2520and%2520PIM-3%2520protein%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4599%26epage%3D4604%26doi%3D10.1016%2Fj.bmcl.2012.05.098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Tsuhako, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltun, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aay, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arcalas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galan, A.</span><span> </span><span class="NLM_article-title">The design, synthesis, and biological evaluation of PIM kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3732</span><span class="NLM_x">–</span> <span class="NLM_lpage">3738</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.04.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2Fj.bmcl.2012.04.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3732-3738&author=A.+L.+Tsuhakoauthor=D.+S.+Brownauthor=E.+S.+Koltunauthor=N.+Aayauthor=A.+Arcalasauthor=V.+Chanauthor=H.+Duauthor=S.+Engstauthor=M.+Franziniauthor=A.+Galan&title=The+design%2C+synthesis%2C+and+biological+evaluation+of+PIM+kinase+inhibitors&doi=10.1016%2Fj.bmcl.2012.04.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.04.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.04.025%26sid%3Dliteratum%253Aachs%26aulast%3DTsuhako%26aufirst%3DA.%2BL.%26aulast%3DBrown%26aufirst%3DD.%2BS.%26aulast%3DKoltun%26aufirst%3DE.%2BS.%26aulast%3DAay%26aufirst%3DN.%26aulast%3DArcalas%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DV.%26aulast%3DDu%26aufirst%3DH.%26aulast%3DEngst%26aufirst%3DS.%26aulast%3DFranzini%26aufirst%3DM.%26aulast%3DGalan%26aufirst%3DA.%26atitle%3DThe%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520PIM%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3732%26epage%3D3738%26doi%3D10.1016%2Fj.bmcl.2012.04.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Xia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knaak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beharry, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraft, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of novel inhibitors of PIM-1 and PIM-2 protein kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span><span class="refDoi"> DOI: 10.1021/jm800937p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800937p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=74-86&author=Z.+Xiaauthor=C.+Knaakauthor=J.+Maauthor=Z.+M.+Beharryauthor=C.+McInnesauthor=W.+Wangauthor=A.+S.+Kraftauthor=C.+D.+Smith&title=Synthesis+and+evaluation+of+novel+inhibitors+of+PIM-1+and+PIM-2+protein+kinases&doi=10.1021%2Fjm800937p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm800937p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800937p%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DZ.%26aulast%3DKnaak%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DBeharry%26aufirst%3DZ.%2BM.%26aulast%3DMcInnes%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DKraft%26aufirst%3DA.%2BS.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%2520inhibitors%2520of%2520PIM-1%2520and%2520PIM-2%2520protein%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D74%26epage%3D86%26doi%3D10.1021%2Fjm800937p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Tao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasvold, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamper, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N.</span><span> </span><span class="NLM_article-title">Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6621</span><span class="NLM_x">–</span> <span class="NLM_lpage">6636</span><span class="refDoi"> DOI: 10.1021/jm900943h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900943h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6621-6636&author=Z.+Taoauthor=L.+A.+Hasvoldauthor=J.+D.+Leversonauthor=E.+K.+Hanauthor=R.+Guanauthor=E.+F.+Johnsonauthor=V.+S.+Stollauthor=K.+D.+Stewartauthor=G.+Stamperauthor=N.+Soni&title=Discovery+of+3H-benzo%5B4%2C5%5Dthieno%5B3%2C2-d%5Dpyrimidin-4-ones+as+potent%2C+highly+selective%2C+and+orally+bioavailable+inhibitors+of+the+human+protooncogene+proviral+insertion+site+in+moloney+murine+leukemia+virus+%28PIM%29+kinases&doi=10.1021%2Fjm900943h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm900943h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900943h%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DZ.%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DHan%26aufirst%3DE.%2BK.%26aulast%3DGuan%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DStoll%26aufirst%3DV.%2BS.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DStamper%26aufirst%3DG.%26aulast%3DSoni%26aufirst%3DN.%26atitle%3DDiscovery%2520of%25203H-benzo%255B4%252C5%255Dthieno%255B3%252C2-d%255Dpyrimidin-4-ones%2520as%2520potent%252C%2520highly%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitors%2520of%2520the%2520human%2520protooncogene%2520proviral%2520insertion%2520site%2520in%2520moloney%2520murine%2520leukemia%2520virus%2520%2528PIM%2529%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6621%26epage%3D6636%26doi%3D10.1021%2Fjm900943h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Haddach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaux, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaebe, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raffaele, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drygin, D.</span><span> </span><span class="NLM_article-title">Discovery of CX-6258. a potent, selective, and orally efficacious pan-PIM kinase inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span><span class="refDoi"> DOI: 10.1021/ml200259q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200259q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=135-139&author=M.+Haddachauthor=J.+Michauxauthor=M.+K.+Schwaebeauthor=F.+Pierreauthor=S.+E.+O%E2%80%99Brienauthor=C.+Borsanauthor=J.+Tranauthor=N.+Raffaeleauthor=S.+Ravulaauthor=D.+Drygin&title=Discovery+of+CX-6258.+a+potent%2C+selective%2C+and+orally+efficacious+pan-PIM+kinase+inhibitor&doi=10.1021%2Fml200259q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml200259q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200259q%26sid%3Dliteratum%253Aachs%26aulast%3DHaddach%26aufirst%3DM.%26aulast%3DMichaux%26aufirst%3DJ.%26aulast%3DSchwaebe%26aufirst%3DM.%2BK.%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DBorsan%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DJ.%26aulast%3DRaffaele%26aufirst%3DN.%26aulast%3DRavula%26aufirst%3DS.%26aulast%3DDrygin%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520CX-6258.%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520efficacious%2520pan-PIM%2520kinase%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D135%26epage%3D139%26doi%3D10.1021%2Fml200259q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Nishiguchi, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atallah, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamacina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klivansky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindvall, M.</span><span> </span><span class="NLM_article-title">Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6366</span><span class="NLM_x">–</span> <span class="NLM_lpage">6369</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.08.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2Fj.bmcl.2011.08.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=21945284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6366-6369&author=G.+A.+Nishiguchiauthor=G.+Atallahauthor=C.+Bellamacinaauthor=M.+T.+Burgerauthor=Y.+Dingauthor=P.+H.+Feuchtauthor=P.+D.+Garciaauthor=W.+Hanauthor=L.+Klivanskyauthor=M.+Lindvall&title=Discovery+of+novel+3%2C5-disubstituted+indole+derivatives+as+potent+inhibitors+of+Pim-1%2C+Pim-2%2C+and+Pim-3+protein+kinases&doi=10.1016%2Fj.bmcl.2011.08.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases</span></div><div class="casAuthors">Nishiguchi, Gisele A.; Atallah, Gordana; Bellamacina, Cornelia; Burger, Matthew T.; Ding, Yu; Feucht, Paul H.; Garcia, Pablo D.; Han, Woo-Seok; Klivansky, Liana; Lindvall, Mika</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6366-6369</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel 3,5-disubstituted indole e. g., I and pyrazolopyridine e. g., II derivs. as potent and selective inhibitors of all three members of the Pim kinase family is described.  High throughput screen identified a pan-Pim kinase inhibitor with a promiscuous scaffold.  Guided by structure-based drug design, SAR of the series afforded a highly selective indole chemotype that was further developed into a potent set of compds. against Pim-1, 2, and 3 (Pim-1 and Pim-3: IC50 ≤ 2 nM and Pim-2: IC50 ≤ 100 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraW5ZPCZ1p-7Vg90H21EOLACvtfcHk0lijVQ_r-Hwh6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FK&md5=9b8f859027daa006c85b6bbf7696ef18</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.105%26sid%3Dliteratum%253Aachs%26aulast%3DNishiguchi%26aufirst%3DG.%2BA.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DFeucht%26aufirst%3DP.%2BH.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DKlivansky%26aufirst%3DL.%26aulast%3DLindvall%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520novel%25203%252C5-disubstituted%2520indole%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520Pim-1%252C%2520Pim-2%252C%2520and%2520Pim-3%2520protein%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6366%26epage%3D6369%26doi%3D10.1016%2Fj.bmcl.2011.08.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallwever, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harstad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eben, A. J.</span><span> </span><span class="NLM_article-title">Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-PIM inhibitors by structure- and property-based drug design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3149</span><span class="NLM_x">–</span> <span class="NLM_lpage">3153</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2Fj.bmcl.2013.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=23623490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1Oisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3149-3153&author=X.+Wangauthor=S.+Magnusonauthor=R.+Pastorauthor=E.+Fanauthor=H.+Huauthor=V.+Tsuiauthor=W.+Dengauthor=J.+Murrayauthor=M.+Steffekauthor=H.+Wallweverauthor=J.+Moffatauthor=J.+Drummondauthor=G.+Chanauthor=E.+Harstadauthor=A.+J.+Eben&title=Discovery+of+novel+pyrazolo%5B1%2C5-a%5Dpyrimidines+as+potent+pan-PIM+inhibitors+by+structure-+and+property-based+drug+design&doi=10.1016%2Fj.bmcl.2013.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design</span></div><div class="casAuthors">Wang, Xiaojing; Magnuson, Steven; Pastor, Rich; Fan, Eric; Hu, Huiyong; Tsui, Vickie; Deng, Wei; Murray, Jeremy; Steffek, Micah; Wallweber, Heidi; Moffat, John; Drummond, Jason; Chan, Grace; Harstad, Eric; Ebens, Allen J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3149-3153</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pim kinases are promising targets for the development of cancer therapeutics.  Among the three Pim isoforms, Pim-2 is particularly important in multiple myeloma, yet is the most difficult to inhibit due to its high affinity for ATP.  We identified compd. 1 via high throughput screening.  Using property-based drug design and co-crystal structures with Pim-1 kinase to guide analog design, we were able to improve potency against all three Pim isoforms including a significant 10,000-fold gain against Pim-2.  Compd. 17 is a novel lead with low picomolar potency on all three Pim kinase isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonWvohEjJoarVg90H21EOLACvtfcHk0lijVQ_r-Hwh6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1Oisbg%253D&md5=9129c2f2897d536317c3243220b37251</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DPastor%26aufirst%3DR.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DDeng%26aufirst%3DW.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DWallwever%26aufirst%3DH.%26aulast%3DMoffat%26aufirst%3DJ.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DEben%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520of%2520novel%2520pyrazolo%255B1%252C5-a%255Dpyrimidines%2520as%2520potent%2520pan-PIM%2520inhibitors%2520by%2520structure-%2520and%2520property-based%2520drug%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3149%26epage%3D3153%26doi%3D10.1016%2Fj.bmcl.2013.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Qian, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barringer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kronkaitis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mische, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmer, B.</span><span> </span><span class="NLM_article-title">Structural basis of constitutive activity and a unique nucleotide binding mode of human Pim-1 kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">6130</span><span class="NLM_x">–</span> <span class="NLM_lpage">6137</span><span class="refDoi"> DOI: 10.1074/jbc.M409123200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1074%2Fjbc.M409123200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=6130-6137&author=K.+C.+Qianauthor=L.+Wangauthor=E.+R.+Hickeyauthor=J.+Studtsauthor=K.+Barringerauthor=C.+Pengauthor=A.+Kronkaitisauthor=J.+Liauthor=A.+Whiteauthor=S.+Mischeauthor=B.+Farmer&title=Structural+basis+of+constitutive+activity+and+a+unique+nucleotide+binding+mode+of+human+Pim-1+kinase&doi=10.1074%2Fjbc.M409123200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M409123200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M409123200%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DK.%2BC.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DStudts%26aufirst%3DJ.%26aulast%3DBarringer%26aufirst%3DK.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DKronkaitis%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DMische%26aufirst%3DS.%26aulast%3DFarmer%26aufirst%3DB.%26atitle%3DStructural%2520basis%2520of%2520constitutive%2520activity%2520and%2520a%2520unique%2520nucleotide%2520binding%2520mode%2520of%2520human%2520Pim-1%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D6130%26epage%3D6137%26doi%3D10.1074%2Fjbc.M409123200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Burger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiguchi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamacina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindvall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atallah, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beans, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavorotinskaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holash, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, P.</span><span> </span><span class="NLM_article-title">Structure guided optimization, in vitro activity and in vivo activity of pan-PIM kinase inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1197</span><span class="refDoi"> DOI: 10.1021/ml400307j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400307j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1193-1197&author=M.+Burgerauthor=W.+Hanauthor=J.+Lanauthor=G.+Nishiguchiauthor=C.+Bellamacinaauthor=M.+Lindvallauthor=G.+Atallahauthor=Y.+Dingauthor=M.+Mathurauthor=C.+McBrideauthor=E.+L.+Beansauthor=K.+Mullerauthor=V.+Tamezauthor=Y.+Zhangauthor=K.+Huhauthor=P.+Feuchtauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=J.+Holashauthor=J.+Castilloauthor=J.+Langowskiauthor=Y.+Wangauthor=M.+Y.+Chenauthor=P.+Garcia&title=Structure+guided+optimization%2C+in+vitro+activity+and+in+vivo+activity+of+pan-PIM+kinase+inhibitors&doi=10.1021%2Fml400307j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fml400307j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400307j%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DNishiguchi%26aufirst%3DG.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DLindvall%26aufirst%3DM.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DMathur%26aufirst%3DM.%26aulast%3DMcBride%26aufirst%3DC.%26aulast%3DBeans%26aufirst%3DE.%2BL.%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DTamez%26aufirst%3DV.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHuh%26aufirst%3DK.%26aulast%3DFeucht%26aufirst%3DP.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DCastillo%26aufirst%3DJ.%26aulast%3DLangowski%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%2BY.%26aulast%3DGarcia%26aufirst%3DP.%26atitle%3DStructure%2520guided%2520optimization%252C%2520in%2520vitro%2520activity%2520and%2520in%2520vivo%2520activity%2520of%2520pan-PIM%2520kinase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1193%26epage%3D1197%26doi%3D10.1021%2Fml400307j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavorotinskaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langowski, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holash, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, P. D.</span><span> </span><span class="NLM_article-title">Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1610</span><span class="NLM_x">–</span> <span class="NLM_lpage">1620</span><span class="refDoi"> DOI: 10.1182/blood-2013-01-481457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1182%2Fblood-2013-01-481457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=23818547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSqu7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=1610-1620&author=J.+Luauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=X.+Niuauthor=J.+Castilloauthor=J.+Simauthor=J.+Yuauthor=Y.+Wangauthor=J.+L.+Langowskiauthor=J.+Holashauthor=K.+Shannonauthor=P.+D.+Garcia&title=Pim2+is+required+for+maintaining+multiple+myeloma+cell+growth+through+modulating+TSC2+phosphorylation&doi=10.1182%2Fblood-2013-01-481457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation</span></div><div class="casAuthors">Lu, Jing; Zavorotinskaya, Tatiana; Dai, Yumin; Niu, Xiao-Hong; Castillo, Joseph; Sim, Janet; Yu, Jianjun; Wang, Yingyun; Langowski, John L.; Holash, Jocelyn; Shannon, Kevin; Garcia, Pablo D.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1610-1620</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Multiple myeloma (MM) is the second most common hematol. malignancy.  Despite recent treatment advances, it remains incurable.  Here, we report that Pim2 kinase expression is highly elevated in MM cells and demonstrate that it is required for MM cell proliferation.  Functional interference of Pim2 activity either by short hairpin RNAs or by a potent and selective small-mol. inhibitor leads to significant inhibition of MM cell proliferation.  Pim inhibition results in a significant decrease of mammalian target of rapamycin C1 (mTOR-C1) activity, which is crit. for cell proliferation.  We identify TSC2, a neg. regulator of mTOR-C1, as a novel Pim2 substrate and show that Pim2 directly phosphorylates TSC2 on Ser-1798 and relieves the suppression of TSC2 on mTOR-C1.  These findings support Pim2 as a promising therapeutic target for MM and define a novel Pim2-TSC2-mTOR-C1 pathway that drives MM proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPXlAZPVNnObVg90H21EOLACvtfcHk0li4FquV-sEXxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSqu7jJ&md5=027403b9b40e4fc57836c398545e71e1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1182%2Fblood-2013-01-481457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2013-01-481457%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DNiu%26aufirst%3DX.%26aulast%3DCastillo%26aufirst%3DJ.%26aulast%3DSim%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLangowski%26aufirst%3DJ.%2BL.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DShannon%26aufirst%3DK.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26atitle%3DPim2%2520is%2520required%2520for%2520maintaining%2520multiple%2520myeloma%2520cell%2520growth%2520through%2520modulating%2520TSC2%2520phosphorylation%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26spage%3D1610%26epage%3D1620%26doi%3D10.1182%2Fblood-2013-01-481457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Cabral, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, M.</span><span> </span><span class="NLM_article-title">Lithium borohydride: a reagent of choice for the selective reductive amination of cyclohexanones</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7134</span><span class="NLM_x">–</span> <span class="NLM_lpage">7136</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2007.07.217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2Fj.tetlet.2007.07.217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSksL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=7134-7136&author=S.+Cabralauthor=B.+Hulinauthor=M.+Kawai&title=Lithium+borohydride%3A+a+reagent+of+choice+for+the+selective+reductive+amination+of+cyclohexanones&doi=10.1016%2Fj.tetlet.2007.07.217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Lithium borohydride: a reagent of choice for the selective reductive amination of cyclohexanones</span></div><div class="casAuthors">Cabral, Shawn; Hulin, Bernard; Kawai, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">7134-7136</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Traditional reductive amination of substituted cyclohexanones are either selective toward the formation of cis-products or show low selectivity.  Herein we report a selective procedure for the reductive amination of substituted cyclohexanones with primary amines using lithium borohydride that is selective toward formation of trans-products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Oc579JMPM7Vg90H21EOLACvtfcHk0li4FquV-sEXxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSksL3N&md5=88ff705f51b0e7ad8fb8b938adfb8e22</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2007.07.217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2007.07.217%26sid%3Dliteratum%253Aachs%26aulast%3DCabral%26aufirst%3DS.%26aulast%3DHulin%26aufirst%3DB.%26aulast%3DKawai%26aufirst%3DM.%26atitle%3DLithium%2520borohydride%253A%2520a%2520reagent%2520of%2520choice%2520for%2520the%2520selective%2520reductive%2520amination%2520of%2520cyclohexanones%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D7134%26epage%3D7136%26doi%3D10.1016%2Fj.tetlet.2007.07.217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Keeton, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillman, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palakurthi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grondine, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platanias, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyne, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, D.</span><span> </span><span class="NLM_article-title">AZD1208, a potent and selective pan-PIM kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span><span class="refDoi"> DOI: 10.1182/blood-2013-04-495366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1182%2Fblood-2013-04-495366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=24363397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFaqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2014&pages=905-913&author=E.+K.+Keetonauthor=K.+McEachernauthor=K.+S.+Dillmanauthor=S.+Palakurthiauthor=Y.+Caoauthor=M.+R.+Grondineauthor=S.+Kaurauthor=S.+Wangauthor=Y.+Chenauthor=A.+Wuauthor=M.+Shenauthor=F.+D.+Gibbonsauthor=M.+L.+Lambauthor=X.+Zhengauthor=R.+M.+Stoneauthor=D.+J.+DeAngeloauthor=L.+C.+Plataniasauthor=L.+A.+Dakinauthor=H.+Chenauthor=P.+D.+Lyneauthor=D.+Huszar&title=AZD1208%2C+a+potent+and+selective+pan-PIM+kinase+inhibitor%2C+demonstrates+efficacy+in+preclinical+models+of+acute+myeloid+leukemia&doi=10.1182%2Fblood-2013-04-495366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia</span></div><div class="casAuthors">Keeton, Erika K.; McEachern, Kristen; Dillman, Keith S.; Palakurthi, Sangeetha; Cao, Yichen; Grondine, Michael R.; Kaur, Surinder; Wang, Suping; Chen, Yuching; Wu, Allan; Shen, Minhui; Gibbson, Francis D.; Lamb, Michelle L.; Zheng, Xiaolan; Stone, Richard M.; DeAngelo, Daniel J.; Platanias, Leonidas C.; Dakin, Les A.; Chen, Huawei; Lyne, Paul D.; Huszar, Dennis</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">905-913</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Upregulation of Pim kinases is obsd. in several types of leukemias and lymphomas.  Pim-1, -2, and -3 promote cell proliferation and survival downstream of cytokine and growth factor signaling pathways.  AZD1208 is a potent, highly selective, and orally available Pim kinase inhibitor that effectively inhibits all three isoforms at <5 nM or <150 nM in enzyme and cell assays, resp.  AZD1208 inhibited the growth of 5 of 14 acute myeloid leukemia (AML) cell lines tested, and sensitivity correlates with Pim-1 expression and STAT5 activation.  AZD1208 causes cell cycle arrest and apoptosis in MOLM-16 cells, accompanied by a dose-dependent redn. in phosphorylation of Bcl-2 antagonist of cell death, 4EBP1, p70S6K, and S6, as well as increases in cleaved caspase 3 and p27.  Inhibition of p4EBP1 and p-p70S6K and suppression of translation are the most representative effects of Pim inhibition in sensitive AML cell lines.  AZD1208 inhibits the growth of MOLM-16 and KG-1a xenograft tumors in vivo with a clear pharmacodynamic-pharmacokinetic relationship.  AZD1208 also potently inhibits colony growth and Pim signaling substrates in primary AML cells from bone marrow that are Flt3 wild-type or Flt3 internal tandem duplication mutant.  These results underscore the therapeutic potential of Pim kinase inhibition for the treatment of AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNGYuN7tp7NrVg90H21EOLACvtfcHk0lg80mBc4ixAIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFaqs7o%253D&md5=4277790b53c9064787cbd68c159e552b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1182%2Fblood-2013-04-495366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2013-04-495366%26sid%3Dliteratum%253Aachs%26aulast%3DKeeton%26aufirst%3DE.%2BK.%26aulast%3DMcEachern%26aufirst%3DK.%26aulast%3DDillman%26aufirst%3DK.%2BS.%26aulast%3DPalakurthi%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DGrondine%26aufirst%3DM.%2BR.%26aulast%3DKaur%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DA.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DGibbons%26aufirst%3DF.%2BD.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DHuszar%26aufirst%3DD.%26atitle%3DAZD1208%252C%2520a%2520potent%2520and%2520selective%2520pan-PIM%2520kinase%2520inhibitor%252C%2520demonstrates%2520efficacy%2520in%2520preclinical%2520models%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DBlood%26date%3D2014%26volume%3D123%26spage%3D905%26epage%3D913%26doi%3D10.1182%2Fblood-2013-04-495366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">Structure of compound <b>8</b> in PIM1 submitted under PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DWR">5DWR</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Garcia, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langowski, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holash, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavorotinskaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Growney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanasse, K. G.</span><span> </span><span class="NLM_article-title">The Pan-PIM kinase inhibitor LGH447 shows activity in PIM2-dependent multiple myeloma and in AML models</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1666</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=1666&author=P.+D.+Garciaauthor=J.+L.+Langowskiauthor=J.+Holashauthor=M.+Burgerauthor=R.+Zangauthor=T.+Zavorotinskayaauthor=C.+Fantonauthor=A.+Saciauthor=J.+Growneyauthor=K.+G.+Vanasse&title=The+Pan-PIM+kinase+inhibitor+LGH447+shows+activity+in+PIM2-dependent+multiple+myeloma+and+in+AML+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26aulast%3DLangowski%26aufirst%3DJ.%2BL.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DBurger%26aufirst%3DM.%26aulast%3DZang%26aufirst%3DR.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DFanton%26aufirst%3DC.%26aulast%3DSaci%26aufirst%3DA.%26aulast%3DGrowney%26aufirst%3DJ.%26aulast%3DVanasse%26aufirst%3DK.%2BG.%26atitle%3DThe%2520Pan-PIM%2520kinase%2520inhibitor%2520LGH447%2520shows%2520activity%2520in%2520PIM2-dependent%2520multiple%2520myeloma%2520and%2520in%2520AML%2520models%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26spage%3D1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Raab, M. S.; Ocio, E. M.; Thomas, S. K.; Gunther, A.; Lebovic, D.; Jakubowiak, A. J.; Song, D.; Xiang, F.; Patel, A.; Vanasse, K. G.; Kumar, S. K.</span><span> </span><span class="NLM_article-title">Phase 1 study update of the novel pan-PIM kinase inhibitor LGH447 in patients with relapsed/refractory multiple myeloma</span>.  <span class="citation_source-journal">Am. Soc. Hemat. Annual Meet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span>Abstract 301.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+S.+Raab&author=E.+M.+Ocio&author=S.+K.+Thomas&author=A.+Gunther&author=D.+Lebovic&author=A.+J.+Jakubowiak&author=D.+Song&author=F.+Xiang&author=A.+Patel&author=K.+G.+Vanasse&author=S.+K.+Kumar&title=Phase+1+study+update+of+the+novel+pan-PIM+kinase+inhibitor+LGH447+in+patients+with+relapsed%2Frefractory+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaab%26aufirst%3DM.%2BS.%26atitle%3DPhase%25201%2520study%2520update%2520of%2520the%2520novel%2520pan-PIM%2520kinase%2520inhibitor%2520LGH447%2520in%2520patients%2520with%2520relapsed%252Frefractory%2520multiple%2520myeloma%26jtitle%3DAm.%2520Soc.%2520Hemat.%2520Annual%2520Meet.%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a> and PIM447, LGH447.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.clinicaltrials.gov+and+PIM447%2C+LGH447."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Manley, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drueckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fendrich, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebetanz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martiny-Baron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trappe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wartmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span> </span><span class="NLM_article-title">Extended kinase profile and properties of the protein kinase inhibitor nilotinib</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1804</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1016/j.bbapap.2009.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2Fj.bbapap.2009.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=19922818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1ynu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=445-53&author=P.+W.+Manleyauthor=P.+Drueckesauthor=G.+Fendrichauthor=P.+Furetauthor=J.+Liebetanzauthor=G.+Martiny-Baronauthor=J.+Mestanauthor=J.+Trappeauthor=M.+Wartmannauthor=D.+Fabbro&title=Extended+kinase+profile+and+properties+of+the+protein+kinase+inhibitor+nilotinib&doi=10.1016%2Fj.bbapap.2009.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Extended kinase profile and properties of the protein kinase inhibitor nilotinib</span></div><div class="casAuthors">Manley, Paul W.; Drueckes, Peter; Fendrich, Gabriele; Furet, Pascal; Liebetanz, Janis; Martiny-Baron, Georg; Mestan, Jurgen; Trappe, Jorg; Wartmann, Markus; Fabbro, Doriano</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1804</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">445-453</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">As a drug used to treat imatinib-resistant and -intolerant, chronic and advanced phase chronic myelogenous leukemia, nilotinib is well characterised as a potent inhibitor of the Abl tyrosine kinase activity of wild-type and imatinib-resistant mutant forms of BCR-Abl.  Here we review the profile of nilotinib as a protein kinase inhibitor.  Although an ATP-competitive inhibitor of Abl, nilotinib binds to a catalytically inactive conformation (DFG-out) of the activation loop.  As a consequence of this, nilotinib exhibits time-dependent inhibition of Abl kinase in enzymic assays, which can be extrapolated to other targets to explain differences between biochem. activity and cellular assays.  Although these differences confound assessment of kinase selectivity, as assessed using a combination of protein binding and transphosphorylation assays, together with cellular autophosporylation and proliferation assays, well established kinase targets of nilotinib in rank order of inhibitory potency are DDR-1 > DDR-2 > BCR-Abl (Abl) > PDGFRα/β > KIT > CSF-1R.  In addn. nilotinib has now been found to bind to both MAPK11 (p38β) and MAPK12 (p38α), as well as with very high affinity to ZAK kinase.  Although neither enzymic nor cellular data are yet available to substantiate the drug as an inhibitor of ZAK phosphorylation, modeling predicts that it binds in an ATP-competitive fashion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriO_qGAGTzcrVg90H21EOLACvtfcHk0lg80mBc4ixAIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1ynu78%253D&md5=a51029ebcfaf07f2e405208936cac28f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2009.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2009.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DDrueckes%26aufirst%3DP.%26aulast%3DFendrich%26aufirst%3DG.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DLiebetanz%26aufirst%3DJ.%26aulast%3DMartiny-Baron%26aufirst%3DG.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DWartmann%26aufirst%3DM.%26aulast%3DFabbro%26aufirst%3DD.%26atitle%3DExtended%2520kinase%2520profile%2520and%2520properties%2520of%2520the%2520protein%2520kinase%2520inhibitor%2520nilotinib%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2010%26volume%3D1804%26spage%3D445%26epage%3D53%26doi%3D10.1016%2Fj.bbapap.2009.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':[],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 41 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Wooseok Han, Yu Ding, Zheng Chen, John L. Langowski, Cornelia Bellamacina, Alice Rico, Gisele A. Nishiguchi, Jiong Lan, Gordana Atallah, Mika Lindvall, Song Lin, Richard Zang, Paul Feucht, Tatiana Zavorotinskaya, Yumin Dai, Pablo Garcia, <span class="NLM_string-name hlFld-ContribAuthor">Matthew T. Burger</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure–Activity Relationship of Tetra-Substituted Cyclohexyl Diol Inhibitors of Proviral Insertion of Moloney Virus (PIM) Kinases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14885-14904. <a href="https://doi.org/10.1021/acs.jmedchem.0c01279" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01279%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Bof%252BTetra-Substituted%252BCyclohexyl%252BDiol%252BInhibitors%252Bof%252BProviral%252BInsertion%252Bof%252BMoloney%252BVirus%252B%252528PIM%252529%252BKinases%26aulast%3DHan%26aufirst%3DWooseok%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11082020%26date%3D01122020%26volume%3D63%26issue%3D23%26spage%3D14885%26epage%3D14904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaojing Wang, Wesley Blackaby, Vivienne Allen, Grace Ka Yan Chan, Jae H. Chang, Po-Chang Chiang, Coura Diène, Jason Drummond, Steven Do, Eric Fan, Eric B. Harstad, Alastair Hodges, Huiyong Hu, Wei Jia, William Kofie, Aleksandr Kolesnikov, Joseph P. Lyssikatos, Justin Ly, Mizio Matteucci, John G. Moffat, Veerendra Munugalavadla, Jeremy Murray, David Nash, Cameron L. Noland, Geoff Del Rosario, Leanne Ross, Craig Rouse, Andrew Sharpe, Dionysos Slaga, Minghua Sun, Vickie Tsui, Heidi Wallweber, Shang-Fan Yu, <span class="NLM_string-name hlFld-ContribAuthor">Allen J. Ebens</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple Myeloma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 2140-2153. <a href="https://doi.org/10.1021/acs.jmedchem.8b01857" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01857%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BPan-Pim%252BKinase%252BActivity%252Band%252BOral%252BBioavailability%252BLeading%252Bto%252BDiaminopyrazole%252B%252528GDC-0339%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BMultiple%252BMyeloma%26aulast%3DWang%26aufirst%3DXiaojing%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D27112018%26date%3D20022019%26date%3D04022019%26volume%3D62%26issue%3D4%26spage%3D2140%26epage%3D2153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hui-Ling Wang, Kristin L. Andrews, Shon K. Booker, Jude Canon, Victor J. Cee, Frank Chavez, Jr., Yuping Chen, Heather Eastwood, Nadia Guerrero, Brad Herberich, Dean Hickman, Brian A. Lanman, Jimmy Laszlo, III, Matthew R. Lee, J. Russell Lipford, Bethany Mattson, Christopher Mohr, Yen Nguyen, Mark H. Norman, Liping H. Pettus, David Powers, Anthony B. Reed, Karen Rex, Christine Sastri, Nuria Tamayo, Paul Wang, Jeffrey T. Winston, Bin Wu, Qiong Wu, Tian Wu, Ryan P. Wurz, Yang Xu, Yihong Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Andrew S. Tasker</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of (R)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4-b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3H)-one, a Potent and Selective Pim-1/2 Kinase Inhibitor for Hematological Malignancies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (3)
                                     , 1523-1540. <a href="https://doi.org/10.1021/acs.jmedchem.8b01733" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01733</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01733%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%252528R%252529-8-%2525286-Methyl-4-oxo-1%25252C4%25252C5%25252C6-tetrahydropyrrolo%25255B3%25252C4-b%25255Dpyrrol-2-yl%252529-3-%2525281-methylcyclopropyl%252529-2-%252528%2525281-methylcyclopropyl%252529amino%252529quinazolin-4%2525283H%252529-one%25252C%252Ba%252BPotent%252Band%252BSelective%252BPim-1%25252F2%252BKinase%252BInhibitor%252Bfor%252BHematological%252BMalignancies%26aulast%3DWang%26aufirst%3DHui-Ling%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D06112018%26date%3D17012019%26date%3D09012019%26volume%3D62%26issue%3D3%26spage%3D1523%26epage%3D1540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yan-Qiao Chen, Zhen Wang, Yongwei Wu, Steven R. Wisniewski, Jennifer X. Qiao, William R. Ewing, Martin D. Eastgate, <span class="NLM_string-name hlFld-ContribAuthor">Jin-Quan Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Overcoming the Limitations of γ- and δ-C–H Arylation of Amines through Ligand Development. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2018,</strong> <em>140 </em>
                                    (51)
                                     , 17884-17894. <a href="https://doi.org/10.1021/jacs.8b07109" title="DOI URL">https://doi.org/10.1021/jacs.8b07109</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.8b07109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.8b07109%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DOvercoming%252Bthe%252BLimitations%252Bof%252B%2525CE%2525B3-%252Band%252B%2525CE%2525B4-C%2525E2%252580%252593H%252BArylation%252Bof%252BAmines%252Bthrough%252BLigand%252BDevelopment%26aulast%3DChen%26aufirst%3DYan-Qiao%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D05072018%26date%3D14122018%26date%3D30112018%26volume%3D140%26issue%3D51%26spage%3D17884%26epage%3D17894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takeshi  Hasegawa</span>, <span class="hlFld-ContribAuthor ">Masatake  Sugita</span>, <span class="hlFld-ContribAuthor ">Takeshi  Kikuchi</span>, and <span class="hlFld-ContribAuthor ">Fumio  Hirata</span>  . </span><span class="cited-content_cbyCitation_article-title">A Systematic Analysis of the Binding Affinity between the Pim-1 Kinase and Its Inhibitors Based on the MM/3D-RISM/KH Method. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (11)
                                     , 2789-2798. <a href="https://doi.org/10.1021/acs.jcim.7b00158" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00158</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00158%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DA%252BSystematic%252BAnalysis%252Bof%252Bthe%252BBinding%252BAffinity%252Bbetween%252Bthe%252BPim-1%252BKinase%252Band%252BIts%252BInhibitors%252BBased%252Bon%252Bthe%252BMM%25252F3D-RISM%25252FKH%252BMethod%26aulast%3DHasegawa%26aufirst%3DTakeshi%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D22032017%26date%3D01112017%26date%3D27112017%26date%3D11102017%26volume%3D57%26issue%3D11%26spage%3D2789%26epage%3D2798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junya  Wang</span>, <span class="hlFld-ContribAuthor ">Ge  Meng</span>, <span class="hlFld-ContribAuthor ">Kun  Xie</span>, <span class="hlFld-ContribAuthor ">Liting  Li</span>, <span class="hlFld-ContribAuthor ">Huaming  Sun</span>, and <span class="hlFld-ContribAuthor ">Zhiyan  Huang</span>  . </span><span class="cited-content_cbyCitation_article-title">Mild and Efficient Ni-Catalyzed Biaryl Synthesis with Polyfluoroaryl Magnesium Species: Verification of the Arrest State, Uncovering the Hidden Competitive Second Transmetalation and Ligand-Accelerated Highly Selective Monoarylation. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2017,</strong> <em>7 </em>
                                    (11)
                                     , 7421-7430. <a href="https://doi.org/10.1021/acscatal.7b02618" title="DOI URL">https://doi.org/10.1021/acscatal.7b02618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.7b02618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.7b02618%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DMild%252Band%252BEfficient%252BNi-Catalyzed%252BBiaryl%252BSynthesis%252Bwith%252BPolyfluoroaryl%252BMagnesium%252BSpecies%25253A%252BVerification%252Bof%252Bthe%252BArrest%252BState%25252C%252BUncovering%252Bthe%252BHidden%252BCompetitive%252BSecond%252BTransmetalation%252Band%252BLigand-Accelerated%252BHighly%252BSelective%252BMonoarylation%26aulast%3DWang%26aufirst%3DJunya%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D08082017%26date%3D06092017%26date%3D29092017%26date%3D03112017%26volume%3D7%26issue%3D11%26spage%3D7421%26epage%3D7430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojing  Wang</span>, <span class="hlFld-ContribAuthor ">Aleksandr  Kolesnikov</span>, <span class="hlFld-ContribAuthor ">Suzanne  Tay</span>, <span class="hlFld-ContribAuthor ">Grace  Chan</span>, <span class="hlFld-ContribAuthor ">Qi  Chao</span>, <span class="hlFld-ContribAuthor ">Steven  Do</span>, <span class="hlFld-ContribAuthor ">Jason  Drummond</span>, <span class="hlFld-ContribAuthor ">Allen J.  Ebens</span>, <span class="hlFld-ContribAuthor ">Ning  Liu</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Eric  Harstad</span>, <span class="hlFld-ContribAuthor ">Huiyong  Hu</span>, <span class="hlFld-ContribAuthor ">John  Moffat</span>, <span class="hlFld-ContribAuthor ">Veerendra  Munugalavadla</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Dionysos  Slaga</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Matthew  Volgraf</span>, <span class="hlFld-ContribAuthor ">Heidi  Wallweber</span>, and <span class="hlFld-ContribAuthor ">Jae H.  Chang</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized Bioavailability. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (10)
                                     , 4458-4473. <a href="https://doi.org/10.1021/acs.jmedchem.7b00418" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00418%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B5-Azaindazole%252B%252528GNE-955%252529%252Bas%252Ba%252BPotent%252BPan-Pim%252BInhibitor%252Bwith%252BOptimized%252BBioavailability%26aulast%3DWang%26aufirst%3DXiaojing%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D21032017%26date%3D05052017%26date%3D25052017%26date%3D26042017%26volume%3D60%26issue%3D10%26spage%3D4458%26epage%3D4473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hirofumi  Nakano</span>, <span class="hlFld-ContribAuthor ">Tsukasa  Hasegawa</span>, <span class="hlFld-ContribAuthor ">Hirotatsu  Kojima</span>, <span class="hlFld-ContribAuthor ">Takayoshi  Okabe</span>, and <span class="hlFld-ContribAuthor ">Tetsuo  Nagano</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Potent and Selective PIM Kinase Inhibitors by Targeting Unique Structure of ATP-Binding Pocket. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (5)
                                     , 504-509. <a href="https://doi.org/10.1021/acsmedchemlett.6b00518" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00518%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BPotent%252Band%252BSelective%252BPIM%252BKinase%252BInhibitors%252Bby%252BTargeting%252BUnique%252BStructure%252Bof%252BATP-Binding%252BPocket%26aulast%3DNakano%26aufirst%3DHirofumi%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D23122016%26date%3D02042017%26date%3D10042017%26date%3D11052017%26date%3D03042017%26volume%3D8%26issue%3D5%26spage%3D504%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (22)
                                     , 10030-10066. <a href="https://doi.org/10.1021/acs.jmedchem.6b00618" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BBrain%252BCancer%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21042016%26date%3D03082016%26date%3D23112016%26date%3D14072016%26volume%3D59%26issue%3D22%26spage%3D10030%26epage%3D10066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liping H.  Pettus</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Shon K.  Booker</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Victor J.  Cee</span>, <span class="hlFld-ContribAuthor ">Frank  Chavez, Jr.</span>, <span class="hlFld-ContribAuthor ">Yuping  Chen</span>, <span class="hlFld-ContribAuthor ">Heather  Eastwood</span>, <span class="hlFld-ContribAuthor ">Nadia  Guerrero</span>, <span class="hlFld-ContribAuthor ">Bradley  Herberich</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Brian A.  Lanman</span>, <span class="hlFld-ContribAuthor ">Jimmy  Laszlo, III</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">J. Russell  Lipford</span>, <span class="hlFld-ContribAuthor ">Bethany  Mattson</span>, <span class="hlFld-ContribAuthor ">Christopher  Mohr</span>, <span class="hlFld-ContribAuthor ">Yen  Nguyen</span>, <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>, <span class="hlFld-ContribAuthor ">David  Powers</span>, <span class="hlFld-ContribAuthor ">Anthony B.  Reed</span>, <span class="hlFld-ContribAuthor ">Karen  Rex</span>, <span class="hlFld-ContribAuthor ">Christine  Sastri</span>, <span class="hlFld-ContribAuthor ">Nuria  Tamayo</span>, <span class="hlFld-ContribAuthor ">Paul  Wang</span>, <span class="hlFld-ContribAuthor ">Jeffrey T.  Winston</span>, <span class="hlFld-ContribAuthor ">Bin  Wu</span>, <span class="hlFld-ContribAuthor ">Tian  Wu</span>, <span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Yang  Xu</span>, <span class="hlFld-ContribAuthor ">Yihong  Zhou</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>, and <span class="hlFld-ContribAuthor ">Hui-Ling  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (13)
                                     , 6407-6430. <a href="https://doi.org/10.1021/acs.jmedchem.6b00610" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00610%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252BQuinazolinone-pyrrolopyrrolones%252Bas%252BPotent%252Band%252BOrally%252BBioavailable%252BPan-Pim%252BKinase%252BInhibitors%26aulast%3DPettus%26aufirst%3DLiping%2BH.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21042016%26date%3D22062016%26date%3D14072016%26date%3D10062016%26volume%3D59%26issue%3D13%26spage%3D6407%26epage%3D6430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raajit K.  Rampal</span>, <span class="hlFld-ContribAuthor ">Maria  Pinzon-Ortiz</span>, <span class="hlFld-ContribAuthor ">Amritha Varshini Hanasoge  Somasundara</span>, <span class="hlFld-ContribAuthor ">Benjamin  Durham</span>, <span class="hlFld-ContribAuthor ">Richard  Koche</span>, <span class="hlFld-ContribAuthor ">Barbara  Spitzer</span>, <span class="hlFld-ContribAuthor ">Shoron  Mowla</span>, <span class="hlFld-ContribAuthor ">Aishwarya  Krishnan</span>, <span class="hlFld-ContribAuthor ">Bing  Li</span>, <span class="hlFld-ContribAuthor ">Wenbin  An</span>, <span class="hlFld-ContribAuthor ">Andriy  Derkach</span>, <span class="hlFld-ContribAuthor ">Sean  Devlin</span>, <span class="hlFld-ContribAuthor ">Xianhui  Rong</span>, <span class="hlFld-ContribAuthor ">Tyler  Longmire</span>, <span class="hlFld-ContribAuthor ">Shira Esther  Eisman</span>, <span class="hlFld-ContribAuthor ">Keith  Cordner</span>, <span class="hlFld-ContribAuthor ">Justin T.  Whitfield</span>, <span class="hlFld-ContribAuthor ">Gary  Vanasse</span>, <span class="hlFld-ContribAuthor ">Zhu A.  Cao</span>, <span class="hlFld-ContribAuthor ">Ross L.  Levine</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2021,</strong> <em>27 </em>
                                    (12)
                                     , 3456-3468. <a href="https://doi.org/10.1158/1078-0432.CCR-20-4898" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-20-4898</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-20-4898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-20-4898%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DTherapeutic%252BEfficacy%252Bof%252BCombined%252BJAK1%25252F2%25252C%252BPan-PIM%25252C%252Band%252BCDK4%25252F6%252BInhibition%252Bin%252BMyeloproliferative%252BNeoplasms%26aulast%3DRampal%26aufirst%3DRaajit%2BK.%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D12%26spage%3D3456%26epage%3D3468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hwangseo  Park</span>, <span class="hlFld-ContribAuthor ">Jinwon  Jeon</span>, <span class="hlFld-ContribAuthor ">Kewon  Kim</span>, <span class="hlFld-ContribAuthor ">Soyeon  Choi</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Virtual Screening and De Novo Design of PIM1 Inhibitors with Anticancer Activity from Natural Products. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (3)
                                     , 275. <a href="https://doi.org/10.3390/ph14030275" title="DOI URL">https://doi.org/10.3390/ph14030275</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14030275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14030275%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DStructure-Based%252BVirtual%252BScreening%252Band%252BDe%252BNovo%252BDesign%252Bof%252BPIM1%252BInhibitors%252Bwith%252BAnticancer%252BActivity%252Bfrom%252BNatural%252BProducts%26aulast%3DPark%26aufirst%3DHwangseo%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D3%26spage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masatake  Sugita</span>, <span class="hlFld-ContribAuthor ">Itaru  Onishi</span>, <span class="hlFld-ContribAuthor ">Masayuki  Irisa</span>, <span class="hlFld-ContribAuthor ">Norio  Yoshida</span>, <span class="hlFld-ContribAuthor ">Fumio  Hirata</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Recognition and Self-Organization in Life Phenomena Studied by a Statistical Mechanics of Molecular Liquids, the RISM/3D-RISM Theory. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (2)
                                     , 271. <a href="https://doi.org/10.3390/molecules26020271" title="DOI URL">https://doi.org/10.3390/molecules26020271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26020271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26020271%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMolecular%252BRecognition%252Band%252BSelf-Organization%252Bin%252BLife%252BPhenomena%252BStudied%252Bby%252Ba%252BStatistical%252BMechanics%252Bof%252BMolecular%252BLiquids%25252C%252Bthe%252BRISM%25252F3D-RISM%252BTheory%26aulast%3DSugita%26aufirst%3DMasatake%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D2%26spage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victor Sukbong  Hong</span>, <span class="hlFld-ContribAuthor ">Seungik  Jeong</span>, <span class="hlFld-ContribAuthor ">Yanghwan  Yun</span>, <span class="hlFld-ContribAuthor ">Hyeonseong  Choo</span>, <span class="hlFld-ContribAuthor ">Jongin  Won</span>, <span class="hlFld-ContribAuthor ">Jinho  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">1,3,
              4‐Oxadiazole
              ‐2(
              
                3
                H
              
              )‐thione Analogs as
              PIM
              Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2020,</strong> <em>41 </em>
                                    (10)
                                     , 994-1001. <a href="https://doi.org/10.1002/bkcs.12101" title="DOI URL">https://doi.org/10.1002/bkcs.12101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bkcs.12101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbkcs.12101%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3D1%25252C3%25252C%252B4%2525E2%252580%252590Oxadiazole%252B%2525E2%252580%2525902%252528%252B3%252BH%252B%252529%2525E2%252580%252590thione%252BAnalogs%252Bas%252BPIM%252BKinase%252BInhibitors%26aulast%3DHong%26aufirst%3DVictor%2BSukbong%26date%3D2020%26date%3D2020%26volume%3D41%26issue%3D10%26spage%3D994%26epage%3D1001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hye Suk  Baek</span>, <span class="hlFld-ContribAuthor ">Hyeon Ji  Min</span>, <span class="hlFld-ContribAuthor ">Victor Sukbong  Hong</span>, <span class="hlFld-ContribAuthor ">Taeg Kyu  Kwon</span>, <span class="hlFld-ContribAuthor ">Jong Wook  Park</span>, <span class="hlFld-ContribAuthor ">Jinho  Lee</span>, <span class="hlFld-ContribAuthor ">Shin  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-Inflammatory Effects of the Novel PIM Kinase Inhibitor KMU-470 in RAW 264.7 Cells through the TLR4-NF-κB-NLRP3 Pathway. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (14)
                                     , 5138. <a href="https://doi.org/10.3390/ijms21145138" title="DOI URL">https://doi.org/10.3390/ijms21145138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21145138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21145138%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DAnti-Inflammatory%252BEffects%252Bof%252Bthe%252BNovel%252BPIM%252BKinase%252BInhibitor%252BKMU-470%252Bin%252BRAW%252B264.7%252BCells%252Bthrough%252Bthe%252BTLR4-NF-%2525CE%2525BAB-NLRP3%252BPathway%26aulast%3DBaek%26aufirst%3DHye%2BSuk%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D14%26spage%3D5138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takeshi  Ashida</span>, <span class="hlFld-ContribAuthor ">Takeshi  Kikuchi</span>. </span><span class="cited-content_cbyCitation_article-title">A new method for estimating the relative binding free energy, derived from a free energy variational principle for the Pim-1-kinase–ligand and FKBP–ligand systems. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2020,</strong> <em>34 </em>
                                    (6)
                                     , 647-658. <a href="https://doi.org/10.1007/s10822-020-00302-4" title="DOI URL">https://doi.org/10.1007/s10822-020-00302-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-020-00302-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-020-00302-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DA%252Bnew%252Bmethod%252Bfor%252Bestimating%252Bthe%252Brelative%252Bbinding%252Bfree%252Benergy%25252C%252Bderived%252Bfrom%252Ba%252Bfree%252Benergy%252Bvariational%252Bprinciple%252Bfor%252Bthe%252BPim-1-kinase%2525E2%252580%252593ligand%252Band%252BFKBP%2525E2%252580%252593ligand%252Bsystems%26aulast%3DAshida%26aufirst%3DTakeshi%26date%3D2020%26date%3D2020%26volume%3D34%26issue%3D6%26spage%3D647%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renate  De Smedt</span>, <span class="hlFld-ContribAuthor ">Julie  Morscio</span>, <span class="hlFld-ContribAuthor ">Lindy  Reunes</span>, <span class="hlFld-ContribAuthor ">Juliette  Roels</span>, <span class="hlFld-ContribAuthor ">Valentina  Bardelli</span>, <span class="hlFld-ContribAuthor ">Beatrice  Lintermans</span>, <span class="hlFld-ContribAuthor ">Wouter  Van Loocke</span>, <span class="hlFld-ContribAuthor ">Afonso  Almeida</span>, <span class="hlFld-ContribAuthor ">Laurence C.  Cheung</span>, <span class="hlFld-ContribAuthor ">Rishi S.  Kotecha</span>, <span class="hlFld-ContribAuthor ">Marc R.  Mansour</span>, <span class="hlFld-ContribAuthor ">Anne  Uyttebroeck</span>, <span class="hlFld-ContribAuthor ">Peter  Vandenberghe</span>, <span class="hlFld-ContribAuthor ">Roberta  La Starza</span>, <span class="hlFld-ContribAuthor ">Cristina  Mecucci</span>, <span class="hlFld-ContribAuthor ">Tim  Lammens</span>, <span class="hlFld-ContribAuthor ">Nadine  Van Roy</span>, <span class="hlFld-ContribAuthor ">Barbara  De Moerloose</span>, <span class="hlFld-ContribAuthor ">João T.  Barata</span>, <span class="hlFld-ContribAuthor ">Tom  Taghon</span>, <span class="hlFld-ContribAuthor ">Steven  Goossens</span>, <span class="hlFld-ContribAuthor ">Pieter  Van Vlierberghe</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma. </span><span class="cited-content_cbyCitation_journal-name">Blood</span><span> <strong>2020,</strong> <em>135 </em>
                                    (19)
                                     , 1685-1695. <a href="https://doi.org/10.1182/blood.2019003880" title="DOI URL">https://doi.org/10.1182/blood.2019003880</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/blood.2019003880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fblood.2019003880%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%26atitle%3DTargeting%252Bcytokine-%252Band%252Btherapy-induced%252BPIM1%252Bactivation%252Bin%252Bpreclinical%252Bmodels%252Bof%252BT-cell%252Bacute%252Blymphoblastic%252Bleukemia%252Band%252Blymphoma%26aulast%3DDe%2BSmedt%26aufirst%3DRenate%26date%3D2020%26volume%3D135%26issue%3D19%26spage%3D1685%26epage%3D1695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lacey M.  Litchfield</span>, <span class="hlFld-ContribAuthor ">Karsten  Boehnke</span>, <span class="hlFld-ContribAuthor ">Manisha  Brahmachary</span>, <span class="hlFld-ContribAuthor ">Cecilia  Mur</span>, <span class="hlFld-ContribAuthor ">Chen  Bi</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Stephens</span>, <span class="hlFld-ContribAuthor ">J. Michael  Sauder</span>, <span class="hlFld-ContribAuthor ">Sonia M.  Gutiérrez</span>, <span class="hlFld-ContribAuthor ">Ann M.  McNulty</span>, <span class="hlFld-ContribAuthor ">Xiang S.  Ye</span>, <span class="hlFld-ContribAuthor ">Wenjuan  Wu</span>, <span class="hlFld-ContribAuthor ">María José  Lallena</span>, <span class="hlFld-ContribAuthor ">Xueqian  Gong</span>, <span class="hlFld-ContribAuthor ">Farhana F.  Merzoug</span>, <span class="hlFld-ContribAuthor ">Valerie M.  Jansen</span>, <span class="hlFld-ContribAuthor ">Sean G.  Buchanan</span>. </span><span class="cited-content_cbyCitation_article-title">Combined inhibition of PIM and CDK4/6 suppresses both mTOR signaling and Rb phosphorylation and potentiates PI3K inhibition in cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2020,</strong> <em>11 </em>
                                    (17)
                                     , 1478-1492. <a href="https://doi.org/10.18632/oncotarget.27539" title="DOI URL">https://doi.org/10.18632/oncotarget.27539</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.27539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.27539%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DCombined%252Binhibition%252Bof%252BPIM%252Band%252BCDK4%25252F6%252Bsuppresses%252Bboth%252BmTOR%252Bsignaling%252Band%252BRb%252Bphosphorylation%252Band%252Bpotentiates%252BPI3K%252Binhibition%252Bin%252Bcancer%252Bcells%26aulast%3DLitchfield%26aufirst%3DLacey%2BM.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D17%26spage%3D1478%26epage%3D1492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sean P.  Kennedy</span>, <span class="hlFld-ContribAuthor ">Michael  O’Neill</span>, <span class="hlFld-ContribAuthor ">Darren  Cunningham</span>, <span class="hlFld-ContribAuthor ">Patrick G.  Morris</span>, <span class="hlFld-ContribAuthor ">Sinead  Toomey</span>, <span class="hlFld-ContribAuthor ">Carmen  Blanco-Aparicio</span>, <span class="hlFld-ContribAuthor ">Sonia  Martinez</span>, <span class="hlFld-ContribAuthor ">Joaquin  Pastor</span>, <span class="hlFld-ContribAuthor ">Alex J.  Eustace</span>, <span class="hlFld-ContribAuthor ">Bryan T.  Hennessy</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical evaluation of a novel triple-acting PIM/PI3K/mTOR inhibitor, IBL-302, in breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2020,</strong> <em>39 </em>
                                    (14)
                                     , 3028-3040. <a href="https://doi.org/10.1038/s41388-020-1202-y" title="DOI URL">https://doi.org/10.1038/s41388-020-1202-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41388-020-1202-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41388-020-1202-y%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DPreclinical%252Bevaluation%252Bof%252Ba%252Bnovel%252Btriple-acting%252BPIM%25252FPI3K%25252FmTOR%252Binhibitor%25252C%252BIBL-302%25252C%252Bin%252Bbreast%252Bcancer%26aulast%3DKennedy%26aufirst%3DSean%2BP.%26date%3D2020%26date%3D2020%26volume%3D39%26issue%3D14%26spage%3D3028%26epage%3D3040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hafez  Razmazma</span>, <span class="hlFld-ContribAuthor ">Ali  Ebrahimi</span>, <span class="hlFld-ContribAuthor ">Mohammad  Hashemi</span>. </span><span class="cited-content_cbyCitation_article-title">Structural insights for rational design of new PIM-1 kinase inhibitors based on 3,5-disubstituted indole derivatives: An integrative computational approach. </span><span class="cited-content_cbyCitation_journal-name">Computers in Biology and Medicine</span><span> <strong>2020,</strong> <em>118 </em>, 103641. <a href="https://doi.org/10.1016/j.compbiomed.2020.103641" title="DOI URL">https://doi.org/10.1016/j.compbiomed.2020.103641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiomed.2020.103641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiomed.2020.103641%26sid%3Dliteratum%253Aachs%26jtitle%3DComputers%2520in%2520Biology%2520and%2520Medicine%26atitle%3DStructural%252Binsights%252Bfor%252Brational%252Bdesign%252Bof%252Bnew%252BPIM-1%252Bkinase%252Binhibitors%252Bbased%252Bon%252B3%25252C5-disubstituted%252Bindole%252Bderivatives%25253A%252BAn%252Bintegrative%252Bcomputational%252Bapproach%26aulast%3DRazmazma%26aufirst%3DHafez%26date%3D2020%26volume%3D118%26spage%3D103641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marc S.  Raab</span>, <span class="hlFld-ContribAuthor ">Sheeba K.  Thomas</span>, <span class="hlFld-ContribAuthor ">Enrique M.  Ocio</span>, <span class="hlFld-ContribAuthor ">Andreas  Guenther</span>, <span class="hlFld-ContribAuthor ">Yeow-Tee  Goh</span>, <span class="hlFld-ContribAuthor ">Moshe  Talpaz</span>, <span class="hlFld-ContribAuthor ">Nicolas  Hohmann</span>, <span class="hlFld-ContribAuthor ">Sylvia  Zhao</span>, <span class="hlFld-ContribAuthor ">Fang  Xiang</span>, <span class="hlFld-ContribAuthor ">Carl  Simon</span>, <span class="hlFld-ContribAuthor ">K. Gary  Vanasse</span>, <span class="hlFld-ContribAuthor ">Shaji K.  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma. </span><span class="cited-content_cbyCitation_journal-name">Leukemia</span><span> <strong>2019,</strong> <em>33 </em>
                                    (12)
                                     , 2924-2933. <a href="https://doi.org/10.1038/s41375-019-0482-0" title="DOI URL">https://doi.org/10.1038/s41375-019-0482-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41375-019-0482-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41375-019-0482-0%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%26atitle%3DThe%252Bfirst-in-human%252Bstudy%252Bof%252Bthe%252Bpan-PIM%252Bkinase%252Binhibitor%252BPIM447%252Bin%252Bpatients%252Bwith%252Brelapsed%252Band%25252For%252Brefractory%252Bmultiple%252Bmyeloma%26aulast%3DRaab%26aufirst%3DMarc%2BS.%26date%3D2019%26date%3D2019%26volume%3D33%26issue%3D12%26spage%3D2924%26epage%3D2933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Watanabe</span>, <span class="hlFld-ContribAuthor ">Nogami</span>, <span class="hlFld-ContribAuthor ">Okada</span>, <span class="hlFld-ContribAuthor ">Akiyama</span>, <span class="hlFld-ContribAuthor ">Umezawa</span>, <span class="hlFld-ContribAuthor ">Miura</span>. </span><span class="cited-content_cbyCitation_article-title">FLT3-ITD Activates RSK1 to Enhance Proliferation and Survival of AML Cells by Activating mTORC1 and eIF4B Cooperatively with PIM or PI3K and by Inhibiting Bad and BIM. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (12)
                                     , 1827. <a href="https://doi.org/10.3390/cancers11121827" title="DOI URL">https://doi.org/10.3390/cancers11121827</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11121827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11121827%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DFLT3-ITD%252BActivates%252BRSK1%252Bto%252BEnhance%252BProliferation%252Band%252BSurvival%252Bof%252BAML%252BCells%252Bby%252BActivating%252BmTORC1%252Band%252BeIF4B%252BCooperatively%252Bwith%252BPIM%252Bor%252BPI3K%252Band%252Bby%252BInhibiting%252BBad%252Band%252BBIM%26aulast%3DWatanabe%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D12%26spage%3D1827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takashi  Nishiyama</span>, <span class="hlFld-ContribAuthor ">Shuuya  Takaiwa</span>, <span class="hlFld-ContribAuthor ">Rika  Kotouge</span>, <span class="hlFld-ContribAuthor ">Satomi  Tani</span>, <span class="hlFld-ContribAuthor ">Rikako  Yoshinaga</span>, <span class="hlFld-ContribAuthor ">Erina  Hamada</span>, <span class="hlFld-ContribAuthor ">Mai  Endo</span>, <span class="hlFld-ContribAuthor ">Yuka  Sugino</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Hatae</span>, <span class="hlFld-ContribAuthor ">Satoshi  Hibino</span>, <span class="hlFld-ContribAuthor ">Tominari  Choshi</span>. </span><span class="cited-content_cbyCitation_article-title">First asymmetric enantioselective total synthesis of phenanthridine alkaloid, (S)-(+)-asiaticumine and its enantiomer. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (48)
                                     , 151278. <a href="https://doi.org/10.1016/j.tetlet.2019.151278" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.151278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.151278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.151278%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DFirst%252Basymmetric%252Benantioselective%252Btotal%252Bsynthesis%252Bof%252Bphenanthridine%252Balkaloid%25252C%252B%252528S%252529-%252528%25252B%252529-asiaticumine%252Band%252Bits%252Benantiomer%26aulast%3DNishiyama%26aufirst%3DTakashi%26date%3D2019%26volume%3D60%26issue%3D48%26spage%3D151278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingqing  Chen</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Shanshan  Shi</span>, <span class="hlFld-ContribAuthor ">Kaihang  Li</span>, <span class="hlFld-ContribAuthor ">Ling  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into the Interaction Mechanisms of the Proviral Integration Site of Moloney Murine Leukemia Virus (Pim) Kinases with Pan-Pim Inhibitors PIM447 and AZD1208: A Molecular Dynamics Simulation and MM/GBSA Calculation Study. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (21)
                                     , 5410. <a href="https://doi.org/10.3390/ijms20215410" title="DOI URL">https://doi.org/10.3390/ijms20215410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20215410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20215410%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DInsights%252Binto%252Bthe%252BInteraction%252BMechanisms%252Bof%252Bthe%252BProviral%252BIntegration%252BSite%252Bof%252BMoloney%252BMurine%252BLeukemia%252BVirus%252B%252528Pim%252529%252BKinases%252Bwith%252BPan-Pim%252BInhibitors%252BPIM447%252Band%252BAZD1208%25253A%252BA%252BMolecular%252BDynamics%252BSimulation%252Band%252BMM%25252FGBSA%252BCalculation%252BStudy%26aulast%3DChen%26aufirst%3DQingqing%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D21%26spage%3D5410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sathish K. R.  Padi</span>, <span class="hlFld-ContribAuthor ">Neha  Singh</span>, <span class="hlFld-ContribAuthor ">Jeremiah J.  Bearss</span>, <span class="hlFld-ContribAuthor ">Virginie  Olive</span>, <span class="hlFld-ContribAuthor ">Jin H.  Song</span>, <span class="hlFld-ContribAuthor ">Marina  Cardó-Vila</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Kraft</span>, <span class="hlFld-ContribAuthor ">Koichi  Okumura</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphorylation of DEPDC5, a component of the GATOR1 complex, releases inhibition of mTORC1 and promotes tumor growth. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2019,</strong> <em>116 </em>
                                    (41)
                                     , 20505-20510. <a href="https://doi.org/10.1073/pnas.1904774116" title="DOI URL">https://doi.org/10.1073/pnas.1904774116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1904774116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1904774116%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DPhosphorylation%252Bof%252BDEPDC5%25252C%252Ba%252Bcomponent%252Bof%252Bthe%252BGATOR1%252Bcomplex%25252C%252Breleases%252Binhibition%252Bof%252BmTORC1%252Band%252Bpromotes%252Btumor%252Bgrowth%26aulast%3DPadi%26aufirst%3DSathish%2BK.%2BR.%26date%3D2019%26date%3D2019%26volume%3D116%26issue%3D41%26spage%3D20505%26epage%3D20510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claude  Barberis</span>, <span class="hlFld-ContribAuthor ">James  Pribish</span>, <span class="hlFld-ContribAuthor ">Elina  Tserlin</span>, <span class="hlFld-ContribAuthor ">Alexandre  Gross</span>, <span class="hlFld-ContribAuthor ">Mark  Czekaj</span>, <span class="hlFld-ContribAuthor ">Matthieu  Barragué</span>, <span class="hlFld-ContribAuthor ">Paul  Erdman</span>, <span class="hlFld-ContribAuthor ">Sachin  Maniar</span>, <span class="hlFld-ContribAuthor ">John  Jiang</span>, <span class="hlFld-ContribAuthor ">Luke  Fire</span>, <span class="hlFld-ContribAuthor ">Vinod  Patel</span>, <span class="hlFld-ContribAuthor ">Andrew  Hebert</span>, <span class="hlFld-ContribAuthor ">Mikhail  Levit</span>, <span class="hlFld-ContribAuthor ">Anlai  Wang</span>, <span class="hlFld-ContribAuthor ">Frank  Sun</span>, <span class="hlFld-ContribAuthor ">Shih-Min A.  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-substituted 7-azaindoles as Pan-PIM kinases inhibitors – Lead optimization – Part III. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (3)
                                     , 491-495. <a href="https://doi.org/10.1016/j.bmcl.2018.12.015" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.12.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.12.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN-substituted%252B7-azaindoles%252Bas%252BPan-PIM%252Bkinases%252Binhibitors%252B%2525E2%252580%252593%252BLead%252Boptimization%252B%2525E2%252580%252593%252BPart%252BIII%26aulast%3DBarberis%26aufirst%3DClaude%26date%3D2019%26volume%3D29%26issue%3D3%26spage%3D491%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin H.  Song</span>, <span class="hlFld-ContribAuthor ">Neha  Singh</span>, <span class="hlFld-ContribAuthor ">Libia A.  Luevano</span>, <span class="hlFld-ContribAuthor ">Sathish K.R.  Padi</span>, <span class="hlFld-ContribAuthor ">Koichi  Okumura</span>, <span class="hlFld-ContribAuthor ">Virginie  Olive</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Black</span>, <span class="hlFld-ContribAuthor ">Noel A.  Warfel</span>, <span class="hlFld-ContribAuthor ">David W.  Goodrich</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Kraft</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2018,</strong> <em>17 </em>
                                    (12)
                                     , 2710-2721. <a href="https://doi.org/10.1158/1535-7163.MCT-18-0374" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-18-0374</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-18-0374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-18-0374%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DMechanisms%252BBehind%252BResistance%252Bto%252BPI3K%252BInhibitor%252BTreatment%252BInduced%252Bby%252Bthe%252BPIM%252BKinase%26aulast%3DSong%26aufirst%3DJin%2BH.%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D12%26spage%3D2710%26epage%3D2721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Chojnacki</span>, <span class="hlFld-ContribAuthor ">P.  Wińska</span>, <span class="hlFld-ContribAuthor ">M.  Wielechowska</span>, <span class="hlFld-ContribAuthor ">E.  Łukowska-Chojnacka</span>, <span class="hlFld-ContribAuthor ">C.  Tölzer</span>, <span class="hlFld-ContribAuthor ">K.  Niefind</span>, <span class="hlFld-ContribAuthor ">M.  Bretner</span>. </span><span class="cited-content_cbyCitation_article-title">Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>80 </em>, 266-275. <a href="https://doi.org/10.1016/j.bioorg.2018.06.022" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.06.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.06.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DBiological%252Bproperties%252Band%252Bstructural%252Bstudy%252Bof%252Bnew%252Baminoalkyl%252Bderivatives%252Bof%252Bbenzimidazole%252Band%252Bbenzotriazole%25252C%252Bdual%252Binhibitors%252Bof%252BCK2%252Band%252BPIM1%252Bkinases%26aulast%3DChojnacki%26aufirst%3DK.%26date%3D2018%26volume%3D80%26spage%3D266%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kunal N.  More</span>, <span class="hlFld-ContribAuthor ">Victor S.  Hong</span>, <span class="hlFld-ContribAuthor ">Ahyeon  Lee</span>, <span class="hlFld-ContribAuthor ">Jongsung  Park</span>, <span class="hlFld-ContribAuthor ">Shin  Kim</span>, <span class="hlFld-ContribAuthor ">Jinho  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and evaluation of 3,5-disubstituted indole derivatives as Pim kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (14)
                                     , 2513-2517. <a href="https://doi.org/10.1016/j.bmcl.2018.05.054" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.05.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.05.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.05.054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Bevaluation%252Bof%252B3%25252C5-disubstituted%252Bindole%252Bderivatives%252Bas%252BPim%252Bkinase%252Binhibitors%26aulast%3DMore%26aufirst%3DKunal%2BN.%26date%3D2018%26volume%3D28%26issue%3D14%26spage%3D2513%26epage%3D2517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diede  Brunen</span>, <span class="hlFld-ContribAuthor ">Romy C.  de Vries</span>, <span class="hlFld-ContribAuthor ">Cor  Lieftink</span>, <span class="hlFld-ContribAuthor ">Roderick L.  Beijersbergen</span>, <span class="hlFld-ContribAuthor ">René  Bernards</span>. </span><span class="cited-content_cbyCitation_article-title">PIM Kinases Are a Potential Prognostic Biomarker and Therapeutic Target in Neuroblastoma. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2018,</strong> <em>17 </em>
                                    (4)
                                     , 849-857. <a href="https://doi.org/10.1158/1535-7163.MCT-17-0868" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-17-0868</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-17-0868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-17-0868%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DPIM%252BKinases%252BAre%252Ba%252BPotential%252BPrognostic%252BBiomarker%252Band%252BTherapeutic%252BTarget%252Bin%252BNeuroblastoma%26aulast%3DBrunen%26aufirst%3DDiede%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D4%26spage%3D849%26epage%3D857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keigo  Okada</span>, <span class="hlFld-ContribAuthor ">Ayako  Nogami</span>, <span class="hlFld-ContribAuthor ">Shinya  Ishida</span>, <span class="hlFld-ContribAuthor ">Hiroki  Akiyama</span>, <span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Umezawa</span>, <span class="hlFld-ContribAuthor ">Osamu  Miura</span>. </span><span class="cited-content_cbyCitation_article-title">FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2018,</strong> <em>9 </em>
                                    (10)
                                     , 8870-8886. <a href="https://doi.org/10.18632/oncotarget.22926" title="DOI URL">https://doi.org/10.18632/oncotarget.22926</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.22926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.22926%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DFLT3-ITD%252Binduces%252Bexpression%252Bof%252BPim%252Bkinases%252Bthrough%252BSTAT5%252Bto%252Bconfer%252Bresistance%252Bto%252Bthe%252BPI3K%25252FAkt%252Bpathway%252Binhibitors%252Bon%252Bleukemic%252Bcells%252Bby%252Benhancing%252Bthe%252BmTORC1%25252FMcl-1%252Bpathway%26aulast%3DOkada%26aufirst%3DKeigo%26date%3D2018%26date%3D2017%26volume%3D9%26issue%3D10%26spage%3D8870%26epage%3D8886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard J.  Rebello</span>, <span class="hlFld-ContribAuthor ">Alisée V.  Huglo</span>, <span class="hlFld-ContribAuthor ">Luc  Furic</span>. </span><span class="cited-content_cbyCitation_article-title">PIM activity in tumours: A key node of therapy resistance. </span><span class="cited-content_cbyCitation_journal-name">Advances in Biological Regulation</span><span> <strong>2018,</strong> <em>67 </em>, 163-169. <a href="https://doi.org/10.1016/j.jbior.2017.10.010" title="DOI URL">https://doi.org/10.1016/j.jbior.2017.10.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jbior.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jbior.2017.10.010%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvances%2520in%2520Biological%2520Regulation%26atitle%3DPIM%252Bactivity%252Bin%252Btumours%25253A%252BA%252Bkey%252Bnode%252Bof%252Btherapy%252Bresistance%26aulast%3DRebello%26aufirst%3DRichard%2BJ.%26date%3D2018%26volume%3D67%26spage%3D163%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niina M.  Santio</span>, <span class="hlFld-ContribAuthor ">Päivi J.  Koskinen</span>. </span><span class="cited-content_cbyCitation_article-title">PIM kinases: From survival factors to regulators of cell motility. </span><span class="cited-content_cbyCitation_journal-name">The International Journal of Biochemistry & Cell Biology</span><span> <strong>2017,</strong> <em>93 </em>, 74-85. <a href="https://doi.org/10.1016/j.biocel.2017.10.016" title="DOI URL">https://doi.org/10.1016/j.biocel.2017.10.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biocel.2017.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biocel.2017.10.016%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520International%2520Journal%2520of%2520Biochemistry%2520%2526%2520Cell%2520Biology%26atitle%3DPIM%252Bkinases%25253A%252BFrom%252Bsurvival%252Bfactors%252Bto%252Bregulators%252Bof%252Bcell%252Bmotility%26aulast%3DSantio%26aufirst%3DNiina%2BM.%26date%3D2017%26volume%3D93%26spage%3D74%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claude  Barberis</span>, <span class="hlFld-ContribAuthor ">Neil  Moorcroft</span>, <span class="hlFld-ContribAuthor ">James  Pribish</span>, <span class="hlFld-ContribAuthor ">Elina  Tserlin</span>, <span class="hlFld-ContribAuthor ">Alexandre  Gross</span>, <span class="hlFld-ContribAuthor ">Mark  Czekaj</span>, <span class="hlFld-ContribAuthor ">Matthieu  Barrague</span>, <span class="hlFld-ContribAuthor ">Paul  Erdman</span>, <span class="hlFld-ContribAuthor ">Tahir  Majid</span>, <span class="hlFld-ContribAuthor ">Joseph  Batchelor</span>, <span class="hlFld-ContribAuthor ">Mikhail  Levit</span>, <span class="hlFld-ContribAuthor ">Andrew  Hebert</span>, <span class="hlFld-ContribAuthor ">Liduo  Shen</span>, <span class="hlFld-ContribAuthor ">Sandra  Moreno-Mazza</span>, <span class="hlFld-ContribAuthor ">Anlai  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N -substituted 7-azaindoles as Pan-PIM kinase inhibitors – Lead series identification – Part II. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (20)
                                     , 4735-4740. <a href="https://doi.org/10.1016/j.bmcl.2017.08.068" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.08.068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.08.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.08.068%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN%252B-substituted%252B7-azaindoles%252Bas%252BPan-PIM%252Bkinase%252Binhibitors%252B%2525E2%252580%252593%252BLead%252Bseries%252Bidentification%252B%2525E2%252580%252593%252BPart%252BII%26aulast%3DBarberis%26aufirst%3DClaude%26date%3D2017%26volume%3D27%26issue%3D20%26spage%3D4735%26epage%3D4740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claude  Barberis</span>, <span class="hlFld-ContribAuthor ">Neil  Moorcroft</span>, <span class="hlFld-ContribAuthor ">Chris  Arendt</span>, <span class="hlFld-ContribAuthor ">Mikhail  Levit</span>, <span class="hlFld-ContribAuthor ">Sandra  Moreno-Mazza</span>, <span class="hlFld-ContribAuthor ">Joseph  Batchelor</span>, <span class="hlFld-ContribAuthor ">Ingrid  Mechin</span>, <span class="hlFld-ContribAuthor ">Tahir  Majid</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N -substituted 7-azaindoles as PIM1 kinase inhibitors – Part I. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (20)
                                     , 4730-4734. <a href="https://doi.org/10.1016/j.bmcl.2017.08.069" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.08.069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.08.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.08.069%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN%252B-substituted%252B7-azaindoles%252Bas%252BPIM1%252Bkinase%252Binhibitors%252B%2525E2%252580%252593%252BPart%252BI%26aulast%3DBarberis%26aufirst%3DClaude%26date%3D2017%26volume%3D27%26issue%3D20%26spage%3D4730%26epage%3D4734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teresa  Paíno</span>, <span class="hlFld-ContribAuthor ">Antonio  Garcia-Gomez</span>, <span class="hlFld-ContribAuthor ">Lorena  González-Méndez</span>, <span class="hlFld-ContribAuthor ">Laura  San-Segundo</span>, <span class="hlFld-ContribAuthor ">Susana  Hernández-García</span>, <span class="hlFld-ContribAuthor ">Ana-Alicia  López-Iglesias</span>, <span class="hlFld-ContribAuthor ">Esperanza M.  Algarín</span>, <span class="hlFld-ContribAuthor ">Montserrat  Martín-Sánchez</span>, <span class="hlFld-ContribAuthor ">David  Corbacho</span>, <span class="hlFld-ContribAuthor ">Carlos  Ortiz-de-Solorzano</span>, <span class="hlFld-ContribAuthor ">Luis A.  Corchete</span>, <span class="hlFld-ContribAuthor ">Norma C.  Gutiérrez</span>, <span class="hlFld-ContribAuthor ">María-Victoria  Maetos</span>, <span class="hlFld-ContribAuthor ">Mercedes  Garayoa</span>, <span class="hlFld-ContribAuthor ">Enrique M.  Ocio</span>. </span><span class="cited-content_cbyCitation_article-title">The Novel Pan-PIM Kinase Inhibitor, PIM447, Displays Dual Antimyeloma and Bone-Protective Effects, and Potently Synergizes with Current Standards of Care. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2017,</strong> <em>23 </em>
                                    (1)
                                     , 225-238. <a href="https://doi.org/10.1158/1078-0432.CCR-16-0230" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-16-0230</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-16-0230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-16-0230%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DThe%252BNovel%252BPan-PIM%252BKinase%252BInhibitor%25252C%252BPIM447%25252C%252BDisplays%252BDual%252BAntimyeloma%252Band%252BBone-Protective%252BEffects%25252C%252Band%252BPotently%252BSynergizes%252Bwith%252BCurrent%252BStandards%252Bof%252BCare%26aulast%3DPa%25C3%25ADno%26aufirst%3DTeresa%26date%3D2017%26date%3D2016%26volume%3D23%26issue%3D1%26spage%3D225%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Christine  Sastri</span>, <span class="hlFld-ContribAuthor ">Derin C.  D’Amico</span>, <span class="hlFld-ContribAuthor ">Brad  Herberich</span>, <span class="hlFld-ContribAuthor ">Claire L.M.  Jackson</span>, <span class="hlFld-ContribAuthor ">Liping H.  Pettus</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>, <span class="hlFld-ContribAuthor ">Bin  Wu</span>, <span class="hlFld-ContribAuthor ">Nadia  Guerrero</span>, <span class="hlFld-ContribAuthor ">J. Russell  Lipford</span>, <span class="hlFld-ContribAuthor ">Jeffrey T.  Winston</span>, <span class="hlFld-ContribAuthor ">Yajing  Yang</span>, <span class="hlFld-ContribAuthor ">Paul  Wang</span>, <span class="hlFld-ContribAuthor ">Yen  Nguyen</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Xin  Huang</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">Christopher  Mohr</span>, <span class="hlFld-ContribAuthor ">J.D.  Zhang</span>, <span class="hlFld-ContribAuthor ">Darren L.  Reid</span>, <span class="hlFld-ContribAuthor ">Yang  Xu</span>, <span class="hlFld-ContribAuthor ">Yihong  Zhou</span>, <span class="hlFld-ContribAuthor ">Hui-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (22)
                                     , 5580-5590. <a href="https://doi.org/10.1016/j.bmcl.2016.09.067" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.09.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.09.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.09.067%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bimidazopyridazines%252Bas%252Bpotent%252BPim-1%25252F2%252Bkinase%252Binhibitors%26aulast%3DWurz%26aufirst%3DRyan%2BP.%26date%3D2016%26volume%3D26%26issue%3D22%26spage%3D5580%26epage%3D5590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dai  Horiuchi</span>, <span class="hlFld-ContribAuthor ">Roman  Camarda</span>, <span class="hlFld-ContribAuthor ">Alicia Y  Zhou</span>, <span class="hlFld-ContribAuthor ">Christina  Yau</span>, <span class="hlFld-ContribAuthor ">Olga  Momcilovic</span>, <span class="hlFld-ContribAuthor ">Sanjeev  Balakrishnan</span>, <span class="hlFld-ContribAuthor ">Alexandra N  Corella</span>, <span class="hlFld-ContribAuthor ">Henok  Eyob</span>, <span class="hlFld-ContribAuthor ">Kai  Kessenbrock</span>, <span class="hlFld-ContribAuthor ">Devon A  Lawson</span>, <span class="hlFld-ContribAuthor ">Lindsey A  Marsh</span>, <span class="hlFld-ContribAuthor ">Brittany N  Anderton</span>, <span class="hlFld-ContribAuthor ">Julia  Rohrberg</span>, <span class="hlFld-ContribAuthor ">Ratika  Kunder</span>, <span class="hlFld-ContribAuthor ">Alexey V  Bazarov</span>, <span class="hlFld-ContribAuthor ">Paul  Yaswen</span>, <span class="hlFld-ContribAuthor ">Michael T  McManus</span>, <span class="hlFld-ContribAuthor ">Hope S  Rugo</span>, <span class="hlFld-ContribAuthor ">Zena  Werb</span>, <span class="hlFld-ContribAuthor ">Andrei  Goga</span>. </span><span class="cited-content_cbyCitation_article-title">PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression. </span><span class="cited-content_cbyCitation_journal-name">Nature Medicine</span><span> <strong>2016,</strong> <em>22 </em>
                                    (11)
                                     , 1321-1329. <a href="https://doi.org/10.1038/nm.4213" title="DOI URL">https://doi.org/10.1038/nm.4213</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nm.4213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnm.4213%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Medicine%26atitle%3DPIM1%252Bkinase%252Binhibition%252Bas%252Ba%252Btargeted%252Btherapy%252Bagainst%252Btriple-negative%252Bbreast%252Btumors%252Bwith%252Belevated%252BMYC%252Bexpression%26aulast%3DHoriuchi%26aufirst%3DDai%26date%3D2016%26date%3D2016%26volume%3D22%26issue%3D11%26spage%3D1321%26epage%3D1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiuning  Le</span>, <span class="hlFld-ContribAuthor ">Rajee  Antony</span>, <span class="hlFld-ContribAuthor ">Pedram  Razavi</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Treacy</span>, <span class="hlFld-ContribAuthor ">Flora  Luo</span>, <span class="hlFld-ContribAuthor ">Mahmoud  Ghandi</span>, <span class="hlFld-ContribAuthor ">Pau  Castel</span>, <span class="hlFld-ContribAuthor ">Maurizio  Scaltriti</span>, <span class="hlFld-ContribAuthor ">José  Baselga</span>, <span class="hlFld-ContribAuthor ">Levi A.  Garraway</span>. </span><span class="cited-content_cbyCitation_article-title">Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Discovery</span><span> <strong>2016,</strong> <em>6 </em>
                                    (10)
                                     , 1134-1147. <a href="https://doi.org/10.1158/2159-8290.CD-16-0305" title="DOI URL">https://doi.org/10.1158/2159-8290.CD-16-0305</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/2159-8290.CD-16-0305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F2159-8290.CD-16-0305%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Discovery%26atitle%3DSystematic%252BFunctional%252BCharacterization%252Bof%252BResistance%252Bto%252BPI3K%252BInhibition%252Bin%252BBreast%252BCancer%26aulast%3DLe%26aufirst%3DXiuning%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D10%26spage%3D1134%26epage%3D1147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gisele A.  Nishiguchi</span>, <span class="hlFld-ContribAuthor ">Matthew T.  Burger</span>, <span class="hlFld-ContribAuthor ">Wooseok  Han</span>, <span class="hlFld-ContribAuthor ">Jiong  Lan</span>, <span class="hlFld-ContribAuthor ">Gordana  Atallah</span>, <span class="hlFld-ContribAuthor ">Victoriano  Tamez</span>, <span class="hlFld-ContribAuthor ">Mika  Lindvall</span>, <span class="hlFld-ContribAuthor ">Cornelia  Bellamacina</span>, <span class="hlFld-ContribAuthor ">Pablo  Garcia</span>, <span class="hlFld-ContribAuthor ">Paul  Feucht</span>, <span class="hlFld-ContribAuthor ">Tatiana  Zavorotinskaya</span>, <span class="hlFld-ContribAuthor ">Yumin  Dai</span>, <span class="hlFld-ContribAuthor ">Kent  Wong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and structure activity relationship of potent pan-PIM kinase inhibitors derived from the pyridyl carboxamide scaffold. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (9)
                                     , 2328-2332. <a href="https://doi.org/10.1016/j.bmcl.2016.03.037" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.03.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.03.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.03.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bstructure%252Bactivity%252Brelationship%252Bof%252Bpotent%252Bpan-PIM%252Bkinase%252Binhibitors%252Bderived%252Bfrom%252Bthe%252Bpyridyl%252Bcarboxamide%252Bscaffold%26aulast%3DNishiguchi%26aufirst%3DGisele%2BA.%26date%3D2016%26volume%3D26%26issue%3D9%26spage%3D2328%26epage%3D2332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heather  Fairfield</span>, <span class="hlFld-ContribAuthor ">Carolyne  Falank</span>, <span class="hlFld-ContribAuthor ">Lindsey  Avery</span>, <span class="hlFld-ContribAuthor ">Michaela R.  Reagan</span>. </span><span class="cited-content_cbyCitation_article-title">Multiple myeloma in the marrow: pathogenesis and treatments. </span><span class="cited-content_cbyCitation_journal-name">Annals of the New York Academy of Sciences</span><span> <strong>2016,</strong> <em>1364 </em>
                                    (1)
                                     , 32-51. <a href="https://doi.org/10.1111/nyas.13038" title="DOI URL">https://doi.org/10.1111/nyas.13038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/nyas.13038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fnyas.13038%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520the%2520New%2520York%2520Academy%2520of%2520Sciences%26atitle%3DMultiple%252Bmyeloma%252Bin%252Bthe%252Bmarrow%25253A%252Bpathogenesis%252Band%252Btreatments%26aulast%3DFairfield%26aufirst%3DHeather%26date%3D2016%26date%3D2016%26volume%3D1364%26issue%3D1%26spage%3D32%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. PIM clinical compounds and starting point <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Metabolism of compound <b>3</b> in human liver microsomes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure of compound <b>3</b> in PIM1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Na<sub>2</sub>CO<sub>3</sub>, Tf<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 3 h; (b) KOAc, Pd(dppf)Cl<sub>2</sub>, pinacolatodiboron, dioxane, 80 °C, 2 h; (c) 4-chloro-3-nitropyridine, Pd(pddf)Cl<sub>2</sub>, dioxane/2 M Na<sub>2</sub>CO<sub>3</sub>, 110 °C, 2 h, 55% (3 steps); (d) NaBH<sub>4</sub>, CeCl<sub>3</sub>·7H<sub>2</sub>O, MeOH, 0 °C, 2 h, 94%; (e) PhthNH, Ph<sub>3</sub>P, (C<sub>4</sub>H<sub>9</sub>O<sub>2</sub>CN)<sub>2</sub>, THF, 0 °C, 2 h, 50%; (f) 400 PSI H<sub>2</sub>, Pd/C, MeOH, 50 °C, 48 h, 53%; (g) chiral separation; (h) heteroaryl acid, EDC, HOAT, DMF; 12 h, 91%; (i) H<sub>2</sub>NNH<sub>2</sub>, MeOH, 50 °C, 2 h, 90%.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Na<sub>2</sub>CO<sub>3</sub>, Tf<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 2 h, 78%; (b) KOAc, Pd(dppf)Cl<sub>2</sub>, pinacolatodiboron, dioxane, 80 °C, 10 h; (c) 4-chloro-3-nitropyridine, Pd(pddf)Cl<sub>2</sub>, dioxane/2 M Na<sub>2</sub>CO<sub>3</sub>, 110 °C, 1 h, 48% (2 steps); (d) NaBH<sub>4</sub>, CeCl<sub>3</sub>·7H<sub>2</sub>O, EtOH, 0 °C, 1 h, 72%; (e) TBDMSCl, imidazole, DMF, 18 h, 77%; (f) H<sub>2</sub>, Pd/C, MeOH, 15 h, 93%; (g) Cbz-OSu, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 90 h, 81%; (h) HCl, EtOH, 1 h, 94%; (i) Dess–Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>, 1 h, 91%; (j)BnNH<sub>2</sub>, LiBH<sub>4</sub>, MeOH, 3.5 h; (k) H<sub>2</sub>, Pd/C, MeOH, Boc<sub>2</sub>O, 46 h, 47% (2 steps); (l) chiral separation; (m) heteroaryl acid, EDC, HOAT, DMF; 12 h, 91%; (n) 4 M HCl/dioxane, 17 h, 80% or 25% TFA/CH<sub>2</sub>Cl<sub>2</sub>, 0.5 h, 90%.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0013.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) p-TsOH, dioxane, 100 °C, 3 h, 68%; (b) NBS, H<sub>2</sub>O, THF, 0.5 h, 80%; (c) KO-<i>t</i>-Bu, THF, 0.5 h; (d) NaN<sub>3</sub>, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, 14 h, 55%; (e) PMe<sub>3</sub>, pyridine, NH<sub>4</sub>OH, 2 h; (f) Boc<sub>2</sub>O, dioxane, NaHCO<sub>3(sat.)</sub>, 2 h, 59% (2 steps); (g) Ac<sub>2</sub>O, pyridine, 14 h; (h) H<sub>2</sub>, Pd/C, MeOH, 72 h, 75% (2 steps); (i) chiral separation; (j) heteroaryl acid, EDC, HOAT, DMF, 14 h; (k) K<sub>2</sub>CO<sub>3</sub>, EtOH, 14 h; (l) 25% TFA/CH<sub>2</sub>Cl<sub>2</sub>, 0.5 h, 80% (3 steps).</p></p></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Kinase activity of compound <b>8</b> against 68 kinases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. KINOMEscan binding of <b>8</b> at 1 μM against 442 kinases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structure of <b>8</b> in PIM1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In vitro pS6RP target modulation by compound <b>8</b> in KG-1 acute myeloid leukemia cell line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0009.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Single dose pS6RP target modulation and plasma exposure of compound <b>8</b> in KG-1 acute myeloid leukemia subcutaneous mouse tumor model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/medium/jm-2015-01275t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0010.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Antitumor activity and tolerability of single agent compound <b>8</b> and compound <b>8</b> in combination with Ara-C in KG-1 acute myeloid leukemia subcutaneous mouse tumor model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b01275/20151106/images/large/jm-2015-01275t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01275&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38702" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38702" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 28 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Brault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bracher, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaller, J.</span><span> </span><span class="NLM_article-title">PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers</span> <span class="citation_source-journal">Haematologica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span><span class="refDoi"> DOI: 10.3324/haematol.2009.017079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.3324%2Fhaematol.2009.017079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=20145274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlShu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2010&pages=1004-1015&author=L.+Braultauthor=C.+Gasserauthor=F.+Bracherauthor=K.+Huberauthor=S.+Knappauthor=J.+Schwaller&title=PIM+serine%2Fthreonine+kinases+in+the+pathogenesis+and+therapy+of+hematologic+malignancies+and+solid+cancers&doi=10.3324%2Fhaematol.2009.017079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers</span></div><div class="casAuthors">Brault, Laurent; Gasser, Christelle; Bracher, Franz; Huber, Kilian; Knapp, Stefan; Schwaller, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Haematologica</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1004-1015</span>CODEN:
                <span class="NLM_cas:coden">HAEMAX</span>;
        ISSN:<span class="NLM_cas:issn">0390-6078</span>.
    
            (<span class="NLM_cas:orgname">Ferrata Storti Foundation</span>)
        </div><div class="casAbstract">A review.  The identification as cooperating targets of Proviral Integrations of Moloney virus in murine lymphomas suggested early on that PIM serine/threonine kinases play an important role in cancer biol.  Whereas elevated levels of PIM1 and PIM2 were mostly found in hematol. malignancies and prostate cancer, increased PIM3 expression was obsd. in different solid tumors.  PIM kinases are constitutively active and their activity supports in vitro and in vivo tumor cell growth and survival through modification of an increasing no. of common as well as isoform-specific substrates including several cell cycle regulators and apoptosis mediators.  PIM1 but not PIM2 seems also to mediate homing and migration of normal and malignant hematopoietic cells by regulating chemokine receptor surface expression.  Knockdown expts. by RNA interference or dominant-neg. acting mutants suggested that PIM kinases are important for maintenance of a transformed phenotype and therefore potential therapeutic targets.  Detn. of the protein structure facilitated identification of an increasing no. of potent small mol. PIM kinase inhibitors with in vitro and in vivo anticancer activity.  Ongoing efforts aim to identify isoform-specific PIM inhibitors that would not only help to dissect the kinase function but hopefully also provide targeted therapeutics.  Here, we summarize the current knowledge about the role of PIM serine/threonine kinases for the pathogenesis and therapy of hematol. malignancies and solid cancers, and we highlight structural principles and recent progress on small mol. PIM kinase inhibitors that are on their way into first clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM0F0X8PArhLVg90H21EOLACvtfcHk0lgGaVWsjkkUwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlShu7%252FO&md5=241c17f65ee9203be2a6ee138a914781</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2009.017079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2009.017079%26sid%3Dliteratum%253Aachs%26aulast%3DBrault%26aufirst%3DL.%26aulast%3DGasser%26aufirst%3DC.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DHuber%26aufirst%3DK.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchwaller%26aufirst%3DJ.%26atitle%3DPIM%2520serine%252Fthreonine%2520kinases%2520in%2520the%2520pathogenesis%2520and%2520therapy%2520of%2520hematologic%2520malignancies%2520and%2520solid%2520cancers%26jtitle%3DHaematologica%26date%3D2010%26volume%3D95%26spage%3D1004%26epage%3D1015%26doi%3D10.3324%2Fhaematol.2009.017079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Cuypers, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selten, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quint, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zijlstra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandaag, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boelens, W.</span><span> </span><span class="NLM_article-title">Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span><span class="refDoi"> DOI: 10.1016/0092-8674(84)90309-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2F0092-8674%2884%2990309-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=6327049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADyaL2cXks1KqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1984&pages=141-150&author=H.+T.+Cuypersauthor=G.+Seltenauthor=W.+Quintauthor=M.+Zijlstraauthor=E.+R.+Mandaagauthor=W.+Boelens&title=Murine+leukemia+virus-induced+T-cell+lymphomagenesis%3A+integration+of+proviruses+in+a+distinct+chromosomal+region&doi=10.1016%2F0092-8674%2884%2990309-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Murine leukemia virus-induced T-cell lymphomagenesis:  integration of proviruses in a distinct chromosomal region</span></div><div class="casAuthors">Cuypers, H. Theo; Selten, Gerard; Quint, Wim; Zijlstra, Maarten; Maandag, Els Robanus; Boelens, Wilbert; Van Wezenbeek, Peter; Melief, Cees; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-50</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Mink cell focus-forming (MCF) proviruses were molecularly cloned from mouse lymphoma DNA.  From each clone, flanking probes were prepd. to detect common integration regions in other murine leukemia virus (MuLV)-induced lymphomas.  One clone frequently revealed variations in the mol. structure of the corresponding region (Pim-1) in other lymphomas.  Changes in the Pim region are seen in 24 of 93 lymphomas tested.  Over 50% of the early T-cell lymphomas show integration in the Pim-1 region.  The alterations are seen in different mouse strains and with various MuLVs.  The obsd. variations are caused by the integration of predominantly MCF genomes.  All integrations occur in a region spanning <20 kilobases and are assocd. with the transcriptional activation of a distinct region within the Pim-1 domain.  The activated region does not show any homol. with 13 known and 3 putative oncogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm89Z9zs2CVrVg90H21EOLACvtfcHk0ljJFw_Dukd2BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXks1KqtLY%253D&md5=8cff87b785ab0a12aacf742106aaf6a2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2884%2990309-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252884%252990309-X%26sid%3Dliteratum%253Aachs%26aulast%3DCuypers%26aufirst%3DH.%2BT.%26aulast%3DSelten%26aufirst%3DG.%26aulast%3DQuint%26aufirst%3DW.%26aulast%3DZijlstra%26aufirst%3DM.%26aulast%3DMandaag%26aufirst%3DE.%2BR.%26aulast%3DBoelens%26aufirst%3DW.%26atitle%3DMurine%2520leukemia%2520virus-induced%2520T-cell%2520lymphomagenesis%253A%2520integration%2520of%2520proviruses%2520in%2520a%2520distinct%2520chromosomal%2520region%26jtitle%3DCell%26date%3D1984%26volume%3D37%26spage%3D141%26epage%3D150%26doi%3D10.1016%2F0092-8674%2884%2990309-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Meeker, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagarajan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ar-Rushdi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croce, C. M.</span><span> </span><span class="NLM_article-title">Cloning and characterization of the human PIM-1 gene: a putative oncogene related to the protein kinases</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1002/jcb.240350204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1002%2Fjcb.240350204" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1987&pages=105-112&author=T.+C.+Meekerauthor=L.+Nagarajanauthor=A.+ar-Rushdiauthor=C.+M.+Croce&title=Cloning+and+characterization+of+the+human+PIM-1+gene%3A+a+putative+oncogene+related+to+the+protein+kinases&doi=10.1002%2Fjcb.240350204"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fjcb.240350204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.240350204%26sid%3Dliteratum%253Aachs%26aulast%3DMeeker%26aufirst%3DT.%2BC.%26aulast%3DNagarajan%26aufirst%3DL.%26aulast%3Dar-Rushdi%26aufirst%3DA.%26aulast%3DCroce%26aufirst%3DC.%2BM.%26atitle%3DCloning%2520and%2520characterization%2520of%2520the%2520human%2520PIM-1%2520gene%253A%2520a%2520putative%2520oncogene%2520related%2520to%2520the%2520protein%2520kinases%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D1987%26volume%3D35%26spage%3D105%26epage%3D112%26doi%3D10.1002%2Fjcb.240350204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">van der Lugt, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoeven, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linders, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">vad der Gulden, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berns, A.</span><span> </span><span class="NLM_article-title">Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2536</span><span class="NLM_x">–</span> <span class="NLM_lpage">2544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=2536-2544&author=N.+M.+van+der+Lugtauthor=J.+Domenauthor=E.+Verhoevenauthor=K.+Lindersauthor=H.+vad+der+Guldenauthor=J.+Allenauthor=A.+Berns&title=Proviral+tagging+in+E+mu-myc+transgenic+mice+lacking+the+Pim-1+proto-oncogene+leads+to+compensatory+activation+of+Pim-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BLugt%26aufirst%3DN.%2BM.%26aulast%3DDomen%26aufirst%3DJ.%26aulast%3DVerhoeven%26aufirst%3DE.%26aulast%3DLinders%26aufirst%3DK.%26aulast%3Dvad%2Bder%2BGulden%26aufirst%3DH.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DProviral%2520tagging%2520in%2520E%2520mu-myc%2520transgenic%2520mice%2520lacking%2520the%2520Pim-1%2520proto-oncogene%2520leads%2520to%2520compensatory%2520activation%2520of%2520Pim-2%26jtitle%3DEMBO%2520J.%26date%3D1995%26volume%3D14%26spage%3D2536%26epage%3D2544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mikkers, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipscheer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeyn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berns, A.</span><span> </span><span class="NLM_article-title">High-throughput retroviral tagging to identify components of specific signaling pathways in cancer</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span><span class="refDoi"> DOI: 10.1038/ng950</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1038%2Fng950" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=12185366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1ajs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=153-159&author=H.+Mikkersauthor=J.+Allenauthor=P.+Knipscheerauthor=L.+Romeynauthor=A.+Hartauthor=E.+Vinkauthor=A.+Berns&title=High-throughput+retroviral+tagging+to+identify+components+of+specific+signaling+pathways+in+cancer&doi=10.1038%2Fng950"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput retroviral tagging to identify components of specific signaling pathways in cancer</span></div><div class="casAuthors">Mikkers, Harald; Allen, John; Knipscheer, Puck; Romeyn, Lieke; Hart, Augustinus; Vink, Edwin; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-159</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Genetic screens carried out in lower organisms such as yeast, Drosophila melanogaster and Caenorhabditis elegans have revealed many signaling pathways.  For example, components of the RAS signaling cascade were identified using a mutant eye phenotype in D. melanogaster as a readout.  Screening is usually based on enhancing or suppressing a phenotype by way of a known mutation in a particular signaling pathway.  Such in vivo screens have been difficult to carry out in mammals, however, owing to their relatively long generation times and the limited no. of animals that can be screened.  Here the authors describe an in vivo mammalian genetic screen used to identify components of pathways contributing to oncogenic transformation.  The authors applied retroviral insertional mutagenesis in Myc transgenic (EμMyc) mice lacking expression of Pim1 and Pim2 to search for genes that can substitute for Pim1 and Pim2 in lymphomagenesis.  The authors detd. the chromosomal positions of 477 retroviral insertion sites (RISs) derived from 38 tumors from EμMyc Pim1-/- Pim2-/- mice and 27 tumors from EμMyc control mice using the Ensembl and Celera annotated mouse genome databases.  There were 52 sites occupied by proviruses in more than one tumor.  These common insertion sites (CISs) are likely to contain genes contributing to tumorigenesis.  Comparison of the RISs in tumors of Pim-null mice with the RISs in tumors of EμMyc control mice indicated that 10 of the 52 CISs belong to the Pim complementation group.  In addn., Pim3 is selectively activated in Pim-null tumor cells, which supports the validity of this approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6i2tPp4vS3rVg90H21EOLACvtfcHk0ljJFw_Dukd2BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1ajs7Y%253D&md5=fa564ec068d8e70c8aefb533008ad738</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fng950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng950%26sid%3Dliteratum%253Aachs%26aulast%3DMikkers%26aufirst%3DH.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DKnipscheer%26aufirst%3DP.%26aulast%3DRomeyn%26aufirst%3DL.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DVink%26aufirst%3DE.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DHigh-throughput%2520retroviral%2520tagging%2520to%2520identify%2520components%2520of%2520specific%2520signaling%2520pathways%2520in%2520cancer%26jtitle%3DNat.%2520Genet.%26date%3D2002%26volume%3D32%26spage%3D153%26epage%3D159%26doi%3D10.1038%2Fng950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Nawijn, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alendar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berns, A.</span><span> </span><span class="NLM_article-title">For better or for worse: the role of PIM oncogenes in tumorigenesis</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1038/nrc2986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1038%2Fnrc2986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=21150935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCjsrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=23-34&author=M.+C.+Nawijnauthor=A.+Alendarauthor=A.+Berns&title=For+better+or+for+worse%3A+the+role+of+PIM+oncogenes+in+tumorigenesis&doi=10.1038%2Fnrc2986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">For better or for worse: the role of Pim oncogenes in tumorigenesis</span></div><div class="casAuthors">Nawijn, Martijn C.; Alendar, Andrej; Berns, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-34</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Pim oncogenes are overexpressed in a wide range of tumors from a hematol. and epithelial origin.  Pim genes encode serine/threonine kinases that have been shown to counteract the increased sensitivity to apoptosis induction that is assocd. with MYC-driven tumorigenesis.  Recently, considerable progress has been made in characterizing the pathways of PIM-mediated survival signalling.  Given the unique structure of their active site and the minimal phenotype of mice mutant for all Pim family members, these oncogenes might be promising targets for highly specific and selective drugs with favorable toxicity profiles.  In this Review, we discuss the physiol. functions and oncogenic activities of Pim kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu23UDfObMZrVg90H21EOLACvtfcHk0lilBv_Ll7yZWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCjsrjE&md5=fe08e70454ca8c4d808715db87d195e1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrc2986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2986%26sid%3Dliteratum%253Aachs%26aulast%3DNawijn%26aufirst%3DM.%2BC.%26aulast%3DAlendar%26aufirst%3DA.%26aulast%3DBerns%26aufirst%3DA.%26atitle%3DFor%2520better%2520or%2520for%2520worse%253A%2520the%2520role%2520of%2520PIM%2520oncogenes%2520in%2520tumorigenesis%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D23%26epage%3D34%26doi%3D10.1038%2Fnrc2986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Garcia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ison, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavorotinskaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, X.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narberes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfister, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drueckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trappe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiguchi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamacina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aycinena, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holash, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, M.</span><span> </span><span class="NLM_article-title">Pan-PIM kinase inhibition provides a novel therapy for treating hematological cancers</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1834</span><span class="NLM_x">–</span> <span class="NLM_lpage">1845</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-2062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1158%2F1078-0432.CCR-13-2062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=24474669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1eiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1834-1845&author=P.+Garciaauthor=J.+Langowskiauthor=Y.+Wanauthor=M.+Chenauthor=J.+Castilloauthor=C.+Fantonauthor=M.+Isonauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=J.+Luauthor=X.-H.+Niuauthor=S.+Bashamauthor=J.+Chanauthor=H.+Yuauthor=M.+Doyleauthor=P.+Feuchtauthor=R.+Warneauthor=J.+Narberesauthor=T.+Tsangauthor=C.+Fritschauthor=A.+Kauffmannauthor=E.+Pfisterauthor=P.+Drueckesauthor=J.+Trappeauthor=C.+Wilsonauthor=W.+Hanauthor=J.+Lanauthor=G.+Nishiguchiauthor=C.+Bellamacinaauthor=J.+A.+Aycinenaauthor=R.+Zangauthor=J.+Holashauthor=M.+Burger&title=Pan-PIM+kinase+inhibition+provides+a+novel+therapy+for+treating+hematological+cancers&doi=10.1158%2F1078-0432.CCR-13-2062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers</span></div><div class="casAuthors">Garcia, Pablo D.; Langowski, John L.; Wang, Yingyun; Chen, Min; Castillo, Joseph; Fanton, Christie; Ison, Marjorie; Zavorotinskaya, Tatiana; Dai, Yumin; Lu, Jing; Niu, Xiao-Hong; Basham, Stephen; Chan, Julie; Yu, Jianjun; Doyle, Michael; Feucht, Paul; Warne, Robert; Narberes, Jamie; Tsang, Tiffany; Fritsch, Christine; Kauffmann, Audrey; Pfister, Estelle; Drueckes, Peter; Trappe, Joerg; Wilson, Christopher; Han, Wooseok; Lan, Jiong; Nishiguchi, Gisele; Lindvall, Mika; Bellamacina, Cornelia; Aycinena, J. Alex; Zang, Richard; Holash, Jocelyn; Burger, Matthew T.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1834-1845</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PIM kinases have been shown to act as oncogenes in mice, with each family member being able to drive progression of hematol. cancers.  Consistent with this, we found that PIMs are highly expressed in human hematol. cancers and show that each isoform has a distinct expression pattern among disease subtypes.  This suggests that inhibitors of all three PIMs would be effective in treating multiple hematol. malignancies.  Pan-PIM inhibitors have proven difficult to develop because PIM2 has a low Km for ATP and, thus, requires a very potent inhibitor to effectively block the kinase activity at the ATP levels in cells.  We developed a potent and specific pan-PIM inhibitor, LGB321, which is active on PIM2 in the cellular context.  LGB321 is active on PIM2-dependent multiple myeloma cell lines, where it inhibits proliferation, mTOR-C1 signaling and phosphorylation of BAD.  Broad cancer cell line profiling of LGB321 demonstrates limited activity in cell lines derived from solid tumors.  In contrast, significant activity in cell lines derived from diverse hematol. lineages was obsd., including acute lymphoblastic leukemia (ALL), acute myelogenous leukemia (AML), multiple myeloma and non-Hodgkin lymphoma (NHL).  Furthermore, we demonstrate LGB321 activity in the KG-1 AML xenograft model, in which modulation of pharmacodynamics markers is predictive of efficacy.  Finally, we demonstrate that LGB321 synergizes with cytarabine in this model.  We have developed a potent and selective pan-PIM inhibitor with single-agent antiproliferative activity and show that it synergizes with cytarabine in an AML xenograft model.  Our results strongly support the development of Pan-PIM inhibitors to treat hematol. malignancies.  Clin Cancer Res; 20(7); 1834-45. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriy2nkB_psKbVg90H21EOLACvtfcHk0lilBv_Ll7yZWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1eiu7k%253D&md5=c563df328e7af3ebf10c31b1a26faae4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2062%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%26aufirst%3DP.%26aulast%3DLangowski%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DCastillo%26aufirst%3DJ.%26aulast%3DFanton%26aufirst%3DC.%26aulast%3DIson%26aufirst%3DM.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DNiu%26aufirst%3DX.-H.%26aulast%3DBasham%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DDoyle%26aufirst%3DM.%26aulast%3DFeucht%26aufirst%3DP.%26aulast%3DWarne%26aufirst%3DR.%26aulast%3DNarberes%26aufirst%3DJ.%26aulast%3DTsang%26aufirst%3DT.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DKauffmann%26aufirst%3DA.%26aulast%3DPfister%26aufirst%3DE.%26aulast%3DDrueckes%26aufirst%3DP.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DNishiguchi%26aufirst%3DG.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DAycinena%26aufirst%3DJ.%2BA.%26aulast%3DZang%26aufirst%3DR.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DBurger%26aufirst%3DM.%26atitle%3DPan-PIM%2520kinase%2520inhibition%2520provides%2520a%2520novel%2520therapy%2520for%2520treating%2520hematological%2520cancers%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26spage%3D1834%26epage%3D1845%26doi%3D10.1158%2F1078-0432.CCR-13-2062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Blanco-Aparicio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnero, A.</span><span> </span><span class="NLM_article-title">PIM kinases in cancer: diagnostic, prognostic and treatment opportunities</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span><span class="refDoi"> DOI: 10.1016/j.bcp.2012.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2Fj.bcp.2012.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=23041228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Sht7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=629-643&author=C.+Blanco-Aparicioauthor=A.+Carnero&title=PIM+kinases+in+cancer%3A+diagnostic%2C+prognostic+and+treatment+opportunities&doi=10.1016%2Fj.bcp.2012.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pim kinases in cancer: Diagnostic, prognostic and treatment opportunities</span></div><div class="casAuthors">Blanco-Aparicio, Carmen; Carnero, Amancio</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">629-643</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  PIM proteins belong to a family of ser/thr kinases composed of 3 members, PIM1, PIM2 and PIM3, with greatly overlapping functions.  PIM kinases are mainly responsible for cell cycle regulation, antiapoptotic activity and the homing and migration of receptor tyrosine kinases mediated via the JAK/STAT pathway.  PIM kinases have been found to be upregulated in many hematol. malignancies and solid tumors.  Although these kinases have been described as weak oncogenes, they are heavily targeted for anticancer drug discovery.  The present review summarizes the discoveries made to date regarding PIM kinases as driving oncogenes in the process of tumorigenesis and their validation as drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtbg06YAgnArVg90H21EOLACvtfcHk0lilBv_Ll7yZWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Sht7nK&md5=63957a55b281d4bbc8c4843249d30273</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DBlanco-Aparicio%26aufirst%3DC.%26aulast%3DCarnero%26aufirst%3DA.%26atitle%3DPIM%2520kinases%2520in%2520cancer%253A%2520diagnostic%252C%2520prognostic%2520and%2520treatment%2520opportunities%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D85%26spage%3D629%26epage%3D643%26doi%3D10.1016%2Fj.bcp.2012.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Jackson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pheneger, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pheneger, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, L. L.</span><span> </span><span class="NLM_article-title">The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel disease</span> <span class="citation_source-journal">Cell. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1016/j.cellimm.2011.10.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2Fj.cellimm.2011.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=22078270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Cit7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=2012&pages=200-213&author=L.+J.+Jacksonauthor=J.+A.+Phenegerauthor=T.+J.+Phenegerauthor=G.+Davisauthor=A.+D.+Wrightauthor=J.+E.+Robinsonauthor=S.+Allenauthor=M.+C.+Munsonauthor=L.+L.+Carter&title=The+role+of+PIM+kinases+in+human+and+mouse+CD4%2B+T+cell+activation+and+inflammatory+bowel+disease&doi=10.1016%2Fj.cellimm.2011.10.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel disease</span></div><div class="casAuthors">Jackson, Leila J.; Pheneger, Jed A.; Pheneger, Tracy J.; Davis, Gregg; Wright, A. Dale; Robinson, John E.; Allen, Shelley; Munson, Mark C.; Carter, Laura L.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">200-213</span>CODEN:
                <span class="NLM_cas:coden">CLIMB8</span>;
        ISSN:<span class="NLM_cas:issn">0008-8749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">PIM kinases are a family of three serine/threonine kinases expressed following T cell activation.  Using potent selective small mol. antagonists of PIM-1/3 kinases, we demonstrate a potential role for these enzymes in naive and effector CD4+ T cell activation.  PIM-1/3 inhibition prevented CD4+ T cell proliferation by inducing a G0/G1 cell cycle arrest without affecting cellular survival.  In the absence of PIM-1/3 kinase activity, naive CD4+ T cells failed to fully differentiate into effector cells both in vitro and in vivo.  Therapeutic dosing of a PIM-1/3 inhibitor was efficacious in a CD4+ T cell-mediated model of inflammatory bowel disease suggesting that PIM-1 and PIM-3 kinase activity contributes to sustained disease severity.  These results demonstrate that PIM-1/3 kinases have an important role in CD4+ T cell responses and inhibition of this activity may provide a therapeutic benefit in T cell-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo49-JUG78zSLVg90H21EOLACvtfcHk0lhitsFc_D2byQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Cit7jP&md5=aa030f7e07e27d4289afdeca873b30a8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cellimm.2011.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellimm.2011.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DL.%2BJ.%26aulast%3DPheneger%26aufirst%3DJ.%2BA.%26aulast%3DPheneger%26aufirst%3DT.%2BJ.%26aulast%3DDavis%26aufirst%3DG.%26aulast%3DWright%26aufirst%3DA.%2BD.%26aulast%3DRobinson%26aufirst%3DJ.%2BE.%26aulast%3DAllen%26aufirst%3DS.%26aulast%3DMunson%26aufirst%3DM.%2BC.%26aulast%3DCarter%26aufirst%3DL.%2BL.%26atitle%3DThe%2520role%2520of%2520PIM%2520kinases%2520in%2520human%2520and%2520mouse%2520CD4%252B%2520T%2520cell%2520activation%2520and%2520inflammatory%2520bowel%2520disease%26jtitle%3DCell.%2520Immunol.%26date%3D2012%26volume%3D272%26spage%3D200%26epage%3D213%26doi%3D10.1016%2Fj.cellimm.2011.10.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Morwick, T.</span><span> </span><span class="NLM_article-title">PIM kinase inhibitors: a survey of the patent literature</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span><div class="note"><p class="first last">and references therein.</p></div><span class="refDoi"> DOI: 10.1517/13543770903496442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1517%2F13543770903496442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=20100002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=193-212&issue=2&author=T.+Morwick&title=PIM+kinase+inhibitors%3A+a+survey+of+the+patent+literature&doi=10.1517%2F13543770903496442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pim kinase inhibitors: a survey of the patent literature</span></div><div class="casAuthors">Morwick, Tina</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">193-212</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Pim kinases have recently emerged as targets of interest in oncol. and immune regulation.  Ongoing studies have identified a role for these proteins in cell survival and proliferation, both functionally and mechanistically, and overexpression has been obsd. in a no. of human cancers and inflammatory states.  Areas covered in this review: This report reviews the patent literature for Pim kinase inhibitors identified from a search of the Thomson patent databases from 1970 through July 2009.  Full analyses are provided for publications reporting Pim kinases as primary targets, and a cursory description is given for those disclosing Pim as one of a limited no. of secondary targets.  What the reader will gain: Readers will gain an overview of the various inhibitor series including coverage, potency, selectivity, protein binding features and therapeutic focus, and an appreciation for which scaffolds and structural features have been most highly exploited.  Take home message: A greater understanding of pathol. mechanisms for Pim kinases has stimulated the recent development of a variety of inhibitor classes with one compd. advancing into the clinic earlier this year.  Ongoing studies will help define applications for these inhibitors in the treatment of Pim-assocd. human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3qJ9wz2Tau7Vg90H21EOLACvtfcHk0lhitsFc_D2byQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGktbg%253D&md5=21d9c3c31b2af04e63bef9ac5adaf549</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1517%2F13543770903496442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903496442%26sid%3Dliteratum%253Aachs%26aulast%3DMorwick%26aufirst%3DT.%26atitle%3DPIM%2520kinase%2520inhibitors%253A%2520a%2520survey%2520of%2520the%2520patent%2520literature%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26issue%3D2%26spage%3D193%26epage%3D212%26doi%3D10.1517%2F13543770903496442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Mumenthaler, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodge, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearss, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanekal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taverna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agus, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A.</span><span> </span><span class="NLM_article-title">Pharmacologic inhibition of PIM kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2882</span><span class="NLM_x">–</span> <span class="NLM_lpage">2893</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1158%2F1535-7163.MCT-09-0293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=19825806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Cqur7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2882-2893&author=S.+M.+Mumenthalerauthor=P.+Y.+Ngauthor=A.+Hodgeauthor=D.+Bearssauthor=G.+Berkauthor=S.+Kanekalauthor=S.+Redkarauthor=P.+Tavernaauthor=D.+B.+Agusauthor=A.+Jain&title=Pharmacologic+inhibition+of+PIM+kinases+alters+prostate+cancer+cell+growth+and+resensitizes+chemoresistant+cells+to+taxanes&doi=10.1158%2F1535-7163.MCT-09-0293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes</span></div><div class="casAuthors">Mumenthaler, Shannon M.; Ng, Patricia Y. B.; Hodge, Amanda; Bearss, David; Berk, Gregory; Kanekal, Sarath; Redkar, Sanjeev; Taverna, Pietro; Agus, David B.; Jain, Anjali</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2882-2893</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The serine/threonine family of Pim kinases function as oncogenes and have been implicated in prostate cancer progression, particularly in hormone-refractory prostate disease, as a result of their antiapoptotic function.  In this study, we used a pharmacol. inhibitor targeting the Pim family members, SGI-1776, to det. whether modulation of Pim kinase activity could alter prostate cancer cell survival and modulate chemotherapy resistance.  Extensive biochem. characterization of SGI-1776 confirmed its specificity for the three isoforms of the Pim family.  Treatment of prostate cancer cells with SGI-1776 resulted in a dose-dependent redn. in phosphorylation of known Pim kinase substrates that are involved in cell cycle progression and apoptosis (p21Cip1/WAF1 and Bad).  Consequently, SGI-1776 compromised overall cell viability by inducing G1 cell cycle arrest and triggering apoptosis.  Overexpression of recombinant Pim-1 markedly increased sensitivity of SGI-1776-mediated prostate cancer cell apoptosis and p21Cip1/WAF1 phosphorylation inhibition, reinforcing the specificity of SGI-1776.  An addnl. cytotoxic effect was obsd. when SGI-1776 was combined with taxane-based chemotherapy agents.  SGI-1776 was able to reduce cell viability in a multidrug resistance 1 protein-based taxane-refractory prostate cancer cell line.  In addn., SGI-1776 treatment was able to resensitize chemoresistant cells to taxane-based therapies by inhibiting multidrug resistance 1 activity and inducing apoptosis.  These findings support the idea that inhibiting Pim kinases, in combination with a chemotherapeutic agent, could play an important role in prostate cancer treatment by targeting the clin. problem of chemoresistance. [Mol Cancer Ther 2009;8(10):2882-93].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnGQXKbXm4Y7Vg90H21EOLACvtfcHk0lhitsFc_D2byQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Cqur7E&md5=b6353cdc3b367e336a707147e5c99a4c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0293%26sid%3Dliteratum%253Aachs%26aulast%3DMumenthaler%26aufirst%3DS.%2BM.%26aulast%3DNg%26aufirst%3DP.%2BY.%26aulast%3DHodge%26aufirst%3DA.%26aulast%3DBearss%26aufirst%3DD.%26aulast%3DBerk%26aufirst%3DG.%26aulast%3DKanekal%26aufirst%3DS.%26aulast%3DRedkar%26aufirst%3DS.%26aulast%3DTaverna%26aufirst%3DP.%26aulast%3DAgus%26aufirst%3DD.%2BB.%26aulast%3DJain%26aufirst%3DA.%26atitle%3DPharmacologic%2520inhibition%2520of%2520PIM%2520kinases%2520alters%2520prostate%2520cancer%2520cell%2520growth%2520and%2520resensitizes%2520chemoresistant%2520cells%2520to%2520taxanes%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D2882%26epage%3D2893%26doi%3D10.1158%2F1535-7163.MCT-09-0293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Code, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowling, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hird, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, T.</span><span> </span><span class="NLM_article-title">Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4599</span><span class="NLM_x">–</span> <span class="NLM_lpage">4604</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.05.098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2Fj.bmcl.2012.05.098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=22727640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpt1Shtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4599-4604&author=L.+A.+Dakinauthor=M.+H.+Blockauthor=H.+Chenauthor=E.+Codeauthor=J.+E.+Dowlingauthor=X.+Fengauthor=A.+D.+Fergusonauthor=I.+Greenauthor=A.+W.+Hirdauthor=T.+Howard&title=Discovery+of+novel+benzylidene-1%2C3-thiazolidine-2%2C4-diones+as+potent+and+selective+inhibitors+of+the+PIM-1%2C+PIM-2%2C+and+PIM-3+protein+kinases&doi=10.1016%2Fj.bmcl.2012.05.098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases</span></div><div class="casAuthors">Dakin, Les A.; Block, Michael H.; Chen, Huawei; Code, Erin; Dowling, James E.; Feng, Xiaomei; Ferguson, Andrew D.; Green, Isabelle; Hird, Alexander W.; Howard, Tina; Keeton, Erika K.; Lamb, Michelle L.; Lyne, Paul D.; Pollard, Hannah; Read, Jon; Wu, Allan J.; Zhang, Tao; Zheng, Xiaolan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4599-4604</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel substituted benzylidene-1,3-thiazolidine-2,4-diones (TZDs) have been identified as potent and highly selective inhibitors of the PIM kinases.  The synthesis and SAR of these compds. are described, along with x-ray crystallog. of deriv. I, anti-proliferative, and selectivity data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLer-JRufp_rVg90H21EOLACvtfcHk0liGm7KrMDWE4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpt1Shtb4%253D&md5=cd1570938d48864bb739d2ccc37888f2</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.05.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.05.098%26sid%3Dliteratum%253Aachs%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DCode%26aufirst%3DE.%26aulast%3DDowling%26aufirst%3DJ.%2BE.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26aulast%3DGreen%26aufirst%3DI.%26aulast%3DHird%26aufirst%3DA.%2BW.%26aulast%3DHoward%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520novel%2520benzylidene-1%252C3-thiazolidine-2%252C4-diones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520PIM-1%252C%2520PIM-2%252C%2520and%2520PIM-3%2520protein%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4599%26epage%3D4604%26doi%3D10.1016%2Fj.bmcl.2012.05.098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Tsuhako, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltun, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aay, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arcalas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galan, A.</span><span> </span><span class="NLM_article-title">The design, synthesis, and biological evaluation of PIM kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3732</span><span class="NLM_x">–</span> <span class="NLM_lpage">3738</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.04.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2Fj.bmcl.2012.04.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3732-3738&author=A.+L.+Tsuhakoauthor=D.+S.+Brownauthor=E.+S.+Koltunauthor=N.+Aayauthor=A.+Arcalasauthor=V.+Chanauthor=H.+Duauthor=S.+Engstauthor=M.+Franziniauthor=A.+Galan&title=The+design%2C+synthesis%2C+and+biological+evaluation+of+PIM+kinase+inhibitors&doi=10.1016%2Fj.bmcl.2012.04.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.04.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.04.025%26sid%3Dliteratum%253Aachs%26aulast%3DTsuhako%26aufirst%3DA.%2BL.%26aulast%3DBrown%26aufirst%3DD.%2BS.%26aulast%3DKoltun%26aufirst%3DE.%2BS.%26aulast%3DAay%26aufirst%3DN.%26aulast%3DArcalas%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DV.%26aulast%3DDu%26aufirst%3DH.%26aulast%3DEngst%26aufirst%3DS.%26aulast%3DFranzini%26aufirst%3DM.%26aulast%3DGalan%26aufirst%3DA.%26atitle%3DThe%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520PIM%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3732%26epage%3D3738%26doi%3D10.1016%2Fj.bmcl.2012.04.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Xia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knaak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beharry, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraft, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. D.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of novel inhibitors of PIM-1 and PIM-2 protein kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span><span class="refDoi"> DOI: 10.1021/jm800937p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800937p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=74-86&author=Z.+Xiaauthor=C.+Knaakauthor=J.+Maauthor=Z.+M.+Beharryauthor=C.+McInnesauthor=W.+Wangauthor=A.+S.+Kraftauthor=C.+D.+Smith&title=Synthesis+and+evaluation+of+novel+inhibitors+of+PIM-1+and+PIM-2+protein+kinases&doi=10.1021%2Fjm800937p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm800937p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800937p%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DZ.%26aulast%3DKnaak%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DBeharry%26aufirst%3DZ.%2BM.%26aulast%3DMcInnes%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DKraft%26aufirst%3DA.%2BS.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%2520inhibitors%2520of%2520PIM-1%2520and%2520PIM-2%2520protein%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D74%26epage%3D86%26doi%3D10.1021%2Fjm800937p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Tao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasvold, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamper, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N.</span><span> </span><span class="NLM_article-title">Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6621</span><span class="NLM_x">–</span> <span class="NLM_lpage">6636</span><span class="refDoi"> DOI: 10.1021/jm900943h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900943h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6621-6636&author=Z.+Taoauthor=L.+A.+Hasvoldauthor=J.+D.+Leversonauthor=E.+K.+Hanauthor=R.+Guanauthor=E.+F.+Johnsonauthor=V.+S.+Stollauthor=K.+D.+Stewartauthor=G.+Stamperauthor=N.+Soni&title=Discovery+of+3H-benzo%5B4%2C5%5Dthieno%5B3%2C2-d%5Dpyrimidin-4-ones+as+potent%2C+highly+selective%2C+and+orally+bioavailable+inhibitors+of+the+human+protooncogene+proviral+insertion+site+in+moloney+murine+leukemia+virus+%28PIM%29+kinases&doi=10.1021%2Fjm900943h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm900943h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900943h%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DZ.%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DHan%26aufirst%3DE.%2BK.%26aulast%3DGuan%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DStoll%26aufirst%3DV.%2BS.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DStamper%26aufirst%3DG.%26aulast%3DSoni%26aufirst%3DN.%26atitle%3DDiscovery%2520of%25203H-benzo%255B4%252C5%255Dthieno%255B3%252C2-d%255Dpyrimidin-4-ones%2520as%2520potent%252C%2520highly%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitors%2520of%2520the%2520human%2520protooncogene%2520proviral%2520insertion%2520site%2520in%2520moloney%2520murine%2520leukemia%2520virus%2520%2528PIM%2529%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6621%26epage%3D6636%26doi%3D10.1021%2Fjm900943h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Haddach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaux, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaebe, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raffaele, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drygin, D.</span><span> </span><span class="NLM_article-title">Discovery of CX-6258. a potent, selective, and orally efficacious pan-PIM kinase inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span><span class="refDoi"> DOI: 10.1021/ml200259q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200259q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=135-139&author=M.+Haddachauthor=J.+Michauxauthor=M.+K.+Schwaebeauthor=F.+Pierreauthor=S.+E.+O%E2%80%99Brienauthor=C.+Borsanauthor=J.+Tranauthor=N.+Raffaeleauthor=S.+Ravulaauthor=D.+Drygin&title=Discovery+of+CX-6258.+a+potent%2C+selective%2C+and+orally+efficacious+pan-PIM+kinase+inhibitor&doi=10.1021%2Fml200259q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml200259q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200259q%26sid%3Dliteratum%253Aachs%26aulast%3DHaddach%26aufirst%3DM.%26aulast%3DMichaux%26aufirst%3DJ.%26aulast%3DSchwaebe%26aufirst%3DM.%2BK.%26aulast%3DPierre%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BE.%26aulast%3DBorsan%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DJ.%26aulast%3DRaffaele%26aufirst%3DN.%26aulast%3DRavula%26aufirst%3DS.%26aulast%3DDrygin%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520CX-6258.%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520efficacious%2520pan-PIM%2520kinase%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D135%26epage%3D139%26doi%3D10.1021%2Fml200259q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Nishiguchi, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atallah, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamacina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klivansky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindvall, M.</span><span> </span><span class="NLM_article-title">Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6366</span><span class="NLM_x">–</span> <span class="NLM_lpage">6369</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.08.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2Fj.bmcl.2011.08.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=21945284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6366-6369&author=G.+A.+Nishiguchiauthor=G.+Atallahauthor=C.+Bellamacinaauthor=M.+T.+Burgerauthor=Y.+Dingauthor=P.+H.+Feuchtauthor=P.+D.+Garciaauthor=W.+Hanauthor=L.+Klivanskyauthor=M.+Lindvall&title=Discovery+of+novel+3%2C5-disubstituted+indole+derivatives+as+potent+inhibitors+of+Pim-1%2C+Pim-2%2C+and+Pim-3+protein+kinases&doi=10.1016%2Fj.bmcl.2011.08.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases</span></div><div class="casAuthors">Nishiguchi, Gisele A.; Atallah, Gordana; Bellamacina, Cornelia; Burger, Matthew T.; Ding, Yu; Feucht, Paul H.; Garcia, Pablo D.; Han, Woo-Seok; Klivansky, Liana; Lindvall, Mika</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6366-6369</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel 3,5-disubstituted indole e. g., I and pyrazolopyridine e. g., II derivs. as potent and selective inhibitors of all three members of the Pim kinase family is described.  High throughput screen identified a pan-Pim kinase inhibitor with a promiscuous scaffold.  Guided by structure-based drug design, SAR of the series afforded a highly selective indole chemotype that was further developed into a potent set of compds. against Pim-1, 2, and 3 (Pim-1 and Pim-3: IC50 ≤ 2 nM and Pim-2: IC50 ≤ 100 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraW5ZPCZ1p-7Vg90H21EOLACvtfcHk0ljyFJsL-zGlqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FK&md5=9b8f859027daa006c85b6bbf7696ef18</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.105%26sid%3Dliteratum%253Aachs%26aulast%3DNishiguchi%26aufirst%3DG.%2BA.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DFeucht%26aufirst%3DP.%2BH.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DKlivansky%26aufirst%3DL.%26aulast%3DLindvall%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520novel%25203%252C5-disubstituted%2520indole%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520Pim-1%252C%2520Pim-2%252C%2520and%2520Pim-3%2520protein%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6366%26epage%3D6369%26doi%3D10.1016%2Fj.bmcl.2011.08.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallwever, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harstad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eben, A. J.</span><span> </span><span class="NLM_article-title">Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-PIM inhibitors by structure- and property-based drug design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3149</span><span class="NLM_x">–</span> <span class="NLM_lpage">3153</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2Fj.bmcl.2013.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=23623490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1Oisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3149-3153&author=X.+Wangauthor=S.+Magnusonauthor=R.+Pastorauthor=E.+Fanauthor=H.+Huauthor=V.+Tsuiauthor=W.+Dengauthor=J.+Murrayauthor=M.+Steffekauthor=H.+Wallweverauthor=J.+Moffatauthor=J.+Drummondauthor=G.+Chanauthor=E.+Harstadauthor=A.+J.+Eben&title=Discovery+of+novel+pyrazolo%5B1%2C5-a%5Dpyrimidines+as+potent+pan-PIM+inhibitors+by+structure-+and+property-based+drug+design&doi=10.1016%2Fj.bmcl.2013.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design</span></div><div class="casAuthors">Wang, Xiaojing; Magnuson, Steven; Pastor, Rich; Fan, Eric; Hu, Huiyong; Tsui, Vickie; Deng, Wei; Murray, Jeremy; Steffek, Micah; Wallweber, Heidi; Moffat, John; Drummond, Jason; Chan, Grace; Harstad, Eric; Ebens, Allen J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3149-3153</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pim kinases are promising targets for the development of cancer therapeutics.  Among the three Pim isoforms, Pim-2 is particularly important in multiple myeloma, yet is the most difficult to inhibit due to its high affinity for ATP.  We identified compd. 1 via high throughput screening.  Using property-based drug design and co-crystal structures with Pim-1 kinase to guide analog design, we were able to improve potency against all three Pim isoforms including a significant 10,000-fold gain against Pim-2.  Compd. 17 is a novel lead with low picomolar potency on all three Pim kinase isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonWvohEjJoarVg90H21EOLACvtfcHk0ljyFJsL-zGlqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1Oisbg%253D&md5=9129c2f2897d536317c3243220b37251</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DPastor%26aufirst%3DR.%26aulast%3DFan%26aufirst%3DE.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DDeng%26aufirst%3DW.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DWallwever%26aufirst%3DH.%26aulast%3DMoffat%26aufirst%3DJ.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DEben%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520of%2520novel%2520pyrazolo%255B1%252C5-a%255Dpyrimidines%2520as%2520potent%2520pan-PIM%2520inhibitors%2520by%2520structure-%2520and%2520property-based%2520drug%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3149%26epage%3D3153%26doi%3D10.1016%2Fj.bmcl.2013.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Qian, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barringer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kronkaitis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mische, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmer, B.</span><span> </span><span class="NLM_article-title">Structural basis of constitutive activity and a unique nucleotide binding mode of human Pim-1 kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">6130</span><span class="NLM_x">–</span> <span class="NLM_lpage">6137</span><span class="refDoi"> DOI: 10.1074/jbc.M409123200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1074%2Fjbc.M409123200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=6130-6137&author=K.+C.+Qianauthor=L.+Wangauthor=E.+R.+Hickeyauthor=J.+Studtsauthor=K.+Barringerauthor=C.+Pengauthor=A.+Kronkaitisauthor=J.+Liauthor=A.+Whiteauthor=S.+Mischeauthor=B.+Farmer&title=Structural+basis+of+constitutive+activity+and+a+unique+nucleotide+binding+mode+of+human+Pim-1+kinase&doi=10.1074%2Fjbc.M409123200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M409123200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M409123200%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DK.%2BC.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DStudts%26aufirst%3DJ.%26aulast%3DBarringer%26aufirst%3DK.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DKronkaitis%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DMische%26aufirst%3DS.%26aulast%3DFarmer%26aufirst%3DB.%26atitle%3DStructural%2520basis%2520of%2520constitutive%2520activity%2520and%2520a%2520unique%2520nucleotide%2520binding%2520mode%2520of%2520human%2520Pim-1%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D6130%26epage%3D6137%26doi%3D10.1074%2Fjbc.M409123200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Burger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiguchi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamacina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindvall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atallah, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beans, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavorotinskaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holash, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, P.</span><span> </span><span class="NLM_article-title">Structure guided optimization, in vitro activity and in vivo activity of pan-PIM kinase inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1197</span><span class="refDoi"> DOI: 10.1021/ml400307j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400307j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1193-1197&author=M.+Burgerauthor=W.+Hanauthor=J.+Lanauthor=G.+Nishiguchiauthor=C.+Bellamacinaauthor=M.+Lindvallauthor=G.+Atallahauthor=Y.+Dingauthor=M.+Mathurauthor=C.+McBrideauthor=E.+L.+Beansauthor=K.+Mullerauthor=V.+Tamezauthor=Y.+Zhangauthor=K.+Huhauthor=P.+Feuchtauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=J.+Holashauthor=J.+Castilloauthor=J.+Langowskiauthor=Y.+Wangauthor=M.+Y.+Chenauthor=P.+Garcia&title=Structure+guided+optimization%2C+in+vitro+activity+and+in+vivo+activity+of+pan-PIM+kinase+inhibitors&doi=10.1021%2Fml400307j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fml400307j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400307j%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DNishiguchi%26aufirst%3DG.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DLindvall%26aufirst%3DM.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DMathur%26aufirst%3DM.%26aulast%3DMcBride%26aufirst%3DC.%26aulast%3DBeans%26aufirst%3DE.%2BL.%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DTamez%26aufirst%3DV.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHuh%26aufirst%3DK.%26aulast%3DFeucht%26aufirst%3DP.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DCastillo%26aufirst%3DJ.%26aulast%3DLangowski%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%2BY.%26aulast%3DGarcia%26aufirst%3DP.%26atitle%3DStructure%2520guided%2520optimization%252C%2520in%2520vitro%2520activity%2520and%2520in%2520vivo%2520activity%2520of%2520pan-PIM%2520kinase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1193%26epage%3D1197%26doi%3D10.1021%2Fml400307j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavorotinskaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langowski, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holash, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, P. D.</span><span> </span><span class="NLM_article-title">Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1610</span><span class="NLM_x">–</span> <span class="NLM_lpage">1620</span><span class="refDoi"> DOI: 10.1182/blood-2013-01-481457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1182%2Fblood-2013-01-481457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=23818547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSqu7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=1610-1620&author=J.+Luauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=X.+Niuauthor=J.+Castilloauthor=J.+Simauthor=J.+Yuauthor=Y.+Wangauthor=J.+L.+Langowskiauthor=J.+Holashauthor=K.+Shannonauthor=P.+D.+Garcia&title=Pim2+is+required+for+maintaining+multiple+myeloma+cell+growth+through+modulating+TSC2+phosphorylation&doi=10.1182%2Fblood-2013-01-481457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation</span></div><div class="casAuthors">Lu, Jing; Zavorotinskaya, Tatiana; Dai, Yumin; Niu, Xiao-Hong; Castillo, Joseph; Sim, Janet; Yu, Jianjun; Wang, Yingyun; Langowski, John L.; Holash, Jocelyn; Shannon, Kevin; Garcia, Pablo D.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1610-1620</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Multiple myeloma (MM) is the second most common hematol. malignancy.  Despite recent treatment advances, it remains incurable.  Here, we report that Pim2 kinase expression is highly elevated in MM cells and demonstrate that it is required for MM cell proliferation.  Functional interference of Pim2 activity either by short hairpin RNAs or by a potent and selective small-mol. inhibitor leads to significant inhibition of MM cell proliferation.  Pim inhibition results in a significant decrease of mammalian target of rapamycin C1 (mTOR-C1) activity, which is crit. for cell proliferation.  We identify TSC2, a neg. regulator of mTOR-C1, as a novel Pim2 substrate and show that Pim2 directly phosphorylates TSC2 on Ser-1798 and relieves the suppression of TSC2 on mTOR-C1.  These findings support Pim2 as a promising therapeutic target for MM and define a novel Pim2-TSC2-mTOR-C1 pathway that drives MM proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPXlAZPVNnObVg90H21EOLACvtfcHk0lj7FTIo4-ZiGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSqu7jJ&md5=027403b9b40e4fc57836c398545e71e1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1182%2Fblood-2013-01-481457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2013-01-481457%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DNiu%26aufirst%3DX.%26aulast%3DCastillo%26aufirst%3DJ.%26aulast%3DSim%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLangowski%26aufirst%3DJ.%2BL.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DShannon%26aufirst%3DK.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26atitle%3DPim2%2520is%2520required%2520for%2520maintaining%2520multiple%2520myeloma%2520cell%2520growth%2520through%2520modulating%2520TSC2%2520phosphorylation%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26spage%3D1610%26epage%3D1620%26doi%3D10.1182%2Fblood-2013-01-481457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Cabral, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, M.</span><span> </span><span class="NLM_article-title">Lithium borohydride: a reagent of choice for the selective reductive amination of cyclohexanones</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7134</span><span class="NLM_x">–</span> <span class="NLM_lpage">7136</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2007.07.217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2Fj.tetlet.2007.07.217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSksL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=7134-7136&author=S.+Cabralauthor=B.+Hulinauthor=M.+Kawai&title=Lithium+borohydride%3A+a+reagent+of+choice+for+the+selective+reductive+amination+of+cyclohexanones&doi=10.1016%2Fj.tetlet.2007.07.217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Lithium borohydride: a reagent of choice for the selective reductive amination of cyclohexanones</span></div><div class="casAuthors">Cabral, Shawn; Hulin, Bernard; Kawai, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">7134-7136</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Traditional reductive amination of substituted cyclohexanones are either selective toward the formation of cis-products or show low selectivity.  Herein we report a selective procedure for the reductive amination of substituted cyclohexanones with primary amines using lithium borohydride that is selective toward formation of trans-products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Oc579JMPM7Vg90H21EOLACvtfcHk0lj7FTIo4-ZiGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSksL3N&md5=88ff705f51b0e7ad8fb8b938adfb8e22</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2007.07.217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2007.07.217%26sid%3Dliteratum%253Aachs%26aulast%3DCabral%26aufirst%3DS.%26aulast%3DHulin%26aufirst%3DB.%26aulast%3DKawai%26aufirst%3DM.%26atitle%3DLithium%2520borohydride%253A%2520a%2520reagent%2520of%2520choice%2520for%2520the%2520selective%2520reductive%2520amination%2520of%2520cyclohexanones%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D7134%26epage%3D7136%26doi%3D10.1016%2Fj.tetlet.2007.07.217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Keeton, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillman, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palakurthi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grondine, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platanias, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyne, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, D.</span><span> </span><span class="NLM_article-title">AZD1208, a potent and selective pan-PIM kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span><span class="refDoi"> DOI: 10.1182/blood-2013-04-495366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1182%2Fblood-2013-04-495366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=24363397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFaqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2014&pages=905-913&author=E.+K.+Keetonauthor=K.+McEachernauthor=K.+S.+Dillmanauthor=S.+Palakurthiauthor=Y.+Caoauthor=M.+R.+Grondineauthor=S.+Kaurauthor=S.+Wangauthor=Y.+Chenauthor=A.+Wuauthor=M.+Shenauthor=F.+D.+Gibbonsauthor=M.+L.+Lambauthor=X.+Zhengauthor=R.+M.+Stoneauthor=D.+J.+DeAngeloauthor=L.+C.+Plataniasauthor=L.+A.+Dakinauthor=H.+Chenauthor=P.+D.+Lyneauthor=D.+Huszar&title=AZD1208%2C+a+potent+and+selective+pan-PIM+kinase+inhibitor%2C+demonstrates+efficacy+in+preclinical+models+of+acute+myeloid+leukemia&doi=10.1182%2Fblood-2013-04-495366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia</span></div><div class="casAuthors">Keeton, Erika K.; McEachern, Kristen; Dillman, Keith S.; Palakurthi, Sangeetha; Cao, Yichen; Grondine, Michael R.; Kaur, Surinder; Wang, Suping; Chen, Yuching; Wu, Allan; Shen, Minhui; Gibbson, Francis D.; Lamb, Michelle L.; Zheng, Xiaolan; Stone, Richard M.; DeAngelo, Daniel J.; Platanias, Leonidas C.; Dakin, Les A.; Chen, Huawei; Lyne, Paul D.; Huszar, Dennis</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">905-913</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Upregulation of Pim kinases is obsd. in several types of leukemias and lymphomas.  Pim-1, -2, and -3 promote cell proliferation and survival downstream of cytokine and growth factor signaling pathways.  AZD1208 is a potent, highly selective, and orally available Pim kinase inhibitor that effectively inhibits all three isoforms at <5 nM or <150 nM in enzyme and cell assays, resp.  AZD1208 inhibited the growth of 5 of 14 acute myeloid leukemia (AML) cell lines tested, and sensitivity correlates with Pim-1 expression and STAT5 activation.  AZD1208 causes cell cycle arrest and apoptosis in MOLM-16 cells, accompanied by a dose-dependent redn. in phosphorylation of Bcl-2 antagonist of cell death, 4EBP1, p70S6K, and S6, as well as increases in cleaved caspase 3 and p27.  Inhibition of p4EBP1 and p-p70S6K and suppression of translation are the most representative effects of Pim inhibition in sensitive AML cell lines.  AZD1208 inhibits the growth of MOLM-16 and KG-1a xenograft tumors in vivo with a clear pharmacodynamic-pharmacokinetic relationship.  AZD1208 also potently inhibits colony growth and Pim signaling substrates in primary AML cells from bone marrow that are Flt3 wild-type or Flt3 internal tandem duplication mutant.  These results underscore the therapeutic potential of Pim kinase inhibition for the treatment of AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNGYuN7tp7NrVg90H21EOLACvtfcHk0lj7FTIo4-ZiGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFaqs7o%253D&md5=4277790b53c9064787cbd68c159e552b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1182%2Fblood-2013-04-495366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2013-04-495366%26sid%3Dliteratum%253Aachs%26aulast%3DKeeton%26aufirst%3DE.%2BK.%26aulast%3DMcEachern%26aufirst%3DK.%26aulast%3DDillman%26aufirst%3DK.%2BS.%26aulast%3DPalakurthi%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DGrondine%26aufirst%3DM.%2BR.%26aulast%3DKaur%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DA.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DGibbons%26aufirst%3DF.%2BD.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DPlatanias%26aufirst%3DL.%2BC.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DHuszar%26aufirst%3DD.%26atitle%3DAZD1208%252C%2520a%2520potent%2520and%2520selective%2520pan-PIM%2520kinase%2520inhibitor%252C%2520demonstrates%2520efficacy%2520in%2520preclinical%2520models%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DBlood%26date%3D2014%26volume%3D123%26spage%3D905%26epage%3D913%26doi%3D10.1182%2Fblood-2013-04-495366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">Structure of compound <b>8</b> in PIM1 submitted under PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DWR">5DWR</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Garcia, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langowski, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holash, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavorotinskaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Growney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanasse, K. G.</span><span> </span><span class="NLM_article-title">The Pan-PIM kinase inhibitor LGH447 shows activity in PIM2-dependent multiple myeloma and in AML models</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1666</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=1666&author=P.+D.+Garciaauthor=J.+L.+Langowskiauthor=J.+Holashauthor=M.+Burgerauthor=R.+Zangauthor=T.+Zavorotinskayaauthor=C.+Fantonauthor=A.+Saciauthor=J.+Growneyauthor=K.+G.+Vanasse&title=The+Pan-PIM+kinase+inhibitor+LGH447+shows+activity+in+PIM2-dependent+multiple+myeloma+and+in+AML+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26aulast%3DLangowski%26aufirst%3DJ.%2BL.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DBurger%26aufirst%3DM.%26aulast%3DZang%26aufirst%3DR.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DFanton%26aufirst%3DC.%26aulast%3DSaci%26aufirst%3DA.%26aulast%3DGrowney%26aufirst%3DJ.%26aulast%3DVanasse%26aufirst%3DK.%2BG.%26atitle%3DThe%2520Pan-PIM%2520kinase%2520inhibitor%2520LGH447%2520shows%2520activity%2520in%2520PIM2-dependent%2520multiple%2520myeloma%2520and%2520in%2520AML%2520models%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26spage%3D1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Raab, M. S.; Ocio, E. M.; Thomas, S. K.; Gunther, A.; Lebovic, D.; Jakubowiak, A. J.; Song, D.; Xiang, F.; Patel, A.; Vanasse, K. G.; Kumar, S. K.</span><span> </span><span class="NLM_article-title">Phase 1 study update of the novel pan-PIM kinase inhibitor LGH447 in patients with relapsed/refractory multiple myeloma</span>.  <span class="citation_source-journal">Am. Soc. Hemat. Annual Meet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span>Abstract 301.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+S.+Raab&author=E.+M.+Ocio&author=S.+K.+Thomas&author=A.+Gunther&author=D.+Lebovic&author=A.+J.+Jakubowiak&author=D.+Song&author=F.+Xiang&author=A.+Patel&author=K.+G.+Vanasse&author=S.+K.+Kumar&title=Phase+1+study+update+of+the+novel+pan-PIM+kinase+inhibitor+LGH447+in+patients+with+relapsed%2Frefractory+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaab%26aufirst%3DM.%2BS.%26atitle%3DPhase%25201%2520study%2520update%2520of%2520the%2520novel%2520pan-PIM%2520kinase%2520inhibitor%2520LGH447%2520in%2520patients%2520with%2520relapsed%252Frefractory%2520multiple%2520myeloma%26jtitle%3DAm.%2520Soc.%2520Hemat.%2520Annual%2520Meet.%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a> and PIM447, LGH447.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.clinicaltrials.gov+and+PIM447%2C+LGH447."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Manley, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drueckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fendrich, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebetanz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martiny-Baron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trappe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wartmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span> </span><span class="NLM_article-title">Extended kinase profile and properties of the protein kinase inhibitor nilotinib</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1804</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1016/j.bbapap.2009.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=10.1016%2Fj.bbapap.2009.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=19922818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1ynu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=445-53&author=P.+W.+Manleyauthor=P.+Drueckesauthor=G.+Fendrichauthor=P.+Furetauthor=J.+Liebetanzauthor=G.+Martiny-Baronauthor=J.+Mestanauthor=J.+Trappeauthor=M.+Wartmannauthor=D.+Fabbro&title=Extended+kinase+profile+and+properties+of+the+protein+kinase+inhibitor+nilotinib&doi=10.1016%2Fj.bbapap.2009.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Extended kinase profile and properties of the protein kinase inhibitor nilotinib</span></div><div class="casAuthors">Manley, Paul W.; Drueckes, Peter; Fendrich, Gabriele; Furet, Pascal; Liebetanz, Janis; Martiny-Baron, Georg; Mestan, Jurgen; Trappe, Jorg; Wartmann, Markus; Fabbro, Doriano</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1804</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">445-453</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">As a drug used to treat imatinib-resistant and -intolerant, chronic and advanced phase chronic myelogenous leukemia, nilotinib is well characterised as a potent inhibitor of the Abl tyrosine kinase activity of wild-type and imatinib-resistant mutant forms of BCR-Abl.  Here we review the profile of nilotinib as a protein kinase inhibitor.  Although an ATP-competitive inhibitor of Abl, nilotinib binds to a catalytically inactive conformation (DFG-out) of the activation loop.  As a consequence of this, nilotinib exhibits time-dependent inhibition of Abl kinase in enzymic assays, which can be extrapolated to other targets to explain differences between biochem. activity and cellular assays.  Although these differences confound assessment of kinase selectivity, as assessed using a combination of protein binding and transphosphorylation assays, together with cellular autophosporylation and proliferation assays, well established kinase targets of nilotinib in rank order of inhibitory potency are DDR-1 > DDR-2 > BCR-Abl (Abl) > PDGFRα/β > KIT > CSF-1R.  In addn. nilotinib has now been found to bind to both MAPK11 (p38β) and MAPK12 (p38α), as well as with very high affinity to ZAK kinase.  Although neither enzymic nor cellular data are yet available to substantiate the drug as an inhibitor of ZAK phosphorylation, modeling predicts that it binds in an ATP-competitive fashion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriO_qGAGTzcrVg90H21EOLACvtfcHk0lhamfDAUKOAwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1ynu78%253D&md5=a51029ebcfaf07f2e405208936cac28f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2009.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2009.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DDrueckes%26aufirst%3DP.%26aulast%3DFendrich%26aufirst%3DG.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DLiebetanz%26aufirst%3DJ.%26aulast%3DMartiny-Baron%26aufirst%3DG.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DWartmann%26aufirst%3DM.%26aulast%3DFabbro%26aufirst%3DD.%26atitle%3DExtended%2520kinase%2520profile%2520and%2520properties%2520of%2520the%2520protein%2520kinase%2520inhibitor%2520nilotinib%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2010%26volume%3D1804%26spage%3D445%26epage%3D53%26doi%3D10.1016%2Fj.bbapap.2009.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N70" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N70','PDB','4N70'); return false;">PDB: 4N70</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DWR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DWR','PDB','5DWR'); return false;">PDB: 5DWR</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i43"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01275">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_50024"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01275">10.1021/acs.jmedchem.5b01275</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Data for the 442 kinase KINOMEscan (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01275/suppl_file/jm5b01275_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01275/suppl_file/jm5b01275_si_001.pdf">jm5b01275_si_001.pdf (155.19 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors have been deposited in the PDB with accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5DWR">5DWR</a> for the PIM1:<b>8</b> complex.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01275&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-21%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01275%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01275" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c60e4f1c3ca0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
